Jncy的个人主页 - 老虎社区

Jncy

暂无个人介绍

IP属地：未知

49关注

5粉丝

0主题

0勋章

2021-11-19

Pls like

54 Biggest Movers From Yesterday

2021-11-14

Pls like

抱歉，原内容已删除

2021-11-07

Pls like

抱歉，原内容已删除

2021-11-06

Pls like

Wall St books records, weekly gains on strong jobs report, Pfizer COVID-19 pill cheer

2021-11-03

Pls like

BMW offsets low deliveries with increased prices for higher Q3 profits

2021-10-30

Pls like

Wall Street shakes off Amazon, Apple weakness to end modestly higher

2021-10-28

Pls like

Rafael Holdings stock plummets after cancer-treatment trial missed primary endpoint

2021-10-24

Pls like

US IPO Week Ahead: Semiconductors, energy storage, designer apparel, and more in a 12 IPO week

2021-10-22

Pls like

Novavax Faces 1 Major Risk Right Now. Should You Buy the Stock Anyway?

2021-10-14

Pls like

Citigroup quarterly results beat expectations

2021-10-03

Pls like

Italy's Leonardo says Boeing to update 787 production plan this month

2021-10-03

Pls like

Why Coinbase Global Stock Was Down 12.2% in September

2021-10-01

Pls like

Here's the Newest Plant-Based Stock to Join the 'Eat More Plants' Boom

2021-09-25

Pls like

抱歉，原内容已删除

2021-09-18

Pls like

Wall Street closes rollercoaster week sharply lower

2021-09-17

Pls like

ADVISORY-China markets closed for Mid-Autumn Festival

2021-09-13

Pls like

抱歉，原内容已删除

2021-09-12

Pls like

US IPO Week Ahead: The Fall IPO market kicks off with a 10 IPO week

2021-09-11

Pls like

Wall Street ends down, Apple sinks on app store ruling

2021-09-04

Please like

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3584074223056401","uuid":"3584074223056401","gmtCreate":1620980400756,"gmtModify":1620980400756,"name":"Jncy","pinyin":"jncy","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":49,"tweetSize":20,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":876227153,"gmtCreate":1637322809726,"gmtModify":1637322951688,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584074223056401","idStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/876227153","repostId":"1153021579","repostType":4,"repost":{"id":"1153021579","kind":"news","pubTimestamp":1637322554,"share":"https://ttm.financial/m/news/1153021579?lang=&edition=full","pubTime":"2021-11-19 19:49","market":"us","language":"en","title":"54 Biggest Movers From Yesterday","url":"https://stock-news.laohu8.com/highlight/detail?id=1153021579","media":"Benzinga","summary":"Gainers\n\nLongeveron Inc. shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FD","content":"<p><b>Gainers</b></p>\n<ul>\n <li><b>Longeveron Inc.</b>&nbsp;shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the treatment of hypoplastic left heart syndrome.</li>\n <li><b>Dicerna Pharmaceuticals, Inc.</b>&nbsp;shares climbed 78.7% to close at $38.03.<b>Novo Nordisk A/S</b>NVO-0.02%agreed to acquire Dicerna Pharmaceuticals for $38.25 per share in cash, representing a total equity value of $3.3 billion and a premium of 80% to Dicerna's closing price on November 17, 2021.</li>\n <li><b>Sweetgreen, Inc.</b>&nbsp;gained 76.8% to close at $49.50 after the company priced its IPO at $28 per share.</li>\n <li><b>Virtuoso Acquisition Corp.</b>&nbsp;jumped 44% to settle at $14.51. Virtuoso Acquisition’s stockholders recently approved proposed merger with Wejo.</li>\n <li><b>Jowell Global Ltd.</b>&nbsp;climbed 25.8% to close at $14.75 after the company announced a collaboration with Unilever's Uni-Excubator.</li>\n <li><b>Macy's, Inc.</b>&nbsp;gained 21.2% to close at $37.37 after the company reported strong Q3 results and also raised FY21 guidance.</li>\n <li><b>BJ's Wholesale Club Holdings, Inc.</b>&nbsp;gained 19.9% to settle at $71.93 after the company reported better-than-expected Q3 EPS and sales results and announced a $500 million buyback.</li>\n <li><b>Cardiff Oncology, Inc.</b>&nbsp;rose 18.7% to close at $6.21. Pfizer made a $15 million equity investment in Cardiff Oncology as part of the Pfizer Breakthrough Growth Initiative.</li>\n <li><b>Arcus Biosciences, Inc.</b>&nbsp;climbed 18% to close at $43.54 after the company announced Gilead has exercised its options to three programs in Arcus's clinical-stage portfolio. The companies also added a research collaboration.</li>\n <li><b>Enthusiast Gaming Holdings Inc.</b>&nbsp;rose 17.6% to close at $4.35 after the company reported US Unique Visitors reached 47.8 million in October.</li>\n <li><b>Smith-Midland Corporation</b>&nbsp;gained 16.4% to settle at $32.27. Smith-Midland recently posted Q3 EPS of $0.71.</li>\n <li><b>Dogness (International) Corporation</b>&nbsp;surged 15.1% to close at $4.50.</li>\n <li><b>Vera Therapeutics, Inc.</b>&nbsp;gained 14.9% to settle at $28.43. Vera Therapeutics recently posted a Q3 loss of $0.36 per share.</li>\n <li><b>Victoria's Secret &amp; Co.</b>&nbsp;rose 14.7% to close at $57.91 after the company reported better-than-expected Q3 earnings.</li>\n <li><b>OMNIQ Corp.</b>&nbsp;jumped 12.7% to settle at $9.47. OMNIQ recently posted a Q3 loss of $0.73 per share.</li>\n <li><b>Volcon, Inc.</b>&nbsp;rose 12.4% to close at $16.48.</li>\n <li><b>Universal Technical Institute, Inc.</b>&nbsp;gained 12.3% to close at $7.75 following Q4 results.</li>\n <li><b>Arco Platform Limited</b>&nbsp;climbed 11.5% to close at $19.28. Arco Platform reported $150 million investments from Dragoneer and General Atlantic Partners.</li>\n <li><b>Yatsen Holding Limited</b>&nbsp;surged 10.7% to close at $2.99 after the company reported better-than-expected Q3 EPS results and announced a $100 million buyback.</li>\n <li><b>Kohl's Corporation</b>&nbsp;jumped 10.6% to close at $62.48 after the company reported better-than-expected Q3 EPS and sales results and raised FY21 EPS guidance.</li>\n <li><b>ReTo Eco-Solutions, Inc.</b>&nbsp;gained 10.1% to close at $3.05.</li>\n <li><b>180 Life Sciences Corp.</b>&nbsp;gained 9.9% to close at $4.01.</li>\n <li><b>ZTO Express (Cayman) Inc.</b>&nbsp;shares rose 9.6% to close at $31.58 following Q3 earnings.</li>\n <li><b>Express, Inc.</b>&nbsp;gained 9.6% to settle at $4.55. Express is expected to report its third quarter 2021 financial results on Thursday, December 2, 2021.</li>\n <li><b>BM Technologies, Inc.</b>&nbsp;rose 9.4% to close at $14.12 after gaining 5% on Wednesday.</li>\n <li><b>NVIDIA Corporation</b>&nbsp;climbed 8.3% to settle at $316.75 after the company reported better-than-expected results for its third quarter, driven by record revenues in Gaming, Data Center and Professional Visualization segments. The company also issued a strong forecast for the fourth quarter.</li>\n</ul>\n<p><b>Losers</b></p>\n<ul>\n <li><b>Amtech Systems, Inc.</b>&nbsp;fell 26.6% to close at $11.20 after the company reported downbeat Q4 results and issued weak Q1 sales forecast.</li>\n <li><b>Zhangmen Education Inc.</b>&nbsp;shares dipped 25.4% to close at $1.56 on Thursday after jumping more than 38% on Wednesday.</li>\n <li><b>Sono Group N.V.</b>&nbsp;fell 23.3% to settle at $29.29.</li>\n <li><b>Gracell Biotechnologies Inc.</b>&nbsp;declined 22.1% to close at $8.98. Gracell Biotechnologies recently reported Q3 sales of $57.00 thousand.</li>\n <li><b>Femasys Inc.</b>&nbsp;fell 20.5% to close at $5.11.</li>\n <li><b>Lottery.com Inc.</b>&nbsp;dropped 19.9% to settle at $8.65. Lottery.com’s S-1 showed registration for primary offering of 30.125 million shares and secondary offering of 25.395 million shares via selling shareholders.</li>\n <li><b>Williams Industrial Services Group Inc.</b>&nbsp;dropped 19.6% to close at $3.70 after the company posted weak Q3 results and lowered FY21 revenue guidance.</li>\n <li><b>Altamira Therapeutics Ltd.</b>&nbsp;dipped 19.6% to settle at $1.68.</li>\n <li><b>Odonate Therapeutics, Inc.</b>&nbsp;dipped 18.5% to settle at $1.90.</li>\n <li><b>Vipshop Holdings Limited</b>&nbsp;dropped 18% to close at $10.03 after the company reported Q3 earnings results and issued guidance.</li>\n <li><b>SeqLL Inc.</b>&nbsp;dropped 17.5% to close at $3.07.</li>\n <li><b>Bilibili Inc.</b>&nbsp;fell 17.2% to close at $67.12 after the company announced a proposed offering of $1,400 million convertible senior notes. The company could also be trading lower following their Q3 earnings results yesterday.</li>\n <li><b>17 Education &amp; Technology Group Inc.</b>&nbsp;dipped 16.4% to settle at $2.35.</li>\n <li><b>Aehr Test Systems</b>&nbsp;dropped 15.7% to close at $19.61.</li>\n <li><b>Rivian Automotive, Inc.</b>&nbsp;fell 15.5% to settle at $123.38 as the stock continued to pull back following its post-IPO surge. CNBC's Jim Cramer discussed momentum in the stock and noted investors may want to consider partial profit taking.</li>\n <li><b>Certara, Inc.</b>&nbsp;fell 14.7% to close at $30.73 after the company priced its underwritten public offering of 10 million shares by certain existing stockholders at $31.00 per share.</li>\n <li><b>Gambling.com Group Limited</b>&nbsp;fell 13.9% to close at $13.00 after the company reported worse-than-expected Q3 sales results.</li>\n <li><b>Petco Health and Wellness Company, Inc.</b>&nbsp;dipped 13.2% to close at $21.45 after the company reported Q3 earnings results and issued updated guidance.</li>\n <li><b>Maxeon Solar Technologies, Ltd.</b>&nbsp;shares declined 12.9% to close at $17.61 after the company reported worse-than-expected Q3 results and issued Q4 revenue guidance below estimates.</li>\n <li><b>Lantronix, Inc.</b>&nbsp;dropped 12.4% to close at $7.88. Lantronix priced underwritten offering of 4.7 million shares of common stock at $7.50 per share.</li>\n <li><b>Progenity, Inc.</b>&nbsp;fell 11.9% to settle at $4.30. Progenity recently reported worse-than-expected Q3 EPS results.</li>\n <li><b>Tivic Health Systems, Inc.</b>&nbsp;dipped 11.8% to close at $4.56. The company recently priced its IPO at $5 per share.</li>\n <li><b>QuickLogic Corporation</b>&nbsp;fell 10.8% to close at $6.88 following Q3 results.</li>\n <li><b>InMed Pharmaceuticals Inc.</b>&nbsp;shares fell 8.7% to close at $1.78. InMed Pharmaceuticals shares jumped around 40% on Wednesday after the company provided a business update.</li>\n <li><b>The Original BARK Company</b>&nbsp;dropped 6.8% to settle at $5.78. Mike Novotny, Insider at Original Bark, made a large buy and sell of company shares on November 12, according to a new SEC filing.</li>\n <li><b>COMSovereign Holding Corp.</b>&nbsp;fell 6.2% to close at $1.37 after jumping 20% on Wednesday.</li>\n <li><b>iBio, Inc.</b>&nbsp;fell 6.1% to close at $0.66. A leading independent proxy advisory firm, Glass Lewis, recommended iBio shareholders vote \"FOR\" all proposals ahead of annual meeting.</li>\n <li><b>Cisco Systems, Inc.</b>&nbsp;fell 5.5% to close at $53.63. Cisco reported upbeat earnings for its first quarter, while sales missed estimates. The company also issued weal sales forecast for the current quarter.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>54 Biggest Movers From Yesterday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n54 Biggest Movers From Yesterday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-19 19:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/11/24189383/54-biggest-movers-from-yesterday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gainers\n\nLongeveron Inc. shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the treatment of ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/11/24189383/54-biggest-movers-from-yesterday\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.benzinga.com/news/21/11/24189383/54-biggest-movers-from-yesterday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153021579","content_text":"Gainers\n\nLongeveron Inc. shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the treatment of hypoplastic left heart syndrome.\nDicerna Pharmaceuticals, Inc. shares climbed 78.7% to close at $38.03.Novo Nordisk A/SNVO-0.02%agreed to acquire Dicerna Pharmaceuticals for $38.25 per share in cash, representing a total equity value of $3.3 billion and a premium of 80% to Dicerna's closing price on November 17, 2021.\nSweetgreen, Inc. gained 76.8% to close at $49.50 after the company priced its IPO at $28 per share.\nVirtuoso Acquisition Corp. jumped 44% to settle at $14.51. Virtuoso Acquisition’s stockholders recently approved proposed merger with Wejo.\nJowell Global Ltd. climbed 25.8% to close at $14.75 after the company announced a collaboration with Unilever's Uni-Excubator.\nMacy's, Inc. gained 21.2% to close at $37.37 after the company reported strong Q3 results and also raised FY21 guidance.\nBJ's Wholesale Club Holdings, Inc. gained 19.9% to settle at $71.93 after the company reported better-than-expected Q3 EPS and sales results and announced a $500 million buyback.\nCardiff Oncology, Inc. rose 18.7% to close at $6.21. Pfizer made a $15 million equity investment in Cardiff Oncology as part of the Pfizer Breakthrough Growth Initiative.\nArcus Biosciences, Inc. climbed 18% to close at $43.54 after the company announced Gilead has exercised its options to three programs in Arcus's clinical-stage portfolio. The companies also added a research collaboration.\nEnthusiast Gaming Holdings Inc. rose 17.6% to close at $4.35 after the company reported US Unique Visitors reached 47.8 million in October.\nSmith-Midland Corporation gained 16.4% to settle at $32.27. Smith-Midland recently posted Q3 EPS of $0.71.\nDogness (International) Corporation surged 15.1% to close at $4.50.\nVera Therapeutics, Inc. gained 14.9% to settle at $28.43. Vera Therapeutics recently posted a Q3 loss of $0.36 per share.\nVictoria's Secret & Co. rose 14.7% to close at $57.91 after the company reported better-than-expected Q3 earnings.\nOMNIQ Corp. jumped 12.7% to settle at $9.47. OMNIQ recently posted a Q3 loss of $0.73 per share.\nVolcon, Inc. rose 12.4% to close at $16.48.\nUniversal Technical Institute, Inc. gained 12.3% to close at $7.75 following Q4 results.\nArco Platform Limited climbed 11.5% to close at $19.28. Arco Platform reported $150 million investments from Dragoneer and General Atlantic Partners.\nYatsen Holding Limited surged 10.7% to close at $2.99 after the company reported better-than-expected Q3 EPS results and announced a $100 million buyback.\nKohl's Corporation jumped 10.6% to close at $62.48 after the company reported better-than-expected Q3 EPS and sales results and raised FY21 EPS guidance.\nReTo Eco-Solutions, Inc. gained 10.1% to close at $3.05.\n180 Life Sciences Corp. gained 9.9% to close at $4.01.\nZTO Express (Cayman) Inc. shares rose 9.6% to close at $31.58 following Q3 earnings.\nExpress, Inc. gained 9.6% to settle at $4.55. Express is expected to report its third quarter 2021 financial results on Thursday, December 2, 2021.\nBM Technologies, Inc. rose 9.4% to close at $14.12 after gaining 5% on Wednesday.\nNVIDIA Corporation climbed 8.3% to settle at $316.75 after the company reported better-than-expected results for its third quarter, driven by record revenues in Gaming, Data Center and Professional Visualization segments. The company also issued a strong forecast for the fourth quarter.\n\nLosers\n\nAmtech Systems, Inc. fell 26.6% to close at $11.20 after the company reported downbeat Q4 results and issued weak Q1 sales forecast.\nZhangmen Education Inc. shares dipped 25.4% to close at $1.56 on Thursday after jumping more than 38% on Wednesday.\nSono Group N.V. fell 23.3% to settle at $29.29.\nGracell Biotechnologies Inc. declined 22.1% to close at $8.98. Gracell Biotechnologies recently reported Q3 sales of $57.00 thousand.\nFemasys Inc. fell 20.5% to close at $5.11.\nLottery.com Inc. dropped 19.9% to settle at $8.65. Lottery.com’s S-1 showed registration for primary offering of 30.125 million shares and secondary offering of 25.395 million shares via selling shareholders.\nWilliams Industrial Services Group Inc. dropped 19.6% to close at $3.70 after the company posted weak Q3 results and lowered FY21 revenue guidance.\nAltamira Therapeutics Ltd. dipped 19.6% to settle at $1.68.\nOdonate Therapeutics, Inc. dipped 18.5% to settle at $1.90.\nVipshop Holdings Limited dropped 18% to close at $10.03 after the company reported Q3 earnings results and issued guidance.\nSeqLL Inc. dropped 17.5% to close at $3.07.\nBilibili Inc. fell 17.2% to close at $67.12 after the company announced a proposed offering of $1,400 million convertible senior notes. The company could also be trading lower following their Q3 earnings results yesterday.\n17 Education & Technology Group Inc. dipped 16.4% to settle at $2.35.\nAehr Test Systems dropped 15.7% to close at $19.61.\nRivian Automotive, Inc. fell 15.5% to settle at $123.38 as the stock continued to pull back following its post-IPO surge. CNBC's Jim Cramer discussed momentum in the stock and noted investors may want to consider partial profit taking.\nCertara, Inc. fell 14.7% to close at $30.73 after the company priced its underwritten public offering of 10 million shares by certain existing stockholders at $31.00 per share.\nGambling.com Group Limited fell 13.9% to close at $13.00 after the company reported worse-than-expected Q3 sales results.\nPetco Health and Wellness Company, Inc. dipped 13.2% to close at $21.45 after the company reported Q3 earnings results and issued updated guidance.\nMaxeon Solar Technologies, Ltd. shares declined 12.9% to close at $17.61 after the company reported worse-than-expected Q3 results and issued Q4 revenue guidance below estimates.\nLantronix, Inc. dropped 12.4% to close at $7.88. Lantronix priced underwritten offering of 4.7 million shares of common stock at $7.50 per share.\nProgenity, Inc. fell 11.9% to settle at $4.30. Progenity recently reported worse-than-expected Q3 EPS results.\nTivic Health Systems, Inc. dipped 11.8% to close at $4.56. The company recently priced its IPO at $5 per share.\nQuickLogic Corporation fell 10.8% to close at $6.88 following Q3 results.\nInMed Pharmaceuticals Inc. shares fell 8.7% to close at $1.78. InMed Pharmaceuticals shares jumped around 40% on Wednesday after the company provided a business update.\nThe Original BARK Company dropped 6.8% to settle at $5.78. Mike Novotny, Insider at Original Bark, made a large buy and sell of company shares on November 12, according to a new SEC filing.\nCOMSovereign Holding Corp. fell 6.2% to close at $1.37 after jumping 20% on Wednesday.\niBio, Inc. fell 6.1% to close at $0.66. A leading independent proxy advisory firm, Glass Lewis, recommended iBio shareholders vote \"FOR\" all proposals ahead of annual meeting.\nCisco Systems, Inc. fell 5.5% to close at $53.63. Cisco reported upbeat earnings for its first quarter, while sales missed estimates. The company also issued weal sales forecast for the current quarter.","news_type":1,"symbols_score_info":{"BILI":0.9,"CSCO":0.9,"M":0.9}},"isVote":1,"tweetType":1,"viewCount":2953,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873136254,"gmtCreate":1636877022008,"gmtModify":1636877022008,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584074223056401","idStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873136254","repostId":"1103944030","repostType":4,"isVote":1,"tweetType":1,"viewCount":1858,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":845007737,"gmtCreate":1636250512994,"gmtModify":1636250513161,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584074223056401","idStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/845007737","repostId":"2181074782","repostType":4,"isVote":1,"tweetType":1,"viewCount":2454,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842206374,"gmtCreate":1636176767406,"gmtModify":1636177198943,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584074223056401","idStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/842206374","repostId":"1173813098","repostType":4,"repost":{"id":"1173813098","kind":"news","pubTimestamp":1636156499,"share":"https://ttm.financial/m/news/1173813098?lang=&edition=full","pubTime":"2021-11-06 07:54","market":"us","language":"en","title":"Wall St books records, weekly gains on strong jobs report, Pfizer COVID-19 pill cheer","url":"https://stock-news.laohu8.com/highlight/detail?id=1173813098","media":"Reuters","summary":"(Reuters) - Wall Street's main indexes scored record closing highs on Friday and booked solid gains ","content":"<p>(Reuters) - Wall Street's main indexes scored record closing highs on Friday and booked solid gains for the week following a strong U.S. jobs report and positive data for Pfizer's experimental pill against COVID-19.</p>\n<p>The S&amp;P 500 and the Nasdaq notched record high closes for their seventh straight sessions, while the Dow Jones Industrial Average also closed at a record. All three indexes posted weekly gains for their fifth straight weeks.</p>\n<p>The Labor Department report showed U.S. employment increased more than expected in October as the headwind from the surge in COVID-19 infections over the summer subsided.</p>\n<p>A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease. Pfizer shares jumped about 11%.</p>\n<p>The news kept the run going for equities after investors earlier in the week digested the Federal Reserve's decision to start reducing its monthly bond purchases put in place to support the economy.</p>\n<p>\"Momentum that we have seen this week has continued, and the jobs report and the Pfizer announcement certainly are providing positive datapoints for investors to put more money into the market right now,” said Chuck Carlson, chief executive officer at Horizon Investment Services in Hammond, Indiana.</p>\n<p>The Dow Jones Industrial Average rose 203.72 points, or 0.56%, to 36,327.95, the S&amp;P 500 gained 17.47 points, or 0.37%, to 4,697.53 and the Nasdaq Composite added 31.28 points, or 0.2%, to 15,971.59.</p>\n<p>For the week, the S&amp;P 500 rose 2%, the Dow added 1.42%, while the Nasdaq gained 3.05%.</p>\n<p>Travel stocks rose following Pfizer's announcement, with the S&amp;P 1500 airlines index climbing 7%, and cruise operators Carnival Corp, Royal Caribbean Cruises and Norwegian Cruise rising between about 8% to 9%.</p>\n<p>\"Still early to be definitive but this (pill) looks like a true game changer for many industries like leisure and transportation, you're seeing it reflected in the prices,\" said Andre Bakhos, managing director at New Vines Capital LLC in Bernardsville, New Jersey.</p>\n<p>Among S&amp;P 500 sectors, energy and industrials led the way, rising 1.4% and 1%, respectively.</p>\n<p>Healthcare was the only sector that ended negative, falling 1%. The Pfizer news weighed on shares of competitors such as Merck, which fell nearly 10%, and COVID-19 vaccine makers such as Moderna, which slumped 16.6%.</p>\n<p>Shares of so-called \"stay-at-home\" names fell, with <a href=\"https://laohu8.com/S/ZM\">Zoom</a> Video Communications down 6.2% and Netflix Inc off 3.4%.</p>\n<p>Better-than-expected third-quarter earnings have helped lift sentiment for equities. With about 440 companies having reported, S&amp;P 500 earnings are expected to have climbed 41.5% in the third quarter from a year earlier, according to Refinitiv IBES.</p>\n<p>Pinterest Inc shares climbed 5.9% after the company's strong fourth-quarter revenue forecast.</p>\n<p>Peloton Interactive Inc shares slumped 35.3% after the company slashed its full-year sales forecast by up to $1 billion.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.16-to-1 ratio; on Nasdaq, a 1.22-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 83 new 52-week highs and two new lows; the Nasdaq Composite recorded 303 new highs and 80 new lows.</p>\n<p>About 11.5 billion shares changed hands in U.S. exchanges, compared with the 10.5 billion daily average over the last 20 sessions.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St books records, weekly gains on strong jobs report, Pfizer COVID-19 pill cheer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St books records, weekly gains on strong jobs report, Pfizer COVID-19 pill cheer\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-06 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19167545><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Wall Street's main indexes scored record closing highs on Friday and booked solid gains for the week following a strong U.S. jobs report and positive data for Pfizer's experimental pill ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19167545\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.streetinsider.com/dr/news.php?id=19167545","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173813098","content_text":"(Reuters) - Wall Street's main indexes scored record closing highs on Friday and booked solid gains for the week following a strong U.S. jobs report and positive data for Pfizer's experimental pill against COVID-19.\nThe S&P 500 and the Nasdaq notched record high closes for their seventh straight sessions, while the Dow Jones Industrial Average also closed at a record. All three indexes posted weekly gains for their fifth straight weeks.\nThe Labor Department report showed U.S. employment increased more than expected in October as the headwind from the surge in COVID-19 infections over the summer subsided.\nA trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease. Pfizer shares jumped about 11%.\nThe news kept the run going for equities after investors earlier in the week digested the Federal Reserve's decision to start reducing its monthly bond purchases put in place to support the economy.\n\"Momentum that we have seen this week has continued, and the jobs report and the Pfizer announcement certainly are providing positive datapoints for investors to put more money into the market right now,” said Chuck Carlson, chief executive officer at Horizon Investment Services in Hammond, Indiana.\nThe Dow Jones Industrial Average rose 203.72 points, or 0.56%, to 36,327.95, the S&P 500 gained 17.47 points, or 0.37%, to 4,697.53 and the Nasdaq Composite added 31.28 points, or 0.2%, to 15,971.59.\nFor the week, the S&P 500 rose 2%, the Dow added 1.42%, while the Nasdaq gained 3.05%.\nTravel stocks rose following Pfizer's announcement, with the S&P 1500 airlines index climbing 7%, and cruise operators Carnival Corp, Royal Caribbean Cruises and Norwegian Cruise rising between about 8% to 9%.\n\"Still early to be definitive but this (pill) looks like a true game changer for many industries like leisure and transportation, you're seeing it reflected in the prices,\" said Andre Bakhos, managing director at New Vines Capital LLC in Bernardsville, New Jersey.\nAmong S&P 500 sectors, energy and industrials led the way, rising 1.4% and 1%, respectively.\nHealthcare was the only sector that ended negative, falling 1%. The Pfizer news weighed on shares of competitors such as Merck, which fell nearly 10%, and COVID-19 vaccine makers such as Moderna, which slumped 16.6%.\nShares of so-called \"stay-at-home\" names fell, with Zoom Video Communications down 6.2% and Netflix Inc off 3.4%.\nBetter-than-expected third-quarter earnings have helped lift sentiment for equities. With about 440 companies having reported, S&P 500 earnings are expected to have climbed 41.5% in the third quarter from a year earlier, according to Refinitiv IBES.\nPinterest Inc shares climbed 5.9% after the company's strong fourth-quarter revenue forecast.\nPeloton Interactive Inc shares slumped 35.3% after the company slashed its full-year sales forecast by up to $1 billion.\nAdvancing issues outnumbered declining ones on the NYSE by a 2.16-to-1 ratio; on Nasdaq, a 1.22-to-1 ratio favored advancers.\nThe S&P 500 posted 83 new 52-week highs and two new lows; the Nasdaq Composite recorded 303 new highs and 80 new lows.\nAbout 11.5 billion shares changed hands in U.S. exchanges, compared with the 10.5 billion daily average over the last 20 sessions.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1925,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841533429,"gmtCreate":1635923405428,"gmtModify":1635923405488,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584074223056401","idStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/841533429","repostId":"1117766576","repostType":4,"repost":{"id":"1117766576","kind":"news","pubTimestamp":1635922978,"share":"https://ttm.financial/m/news/1117766576?lang=&edition=full","pubTime":"2021-11-03 15:02","market":"us","language":"en","title":"BMW offsets low deliveries with increased prices for higher Q3 profits","url":"https://stock-news.laohu8.com/highlight/detail?id=1117766576","media":"Reuters","summary":"German automaker BMW reported third-quarter earnings before interest and taxes of 2.88 billion euros","content":"<p>German automaker BMW&nbsp;reported third-quarter earnings before interest and taxes of 2.88 billion euros ($3.33 billion) on Wednesday, beating analysts' expectations of 2.34 billion euros, as it offset reduced deliveries with higher prices.</p>\n<p>The company's net profit was 2.58 billion euros, with an EBIT margin in its automotive division of 7.8%.</p>\n<p>\"A better product mix and good price setting of new vehicles alongside a stable pricing trend of used vehicles strengthened the financial performance of the business,\" a company statement said.</p>\n<p>The premium automaker saw a significant boost to its electric vehicle sales, including both fully electric and hybrid vehicles, in the first nine months of the year to nearly 232,000 vehicles, almost double as many as were sold in the same period last year.</p>\n<p>Chip supply will remain an issue into 2022, CFO Nicolas Peter said, echoing a previous statement from CEO Oliver Zipse in September that the crisis could last up to 12 months.</p>\n<p>($1 = 0.8636 euros)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BMW offsets low deliveries with increased prices for higher Q3 profits</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBMW offsets low deliveries with increased prices for higher Q3 profits\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-03 15:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/business/cop/bmw-reports-q3-earnings-288-billion-euros-beating-expectations-2021-11-03/><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>German automaker BMW reported third-quarter earnings before interest and taxes of 2.88 billion euros ($3.33 billion) on Wednesday, beating analysts' expectations of 2.34 billion euros, as it offset ...</p>\n\n<a href=\"https://www.reuters.com/business/cop/bmw-reports-q3-earnings-288-billion-euros-beating-expectations-2021-11-03/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.reuters.com/business/cop/bmw-reports-q3-earnings-288-billion-euros-beating-expectations-2021-11-03/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117766576","content_text":"German automaker BMW reported third-quarter earnings before interest and taxes of 2.88 billion euros ($3.33 billion) on Wednesday, beating analysts' expectations of 2.34 billion euros, as it offset reduced deliveries with higher prices.\nThe company's net profit was 2.58 billion euros, with an EBIT margin in its automotive division of 7.8%.\n\"A better product mix and good price setting of new vehicles alongside a stable pricing trend of used vehicles strengthened the financial performance of the business,\" a company statement said.\nThe premium automaker saw a significant boost to its electric vehicle sales, including both fully electric and hybrid vehicles, in the first nine months of the year to nearly 232,000 vehicles, almost double as many as were sold in the same period last year.\nChip supply will remain an issue into 2022, CFO Nicolas Peter said, echoing a previous statement from CEO Oliver Zipse in September that the crisis could last up to 12 months.\n($1 = 0.8636 euros)","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":1789,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840089266,"gmtCreate":1635567994264,"gmtModify":1635567994264,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584074223056401","idStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/840089266","repostId":"2179424781","repostType":4,"repost":{"id":"2179424781","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1635538990,"share":"https://ttm.financial/m/news/2179424781?lang=&edition=full","pubTime":"2021-10-30 04:23","market":"sh","language":"en","title":"Wall Street shakes off Amazon, Apple weakness to end modestly higher","url":"https://stock-news.laohu8.com/highlight/detail?id=2179424781","media":"Reuters","summary":"* $Apple$, Amazon fall on dismal holiday-quarter forecast. * $Microsoft$ tops Apple as the most valuable U.S. public company. The S&P 500 had fallen as much as 0.65% earlier in the day. The benchmark index advanced 1.3% for the week, its fourth straight weekly climb, marking its longest weekly streak of gains since April. For the month, the S&P rose 6.9%, its biggest monthly rise since November 2020.The Dow rose 0.4% for the week while the Nasdaq gained 2.7%, also marking four straight weekly ga","content":"<p>* <a href=\"https://laohu8.com/S/AAPL\">Apple</a>, Amazon fall on dismal holiday-quarter forecast</p>\n<p>* <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> tops Apple as the most valuable U.S. public company</p>\n<p>* Dow up 0.25%, S&amp;P 500 up 0.19%, <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> up 0.33%</p>\n<p>(Updates with volume data, market breadth)</p>\n<p>By Chuck Mikolajczak</p>\n<p>NEW YORK, Oct 29 (Reuters) - U.S. stocks shook off early declines and closed out the last trading day of the month with modest gains on Friday as a rise in Microsoft helped offset declines in Amazon and Apple after disappointing quarterly earnings from the online retailer and iPhone maker.</p>\n<p>Microsoft Corp's shares closed at a record high of $331.62 and ended the session with a market capitalization of $2.49 trillion, surpassing Apple Inc's market cap of roughly $2.48 trillion.</p>\n<p>Apple lost 1.81% after it warned the impact of supply-chain disruptions will be even worse during the current holiday sales quarter, while <a href=\"https://laohu8.com/S/AMZN\">Amazon.com</a> Inc declined 2.15% as it forecast downbeat holiday-quarter sales amid labor shortages.</p>\n<p>\"The takeaway from today is the resilience to the overall index despite 10% of market cap in two companies disappointing and yet the market is flat. It’s the resilience of the marketplace, it suggests to me the trend is still intact,\" said David Joy, chief market strategist at <a href=\"https://laohu8.com/S/AMP\">Ameriprise</a> Financial in Boston.</p>\n<p>\"Maybe the numbers were a surprise to the analyst community but not the reasons for the disappointment so there is still a general view that this is not business lost but business postponed and the trend in the economy and in the market continues to be to the upside.\"</p>\n<p>The Dow Jones Industrial Average rose 89.08 points, or 0.25%, to 35,819.56, the S&amp;P 500 gained 8.96 points, or 0.19%, to 4,605.38 and the Nasdaq Composite added 50.27 points, or 0.33%, to 15,498.39.</p>\n<p>The S&amp;P 500 had fallen as much as 0.65% earlier in the day. The benchmark index advanced 1.3% for the week, its fourth straight weekly climb, marking its longest weekly streak of gains since April. For the month, the S&amp;P rose 6.9%, its biggest monthly rise since November 2020.</p>\n<p>The Dow rose 0.4% for the week while the Nasdaq gained 2.7%, also marking four straight weekly gains for each. The Dow climbed 5.8% for October, its best monthly performance since March, while the Nasdaq jumped 7.3% for its biggest monthly percentage gain since November 2020.</p>\n<p>Apple had risen about 2.5% while Amazon gained 1.6% in Thursday's session, helping to send the S&amp;P 500 and Nasdaq to closing record highs.</p>\n<p>With 279 companies in the S&amp;P 500 having reported results through Friday morning, 82.1% have topped earnings expectations, according to Refinitiv data. The current year-over-year earnings growth rate for the third quarter is 39.2%.</p>\n<p>Market participants have been closely attuned to the ability of companies to maneuver through labor shortages, rising price pressures and clogs in the supply chain, and a solid earnings season has helped investors overlook a mixed macroeconomic picture with a Federal Reserve that is poised to begin to trim its massive bond purchases soon.</p>\n<p>The central bank's next policy announcement is on Nov. 3.</p>\n<p>Data showed U.S. consumer spending increased solidly in September, while inflation pressures are broadening.</p>\n<p>The data indicated the jury is still out on whether the Fed's \"transitory\" view on inflation will hold true.</p>\n<p><a href=\"https://laohu8.com/S/ABBV\">AbbVie</a> Inc advanced 4.56% as the U.S. drugmaker raised its 2021 adjusted profit forecast for the third time this year.</p>\n<p><a href=\"https://laohu8.com/S/SBUX\">Starbucks</a> Corp tumbled 6.30% after the coffee chain said it expects fiscal 2022 operating margin to be below its long-term target due to inflation and investments.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.14-to-1 ratio; on Nasdaq, a 1.02-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 50 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 127 new highs and 78 new lows.</p>\n<p>Volume on U.S. exchanges was 11.12 billion shares, compared with the 10.35 billion average for the full session over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street shakes off Amazon, Apple weakness to end modestly higher</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street shakes off Amazon, Apple weakness to end modestly higher\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-10-30 04:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* <a href=\"https://laohu8.com/S/AAPL\">Apple</a>, Amazon fall on dismal holiday-quarter forecast</p>\n<p>* <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> tops Apple as the most valuable U.S. public company</p>\n<p>* Dow up 0.25%, S&amp;P 500 up 0.19%, <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> up 0.33%</p>\n<p>(Updates with volume data, market breadth)</p>\n<p>By Chuck Mikolajczak</p>\n<p>NEW YORK, Oct 29 (Reuters) - U.S. stocks shook off early declines and closed out the last trading day of the month with modest gains on Friday as a rise in Microsoft helped offset declines in Amazon and Apple after disappointing quarterly earnings from the online retailer and iPhone maker.</p>\n<p>Microsoft Corp's shares closed at a record high of $331.62 and ended the session with a market capitalization of $2.49 trillion, surpassing Apple Inc's market cap of roughly $2.48 trillion.</p>\n<p>Apple lost 1.81% after it warned the impact of supply-chain disruptions will be even worse during the current holiday sales quarter, while <a href=\"https://laohu8.com/S/AMZN\">Amazon.com</a> Inc declined 2.15% as it forecast downbeat holiday-quarter sales amid labor shortages.</p>\n<p>\"The takeaway from today is the resilience to the overall index despite 10% of market cap in two companies disappointing and yet the market is flat. It’s the resilience of the marketplace, it suggests to me the trend is still intact,\" said David Joy, chief market strategist at <a href=\"https://laohu8.com/S/AMP\">Ameriprise</a> Financial in Boston.</p>\n<p>\"Maybe the numbers were a surprise to the analyst community but not the reasons for the disappointment so there is still a general view that this is not business lost but business postponed and the trend in the economy and in the market continues to be to the upside.\"</p>\n<p>The Dow Jones Industrial Average rose 89.08 points, or 0.25%, to 35,819.56, the S&amp;P 500 gained 8.96 points, or 0.19%, to 4,605.38 and the Nasdaq Composite added 50.27 points, or 0.33%, to 15,498.39.</p>\n<p>The S&amp;P 500 had fallen as much as 0.65% earlier in the day. The benchmark index advanced 1.3% for the week, its fourth straight weekly climb, marking its longest weekly streak of gains since April. For the month, the S&amp;P rose 6.9%, its biggest monthly rise since November 2020.</p>\n<p>The Dow rose 0.4% for the week while the Nasdaq gained 2.7%, also marking four straight weekly gains for each. The Dow climbed 5.8% for October, its best monthly performance since March, while the Nasdaq jumped 7.3% for its biggest monthly percentage gain since November 2020.</p>\n<p>Apple had risen about 2.5% while Amazon gained 1.6% in Thursday's session, helping to send the S&amp;P 500 and Nasdaq to closing record highs.</p>\n<p>With 279 companies in the S&amp;P 500 having reported results through Friday morning, 82.1% have topped earnings expectations, according to Refinitiv data. The current year-over-year earnings growth rate for the third quarter is 39.2%.</p>\n<p>Market participants have been closely attuned to the ability of companies to maneuver through labor shortages, rising price pressures and clogs in the supply chain, and a solid earnings season has helped investors overlook a mixed macroeconomic picture with a Federal Reserve that is poised to begin to trim its massive bond purchases soon.</p>\n<p>The central bank's next policy announcement is on Nov. 3.</p>\n<p>Data showed U.S. consumer spending increased solidly in September, while inflation pressures are broadening.</p>\n<p>The data indicated the jury is still out on whether the Fed's \"transitory\" view on inflation will hold true.</p>\n<p><a href=\"https://laohu8.com/S/ABBV\">AbbVie</a> Inc advanced 4.56% as the U.S. drugmaker raised its 2021 adjusted profit forecast for the third time this year.</p>\n<p><a href=\"https://laohu8.com/S/SBUX\">Starbucks</a> Corp tumbled 6.30% after the coffee chain said it expects fiscal 2022 operating margin to be below its long-term target due to inflation and investments.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.14-to-1 ratio; on Nasdaq, a 1.02-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 50 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 127 new highs and 78 new lows.</p>\n<p>Volume on U.S. exchanges was 11.12 billion shares, compared with the 10.35 billion average for the full session over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯","AAPL":"苹果",".IXIC":"NASDAQ Composite","MSFT":"微软"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2179424781","content_text":"* Apple, Amazon fall on dismal holiday-quarter forecast\n* Microsoft tops Apple as the most valuable U.S. public company\n* Dow up 0.25%, S&P 500 up 0.19%, Nasdaq up 0.33%\n(Updates with volume data, market breadth)\nBy Chuck Mikolajczak\nNEW YORK, Oct 29 (Reuters) - U.S. stocks shook off early declines and closed out the last trading day of the month with modest gains on Friday as a rise in Microsoft helped offset declines in Amazon and Apple after disappointing quarterly earnings from the online retailer and iPhone maker.\nMicrosoft Corp's shares closed at a record high of $331.62 and ended the session with a market capitalization of $2.49 trillion, surpassing Apple Inc's market cap of roughly $2.48 trillion.\nApple lost 1.81% after it warned the impact of supply-chain disruptions will be even worse during the current holiday sales quarter, while Amazon.com Inc declined 2.15% as it forecast downbeat holiday-quarter sales amid labor shortages.\n\"The takeaway from today is the resilience to the overall index despite 10% of market cap in two companies disappointing and yet the market is flat. It’s the resilience of the marketplace, it suggests to me the trend is still intact,\" said David Joy, chief market strategist at Ameriprise Financial in Boston.\n\"Maybe the numbers were a surprise to the analyst community but not the reasons for the disappointment so there is still a general view that this is not business lost but business postponed and the trend in the economy and in the market continues to be to the upside.\"\nThe Dow Jones Industrial Average rose 89.08 points, or 0.25%, to 35,819.56, the S&P 500 gained 8.96 points, or 0.19%, to 4,605.38 and the Nasdaq Composite added 50.27 points, or 0.33%, to 15,498.39.\nThe S&P 500 had fallen as much as 0.65% earlier in the day. The benchmark index advanced 1.3% for the week, its fourth straight weekly climb, marking its longest weekly streak of gains since April. For the month, the S&P rose 6.9%, its biggest monthly rise since November 2020.\nThe Dow rose 0.4% for the week while the Nasdaq gained 2.7%, also marking four straight weekly gains for each. The Dow climbed 5.8% for October, its best monthly performance since March, while the Nasdaq jumped 7.3% for its biggest monthly percentage gain since November 2020.\nApple had risen about 2.5% while Amazon gained 1.6% in Thursday's session, helping to send the S&P 500 and Nasdaq to closing record highs.\nWith 279 companies in the S&P 500 having reported results through Friday morning, 82.1% have topped earnings expectations, according to Refinitiv data. The current year-over-year earnings growth rate for the third quarter is 39.2%.\nMarket participants have been closely attuned to the ability of companies to maneuver through labor shortages, rising price pressures and clogs in the supply chain, and a solid earnings season has helped investors overlook a mixed macroeconomic picture with a Federal Reserve that is poised to begin to trim its massive bond purchases soon.\nThe central bank's next policy announcement is on Nov. 3.\nData showed U.S. consumer spending increased solidly in September, while inflation pressures are broadening.\nThe data indicated the jury is still out on whether the Fed's \"transitory\" view on inflation will hold true.\nAbbVie Inc advanced 4.56% as the U.S. drugmaker raised its 2021 adjusted profit forecast for the third time this year.\nStarbucks Corp tumbled 6.30% after the coffee chain said it expects fiscal 2022 operating margin to be below its long-term target due to inflation and investments.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.14-to-1 ratio; on Nasdaq, a 1.02-to-1 ratio favored advancers.\nThe S&P 500 posted 50 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 127 new highs and 78 new lows.\nVolume on U.S. exchanges was 11.12 billion shares, compared with the 10.35 billion average for the full session over the last 20 trading days.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"AAPL":0.9,"MSFT":0.9}},"isVote":1,"tweetType":1,"viewCount":2893,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":854156844,"gmtCreate":1635429461642,"gmtModify":1635429764889,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584074223056401","idStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/854156844","repostId":"1153909226","repostType":4,"repost":{"id":"1153909226","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635428011,"share":"https://ttm.financial/m/news/1153909226?lang=&edition=full","pubTime":"2021-10-28 21:33","market":"us","language":"en","title":"Rafael Holdings stock plummets after cancer-treatment trial missed primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=1153909226","media":"Tiger Newspress","summary":"Shares of Rafael Holdings Inc. $(RFL)$ plummeted 78% in morning trading Thursday, after the develope","content":"<p>Shares of Rafael Holdings Inc. <a href=\"https://laohu8.com/S/RFL\">$(RFL)$</a> plummeted 78% in morning trading Thursday,&nbsp;after the developer of cancer treatments said a Phase 3 trial of CPI-613 (devimistat) in patients with relapsed or refractory acute myeloid leukemia failed to meet its primary endpoint. </p>\n<p><img src=\"https://static.tigerbbs.com/0208843fbf8264bc77269e3fd7a5cba5\" tg-width=\"885\" tg-height=\"630\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>The company said devimistat, given with Folfirinox (mFFX), a current standard of care chemotherapy regimen, did not significantly improve overall survival. </p>\n<p>\"While we are disappointed by the outcomes of these well-designed and well-executed studies, we remain committed to furthering our research and development in cancer metabolism for the treatment of hard-to-treat cancers, as our other studies continue,\" said Rafael Chief Executive Sanjeev Luther. </p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rafael Holdings stock plummets after cancer-treatment trial missed primary endpoint</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRafael Holdings stock plummets after cancer-treatment trial missed primary endpoint\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-28 21:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Rafael Holdings Inc. <a href=\"https://laohu8.com/S/RFL\">$(RFL)$</a> plummeted 78% in morning trading Thursday,&nbsp;after the developer of cancer treatments said a Phase 3 trial of CPI-613 (devimistat) in patients with relapsed or refractory acute myeloid leukemia failed to meet its primary endpoint. </p>\n<p><img src=\"https://static.tigerbbs.com/0208843fbf8264bc77269e3fd7a5cba5\" tg-width=\"885\" tg-height=\"630\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>The company said devimistat, given with Folfirinox (mFFX), a current standard of care chemotherapy regimen, did not significantly improve overall survival. </p>\n<p>\"While we are disappointed by the outcomes of these well-designed and well-executed studies, we remain committed to furthering our research and development in cancer metabolism for the treatment of hard-to-treat cancers, as our other studies continue,\" said Rafael Chief Executive Sanjeev Luther. </p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153909226","content_text":"Shares of Rafael Holdings Inc. $(RFL)$ plummeted 78% in morning trading Thursday, after the developer of cancer treatments said a Phase 3 trial of CPI-613 (devimistat) in patients with relapsed or refractory acute myeloid leukemia failed to meet its primary endpoint. \n\nThe company said devimistat, given with Folfirinox (mFFX), a current standard of care chemotherapy regimen, did not significantly improve overall survival. \n\"While we are disappointed by the outcomes of these well-designed and well-executed studies, we remain committed to furthering our research and development in cancer metabolism for the treatment of hard-to-treat cancers, as our other studies continue,\" said Rafael Chief Executive Sanjeev Luther.","news_type":1,"symbols_score_info":{"RFL":0.9}},"isVote":1,"tweetType":1,"viewCount":1483,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":858285978,"gmtCreate":1635058911987,"gmtModify":1635058912161,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584074223056401","idStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/858285978","repostId":"1174514229","repostType":4,"repost":{"id":"1174514229","kind":"news","pubTimestamp":1635035471,"share":"https://ttm.financial/m/news/1174514229?lang=&edition=full","pubTime":"2021-10-24 08:31","market":"us","language":"en","title":"US IPO Week Ahead: Semiconductors, energy storage, designer apparel, and more in a 12 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1174514229","media":"Renaissance Capital","summary":"The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.","content":"<p>The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.</p>\n<p>Semiconductor foundry&nbsp;<b>GlobalFoundries</b>(GFS) plans to raise $2.4 billion at a $24.6 billion market cap. Backed by Abu Dhabi’s Mubadala, US-based GlobalFoundries is one of the world’s leading specialty semiconductor foundries. Unprofitable with lumpy growth, the company states that it is the only scaled pure-play foundry with a global footprint that is not based in China.</p>\n<p>Enterprise cloud data management platform&nbsp;<b>Informatica</b>(INFA) plans to raise $885 million at an $8.7 billion market cap. This company provides data integration services on its AI-powered platform to over 5,700 customers through both licenses and subscriptions. Although it will be highly leveraged post-IPO, Informatica is a recognized leader in the global data management market and saw strong subscription ARR growth in the 1H21.</p>\n<p>Energy storage provider&nbsp;<b>Fluence Energy</b>(FLNC) plans to raise $698 million at a $3.8 billion market cap. Formed by Siemens and AES, this company sells energy storage products and services to utilities, independent power producers, project developers, and commercial and industrial customers. Fast growing but unprofitable, Fluence Energy deployed 942 MW of storage products as of 6/30/21.</p>\n<p>Revenue cycle management platform&nbsp;<b>Ensemble Health Partners</b>(ENSB) plans to raise $605 million at a $3.6 billion market cap. This platform provides revenue cycle management solutions to the healthcare industry. Profitable with accelerating growth in the 1H21, Ensemble Health has over $20 billion in annual client net patient revenue under management.</p>\n<p>Hiring solutions provider&nbsp;<b>HireRight Holdings</b>(HRT) plans to raise $500 million at a $1.8 billion market cap. This company provides background checks, verification, identification, monitoring, and drug and health screening services to over 40,000 customers. HireRight was profitable on an EBIT basis in the 1H21, though cash flow swung negative.</p>\n<p>Online education marketplace&nbsp;<b>Udemy</b>(UDMY) plans to raise $406 million at a $4.3 billion market cap. This education platform provides over 183,000 courses in 75 languages to over 44 million customers in over 180 countries. Growing but unprofitable, Udemy has registered more than 73 million users since its inception.</p>\n<p>Chinese drug in-licensor&nbsp;<b>LianBio</b>(LIAN) plans to raise $325 million at a $1.8 billion market cap. Focused on China and other Asian markets, this biopharmaceutical company develops and commercializes drugs for a variety of indications. LianBio’s pipeline currently consists of nine product candidates across five different therapeutics areas.</p>\n<p><b>Rent the Runway</b>(RENT) plans to raise $293 million at a $1.4 billion market cap. This apparel rental company originally focused on a-la-carte rentals of dresses for events, but has gradually transitioned to mostly generating revenue from monthly subscription boxes. While the company has seen active subscribers and revenue rebound in the last two quarters, it is unprofitable and leveraged post-IPO.</p>\n<p>Aesthetic medical device maker&nbsp;<b>Candela Medical</b>(CDLA) plans to raise $250 million at a $1.7 billion market cap. Selling products directly in 18 countries and indirectly in 66 countries, this company develops medical devices for elective aesthetic procedures. Despite being hard hit by the pandemic, Candela Medical saw strong growth and turned profitable in the 1H21.</p>\n<p>Fire pit brand&nbsp;<b>Solo Brands</b>(DTC) plans to raise $200 million at a $1.5 billion market cap. Solo Brands sells fire pits, camp stoves, and other outdoor gear through its DTC platform. Fast growing and profitable, this outdoor e-commerce has an installed base of more than 2.3 million customers.</p>\n<p>Body contouring provider&nbsp;<b>AirSculpt Technologies</b>(AIRS) plans to raise $160 million at an $886 million market cap. This company provides minimally-invasive body contouring procedures through 16 centers across 13 states in the US. AirSculpt Technologies is profitable with solid growth, and has seen an increase in same-center case volume as a result of lessening effects of COVID-19.</p>\n<p>Technology firm&nbsp;<b>Arteris</b>(AIP) plans to raise $75 million at a $555 million market cap. This technology company develops and licenses interconnect intellectual property that manages the on-chip communications in System-on-Chip semiconductor devices. Arteris is unprofitable but saw growth accelerate in the 1H21.</p>\n<p><img src=\"https://static.tigerbbs.com/99c3b0173e59f4e69ff484c12bd137e7\" tg-width=\"1270\" tg-height=\"704\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/64e34b3c49a856e99ba64a2d57410844\" tg-width=\"1272\" tg-height=\"582\" referrerpolicy=\"no-referrer\"></p>\n<p>Street research is expected for six companies, and lock-up periods will be expiring for up to 12 companies.</p>\n<p><b>IPO Market Snapshot</b></p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 10/22/21, the Renaissance IPO Index was up 8.2% year-to-date, while the S&amp;P 500 was up 21.1%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Uber Technologies (UBER) and Moderna (MRNA). The Renaissance International IPO Index was down 15.8% year-to-date, while the ACWX was up 9.1%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.</p>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: Semiconductors, energy storage, designer apparel, and more in a 12 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: Semiconductors, energy storage, designer apparel, and more in a 12 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-24 08:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/87676/US-IPO-Week-Ahead-Semiconductors-energy-storage-designer-apparel-and-more-i><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.\nSemiconductor foundry GlobalFoundries(GFS) plans to raise $2.4 billion at a $24.6 billion market ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/87676/US-IPO-Week-Ahead-Semiconductors-energy-storage-designer-apparel-and-more-i\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DTC":"Solo Brands, Inc.","RENT":"Rent the Runway, Inc.",".DJI":"道琼斯","HRT":"HireRight Holdings Corp.",".IXIC":"NASDAQ Composite","AIRS":"Airsculpt Technologies","FLNC":"Fluence Energy, Inc.","GFS":"GLOBALFOUNDRIES Inc.","AIP":"Arteris, Inc.",".SPX":"S&P 500 Index","UDMY":"Udemy, Inc.","INFA":"Informatica Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/87676/US-IPO-Week-Ahead-Semiconductors-energy-storage-designer-apparel-and-more-i","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174514229","content_text":"The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.\nSemiconductor foundry GlobalFoundries(GFS) plans to raise $2.4 billion at a $24.6 billion market cap. Backed by Abu Dhabi’s Mubadala, US-based GlobalFoundries is one of the world’s leading specialty semiconductor foundries. Unprofitable with lumpy growth, the company states that it is the only scaled pure-play foundry with a global footprint that is not based in China.\nEnterprise cloud data management platform Informatica(INFA) plans to raise $885 million at an $8.7 billion market cap. This company provides data integration services on its AI-powered platform to over 5,700 customers through both licenses and subscriptions. Although it will be highly leveraged post-IPO, Informatica is a recognized leader in the global data management market and saw strong subscription ARR growth in the 1H21.\nEnergy storage provider Fluence Energy(FLNC) plans to raise $698 million at a $3.8 billion market cap. Formed by Siemens and AES, this company sells energy storage products and services to utilities, independent power producers, project developers, and commercial and industrial customers. Fast growing but unprofitable, Fluence Energy deployed 942 MW of storage products as of 6/30/21.\nRevenue cycle management platform Ensemble Health Partners(ENSB) plans to raise $605 million at a $3.6 billion market cap. This platform provides revenue cycle management solutions to the healthcare industry. Profitable with accelerating growth in the 1H21, Ensemble Health has over $20 billion in annual client net patient revenue under management.\nHiring solutions provider HireRight Holdings(HRT) plans to raise $500 million at a $1.8 billion market cap. This company provides background checks, verification, identification, monitoring, and drug and health screening services to over 40,000 customers. HireRight was profitable on an EBIT basis in the 1H21, though cash flow swung negative.\nOnline education marketplace Udemy(UDMY) plans to raise $406 million at a $4.3 billion market cap. This education platform provides over 183,000 courses in 75 languages to over 44 million customers in over 180 countries. Growing but unprofitable, Udemy has registered more than 73 million users since its inception.\nChinese drug in-licensor LianBio(LIAN) plans to raise $325 million at a $1.8 billion market cap. Focused on China and other Asian markets, this biopharmaceutical company develops and commercializes drugs for a variety of indications. LianBio’s pipeline currently consists of nine product candidates across five different therapeutics areas.\nRent the Runway(RENT) plans to raise $293 million at a $1.4 billion market cap. This apparel rental company originally focused on a-la-carte rentals of dresses for events, but has gradually transitioned to mostly generating revenue from monthly subscription boxes. While the company has seen active subscribers and revenue rebound in the last two quarters, it is unprofitable and leveraged post-IPO.\nAesthetic medical device maker Candela Medical(CDLA) plans to raise $250 million at a $1.7 billion market cap. Selling products directly in 18 countries and indirectly in 66 countries, this company develops medical devices for elective aesthetic procedures. Despite being hard hit by the pandemic, Candela Medical saw strong growth and turned profitable in the 1H21.\nFire pit brand Solo Brands(DTC) plans to raise $200 million at a $1.5 billion market cap. Solo Brands sells fire pits, camp stoves, and other outdoor gear through its DTC platform. Fast growing and profitable, this outdoor e-commerce has an installed base of more than 2.3 million customers.\nBody contouring provider AirSculpt Technologies(AIRS) plans to raise $160 million at an $886 million market cap. This company provides minimally-invasive body contouring procedures through 16 centers across 13 states in the US. AirSculpt Technologies is profitable with solid growth, and has seen an increase in same-center case volume as a result of lessening effects of COVID-19.\nTechnology firm Arteris(AIP) plans to raise $75 million at a $555 million market cap. This technology company develops and licenses interconnect intellectual property that manages the on-chip communications in System-on-Chip semiconductor devices. Arteris is unprofitable but saw growth accelerate in the 1H21.\n\nStreet research is expected for six companies, and lock-up periods will be expiring for up to 12 companies.\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 10/22/21, the Renaissance IPO Index was up 8.2% year-to-date, while the S&P 500 was up 21.1%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Uber Technologies (UBER) and Moderna (MRNA). The Renaissance International IPO Index was down 15.8% year-to-date, while the ACWX was up 9.1%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"AIP":0.9,"AIRS":0.9,"CDLA":0.9,"DTC":0.9,"ENSB":0.9,"FLNC":0.9,"GFS":0.9,"HRT":0.9,"INFA":0.9,"LIAN":0.9,"RENT":0.9,"UDMY":0.9}},"isVote":1,"tweetType":1,"viewCount":1428,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":851613538,"gmtCreate":1634902061887,"gmtModify":1634902138766,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584074223056401","idStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/851613538","repostId":"2177663497","repostType":4,"repost":{"id":"2177663497","kind":"highlight","pubTimestamp":1634901730,"share":"https://ttm.financial/m/news/2177663497?lang=&edition=full","pubTime":"2021-10-22 19:22","market":"us","language":"en","title":"Novavax Faces 1 Major Risk Right Now. Should You Buy the Stock Anyway?","url":"https://stock-news.laohu8.com/highlight/detail?id=2177663497","media":"Motley Fool","summary":"Novavax (NASDAQ:NVAX) started the coronavirus vaccine race as a favorite. The company's shares even ","content":"<p><b>Novavax</b> (NASDAQ:NVAX) started the coronavirus vaccine race as a favorite. The company's shares even soared more than 2,700% last year. But the tide has turned for the biotech company. The problem? Manufacturing issues have delayed Novavax's submission for emergency authorization in the U.S. and other countries. As a result, the shares have given back a large percentage of this year's gain.</p>\n<p>But things worsened in recent days. A news report suggested Novavax's delays may not be over. The stock sank nearly 15% in one trading session. Even before that decline, the shares were trading below Wall Street's most pessimistic 12-month share price forecast.</p>\n<p>As you might be guessing right now, the biggest risk Novavax faces is this: missing its latest goal to apply for authorization in the U.S., Europe, and other areas by the end of the year. That kind of news could crush the stock. Does this mean you should flee Novavax shares -- or use recent declines as a buying opportunity?</p>\n<h2>U.K. and U.S. trial data</h2>\n<p>First, let's take a look at what's happened so far. Novavax reported positive data from a U.K. trial early this year -- and solid results from its U.S. trial a few months later. With data from both trials, Novavax aimed to file for emergency authorization in the second quarter.</p>\n<p>Then, in May, Novavax said it wouldn't make that deadline. That was due to raw materials shortages and other manufacturing issues. To win authorization, a company must demonstrate it can manufacture quality product at scale over time. At this point, Novavax said it would complete its regulatory submission in the third quarter.</p>\n<p>In the most recent earnings call, Novavax extended the deadline once again -- to the fourth quarter. The company said it was still working with third parties on some elements and completing the validation of its analytical methods.</p>\n<p>So that brings us to the latest news. This week, Politico, citing people familiar with the situation, reported more troubles: Novavax's testing method to ensure the purity of vaccine batches hasn't met regulators' expectations. These people told Politico the manufacturing and testing issues could delay authorization of Novavax's vaccine candidate until the end of 2022.</p>\n<h2>Novavax reconfirms timeline</h2>\n<p>In response, Novavax issued a statement reconfirming its regulatory timeline. The company says it's \"now routinely producing high-quality product at commercial scale at multiple sites across the world.\"</p>\n<p>Now, let's talk about risk. Do we put our confidence in Novavax and its management team? The company <i>has</i> postponed its filing goal more than once. It's not impossible that another delay might be on the horizon. So, this is a risk we have to face. It's clear that more delays would damage investors' confidence in the company -- even if Novavax is trying its hardest to get everything right. And the share price would suffer.</p>\n<p>But if Novavax files for authorization according to plan, the shares could skyrocket. And vaccine revenue down the road represents another catalyst for share performance. In an earnings call earlier this year, Novavax predicted billions of dollars in revenue over the four to six quarters ahead. That's huge for a company's first commercialized product.</p>\n<p>From today's level, Novavax stock could climb 91% in the coming 12 months, according to Wall Street's average forecast. And if it meets its goals, it could move much higher over the longer term.</p>\n<p>Speaking of the long term, Novavax has a lot to offer down the road. The company's flu vaccine candidate -- NanoFlu -- met primary endpoints in its pivotal trial. The next step is a regulatory submission. And Novavax has launched a clinical trial of a combined COVID/flu vaccine. So far, it's ahead of rivals on that potential product.</p>\n<p>Of course, all of that sounds great. But to be successful in today's or future projects, it's critical that Novavax resolve any manufacturing and testing issues. They are key to gaining the regulatory nod -- and eventually selling products.</p>\n<h2>Should you buy Novavax?</h2>\n<p>So, should you flee Novavax or buy the shares? It all depends on your investing style. If you're a cautious investor, you probably should avoid Novavax shares right now. If Novavax disappoints investors again, the shares likely will tumble. And if the timeline to commercialization is long, the stock may take quite a while to recover.</p>\n<p>That said, if you're an aggressive investor, this could be a buying opportunity. Novavax still has what it takes to win in coronavirus and flu prevention down the road. I'm optimistic that it eventually will work out manufacturing problems. So, if you're willing to go through potential ups and downs in the meantime, now might be a good time to get in on this biotech stock.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Faces 1 Major Risk Right Now. Should You Buy the Stock Anyway?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Faces 1 Major Risk Right Now. Should You Buy the Stock Anyway?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-22 19:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/22/novavax-faces-1-major-risk-should-you-buy-anyway/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novavax (NASDAQ:NVAX) started the coronavirus vaccine race as a favorite. The company's shares even soared more than 2,700% last year. But the tide has turned for the biotech company. The problem? ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/22/novavax-faces-1-major-risk-should-you-buy-anyway/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/10/22/novavax-faces-1-major-risk-should-you-buy-anyway/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2177663497","content_text":"Novavax (NASDAQ:NVAX) started the coronavirus vaccine race as a favorite. The company's shares even soared more than 2,700% last year. But the tide has turned for the biotech company. The problem? Manufacturing issues have delayed Novavax's submission for emergency authorization in the U.S. and other countries. As a result, the shares have given back a large percentage of this year's gain.\nBut things worsened in recent days. A news report suggested Novavax's delays may not be over. The stock sank nearly 15% in one trading session. Even before that decline, the shares were trading below Wall Street's most pessimistic 12-month share price forecast.\nAs you might be guessing right now, the biggest risk Novavax faces is this: missing its latest goal to apply for authorization in the U.S., Europe, and other areas by the end of the year. That kind of news could crush the stock. Does this mean you should flee Novavax shares -- or use recent declines as a buying opportunity?\nU.K. and U.S. trial data\nFirst, let's take a look at what's happened so far. Novavax reported positive data from a U.K. trial early this year -- and solid results from its U.S. trial a few months later. With data from both trials, Novavax aimed to file for emergency authorization in the second quarter.\nThen, in May, Novavax said it wouldn't make that deadline. That was due to raw materials shortages and other manufacturing issues. To win authorization, a company must demonstrate it can manufacture quality product at scale over time. At this point, Novavax said it would complete its regulatory submission in the third quarter.\nIn the most recent earnings call, Novavax extended the deadline once again -- to the fourth quarter. The company said it was still working with third parties on some elements and completing the validation of its analytical methods.\nSo that brings us to the latest news. This week, Politico, citing people familiar with the situation, reported more troubles: Novavax's testing method to ensure the purity of vaccine batches hasn't met regulators' expectations. These people told Politico the manufacturing and testing issues could delay authorization of Novavax's vaccine candidate until the end of 2022.\nNovavax reconfirms timeline\nIn response, Novavax issued a statement reconfirming its regulatory timeline. The company says it's \"now routinely producing high-quality product at commercial scale at multiple sites across the world.\"\nNow, let's talk about risk. Do we put our confidence in Novavax and its management team? The company has postponed its filing goal more than once. It's not impossible that another delay might be on the horizon. So, this is a risk we have to face. It's clear that more delays would damage investors' confidence in the company -- even if Novavax is trying its hardest to get everything right. And the share price would suffer.\nBut if Novavax files for authorization according to plan, the shares could skyrocket. And vaccine revenue down the road represents another catalyst for share performance. In an earnings call earlier this year, Novavax predicted billions of dollars in revenue over the four to six quarters ahead. That's huge for a company's first commercialized product.\nFrom today's level, Novavax stock could climb 91% in the coming 12 months, according to Wall Street's average forecast. And if it meets its goals, it could move much higher over the longer term.\nSpeaking of the long term, Novavax has a lot to offer down the road. The company's flu vaccine candidate -- NanoFlu -- met primary endpoints in its pivotal trial. The next step is a regulatory submission. And Novavax has launched a clinical trial of a combined COVID/flu vaccine. So far, it's ahead of rivals on that potential product.\nOf course, all of that sounds great. But to be successful in today's or future projects, it's critical that Novavax resolve any manufacturing and testing issues. They are key to gaining the regulatory nod -- and eventually selling products.\nShould you buy Novavax?\nSo, should you flee Novavax or buy the shares? It all depends on your investing style. If you're a cautious investor, you probably should avoid Novavax shares right now. If Novavax disappoints investors again, the shares likely will tumble. And if the timeline to commercialization is long, the stock may take quite a while to recover.\nThat said, if you're an aggressive investor, this could be a buying opportunity. Novavax still has what it takes to win in coronavirus and flu prevention down the road. I'm optimistic that it eventually will work out manufacturing problems. So, if you're willing to go through potential ups and downs in the meantime, now might be a good time to get in on this biotech stock.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":2527,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":825898799,"gmtCreate":1634215107459,"gmtModify":1634215107459,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584074223056401","idStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/825898799","repostId":"1160666478","repostType":4,"repost":{"id":"1160666478","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1634212896,"share":"https://ttm.financial/m/news/1160666478?lang=&edition=full","pubTime":"2021-10-14 20:01","market":"us","language":"en","title":"Citigroup quarterly results beat expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=1160666478","media":"Tiger Newspress","summary":"Citigroup Q3 revenue $17.2 bln vs. $17.3 bln a year ago; FactSet consensus $16.9 bln\n\n\nCitigroup Q3 ","content":"<ul>\n <li>Citigroup Q3 revenue $17.2 bln vs. $17.3 bln a year ago; FactSet consensus $16.9 bln</li>\n</ul>\n<ul>\n <li>Citigroup Q3 EPS $2.15 vs. $1.36 a year ago; FactSet consensus $1.71</li>\n</ul>\n<p>Citigroup shares rose 1.5% after quarterly results beat expectations.</p>\n<p><img src=\"https://static.tigerbbs.com/fef76426b619190cc345d929c570d03b\" tg-width=\"847\" tg-height=\"623\" referrerpolicy=\"no-referrer\"></p>\n<p>Citigroup Inc. today reported net income for the third quarter 2021 of $4.6 billion, or $2.15 per diluted share, on revenues of $17.2 billion. This compared to net income of $3.1 billion, or $1.36 per diluted share, on revenues of $17.3 billion for the third quarter 2020.</p>\n<p>Revenues declined 1% from the prior-year period, including a pre-tax loss of approximately $680 million related to the sale of the Australia consumer business in&nbsp;<i>Global Consumer Banking (GCB)</i>. Excluding the loss on sale5, revenues increased 3%, largely driven by growth across the<i>Institutional Clients Group (ICG)</i>.</p>\n<p>Net income of $4.6 billion increased 48% from the prior-year period driven by a lower cost of credit, partially offset by the lower revenues and higher expenses.</p>\n<p>Earnings per share of $2.15 increased 58% from the prior-year period, reflecting the growth in net income, as well as a 3% decline in shares outstanding.</p>\n<p>Jane Fraser, Citi CEO, said, “The recovery from the pandemic continues to drive corporate and consumer confidence and is creating very active client engagement as you can see through our strong results in Investment Banking and Equity Markets, both up approximately 40% year-over-year, in addition to double- digit fee growth in Treasury and Trade Solutions as we help our clients reposition their supply chains. And while strong consumer balance sheets have impacted lending, we are seeing higher consumer spending across our cards products. We also continue to show momentum in deposits and wealth management AUM as well as growing engagement across our digital channels. Overall, our revenues were 3% higher than last year excluding the impact of the sale of our consumer business in Australia.</p>\n<p>“We are moving forward with urgency on our top priorities in order to responsibly narrow the returns gap with our peers: the Transformation, refreshing our strategy and building a culture of excellence. So far this year, we have returned close to $11 billion to shareholders through a healthy dividend and stock repurchases. We remain committed to returning excess capital over and above the amount necessary to invest in our franchise and to maintain our safety and soundness.</p>\n<p>“Overall, I am quite pleased with $4.6 billion in net income given the environment we are operating in. While we have much work ahead, we are getting results from the investments we have been making and seeing both the strength and durability of our franchise,\" Ms. Fraser concluded.</p>\n<p>Percentage comparisons throughout this press release are calculated for the third quarter 2021 versus the third quarter 2020, unless otherwise specified.</p>\n<p><b>Third Quarter Financial Results</b></p>\n<p><img src=\"https://static.tigerbbs.com/52108aff6825605868540370d71c855d\" tg-width=\"1390\" tg-height=\"1256\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Citigroup quarterly results beat expectations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCitigroup quarterly results beat expectations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-14 20:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Citigroup Q3 revenue $17.2 bln vs. $17.3 bln a year ago; FactSet consensus $16.9 bln</li>\n</ul>\n<ul>\n <li>Citigroup Q3 EPS $2.15 vs. $1.36 a year ago; FactSet consensus $1.71</li>\n</ul>\n<p>Citigroup shares rose 1.5% after quarterly results beat expectations.</p>\n<p><img src=\"https://static.tigerbbs.com/fef76426b619190cc345d929c570d03b\" tg-width=\"847\" tg-height=\"623\" referrerpolicy=\"no-referrer\"></p>\n<p>Citigroup Inc. today reported net income for the third quarter 2021 of $4.6 billion, or $2.15 per diluted share, on revenues of $17.2 billion. This compared to net income of $3.1 billion, or $1.36 per diluted share, on revenues of $17.3 billion for the third quarter 2020.</p>\n<p>Revenues declined 1% from the prior-year period, including a pre-tax loss of approximately $680 million related to the sale of the Australia consumer business in&nbsp;<i>Global Consumer Banking (GCB)</i>. Excluding the loss on sale5, revenues increased 3%, largely driven by growth across the<i>Institutional Clients Group (ICG)</i>.</p>\n<p>Net income of $4.6 billion increased 48% from the prior-year period driven by a lower cost of credit, partially offset by the lower revenues and higher expenses.</p>\n<p>Earnings per share of $2.15 increased 58% from the prior-year period, reflecting the growth in net income, as well as a 3% decline in shares outstanding.</p>\n<p>Jane Fraser, Citi CEO, said, “The recovery from the pandemic continues to drive corporate and consumer confidence and is creating very active client engagement as you can see through our strong results in Investment Banking and Equity Markets, both up approximately 40% year-over-year, in addition to double- digit fee growth in Treasury and Trade Solutions as we help our clients reposition their supply chains. And while strong consumer balance sheets have impacted lending, we are seeing higher consumer spending across our cards products. We also continue to show momentum in deposits and wealth management AUM as well as growing engagement across our digital channels. Overall, our revenues were 3% higher than last year excluding the impact of the sale of our consumer business in Australia.</p>\n<p>“We are moving forward with urgency on our top priorities in order to responsibly narrow the returns gap with our peers: the Transformation, refreshing our strategy and building a culture of excellence. So far this year, we have returned close to $11 billion to shareholders through a healthy dividend and stock repurchases. We remain committed to returning excess capital over and above the amount necessary to invest in our franchise and to maintain our safety and soundness.</p>\n<p>“Overall, I am quite pleased with $4.6 billion in net income given the environment we are operating in. While we have much work ahead, we are getting results from the investments we have been making and seeing both the strength and durability of our franchise,\" Ms. Fraser concluded.</p>\n<p>Percentage comparisons throughout this press release are calculated for the third quarter 2021 versus the third quarter 2020, unless otherwise specified.</p>\n<p><b>Third Quarter Financial Results</b></p>\n<p><img src=\"https://static.tigerbbs.com/52108aff6825605868540370d71c855d\" tg-width=\"1390\" tg-height=\"1256\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"C":"花旗"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160666478","content_text":"Citigroup Q3 revenue $17.2 bln vs. $17.3 bln a year ago; FactSet consensus $16.9 bln\n\n\nCitigroup Q3 EPS $2.15 vs. $1.36 a year ago; FactSet consensus $1.71\n\nCitigroup shares rose 1.5% after quarterly results beat expectations.\n\nCitigroup Inc. today reported net income for the third quarter 2021 of $4.6 billion, or $2.15 per diluted share, on revenues of $17.2 billion. This compared to net income of $3.1 billion, or $1.36 per diluted share, on revenues of $17.3 billion for the third quarter 2020.\nRevenues declined 1% from the prior-year period, including a pre-tax loss of approximately $680 million related to the sale of the Australia consumer business in Global Consumer Banking (GCB). Excluding the loss on sale5, revenues increased 3%, largely driven by growth across theInstitutional Clients Group (ICG).\nNet income of $4.6 billion increased 48% from the prior-year period driven by a lower cost of credit, partially offset by the lower revenues and higher expenses.\nEarnings per share of $2.15 increased 58% from the prior-year period, reflecting the growth in net income, as well as a 3% decline in shares outstanding.\nJane Fraser, Citi CEO, said, “The recovery from the pandemic continues to drive corporate and consumer confidence and is creating very active client engagement as you can see through our strong results in Investment Banking and Equity Markets, both up approximately 40% year-over-year, in addition to double- digit fee growth in Treasury and Trade Solutions as we help our clients reposition their supply chains. And while strong consumer balance sheets have impacted lending, we are seeing higher consumer spending across our cards products. We also continue to show momentum in deposits and wealth management AUM as well as growing engagement across our digital channels. Overall, our revenues were 3% higher than last year excluding the impact of the sale of our consumer business in Australia.\n“We are moving forward with urgency on our top priorities in order to responsibly narrow the returns gap with our peers: the Transformation, refreshing our strategy and building a culture of excellence. So far this year, we have returned close to $11 billion to shareholders through a healthy dividend and stock repurchases. We remain committed to returning excess capital over and above the amount necessary to invest in our franchise and to maintain our safety and soundness.\n“Overall, I am quite pleased with $4.6 billion in net income given the environment we are operating in. While we have much work ahead, we are getting results from the investments we have been making and seeing both the strength and durability of our franchise,\" Ms. Fraser concluded.\nPercentage comparisons throughout this press release are calculated for the third quarter 2021 versus the third quarter 2020, unless otherwise specified.\nThird Quarter Financial Results","news_type":1,"symbols_score_info":{"C":0.9}},"isVote":1,"tweetType":1,"viewCount":1406,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":867683213,"gmtCreate":1633252411906,"gmtModify":1633252412028,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584074223056401","idStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/867683213","repostId":"2172964018","repostType":4,"repost":{"id":"2172964018","kind":"news","pubTimestamp":1633238325,"share":"https://ttm.financial/m/news/2172964018?lang=&edition=full","pubTime":"2021-10-03 13:18","market":"us","language":"en","title":"Italy's Leonardo says Boeing to update 787 production plan this month","url":"https://stock-news.laohu8.com/highlight/detail?id=2172964018","media":"Reuters","summary":"DUBAI, Oct 3 (Reuters) - The chief executive of Italian aerospace firm Leonardo said Boeing was expe","content":"<p>DUBAI, Oct 3 (Reuters) - The chief executive of Italian aerospace firm Leonardo said Boeing was expected this month to release an updated production plan for its 787 Dreamliner wide-body jet.</p>\n<p>\"In the next day they will come out with a new plan,\" Leonardo CEO Alessandro Profumo told Reuters at the Dubai Expo on Saturday. \"They are saying they are 'slightly more optimistic', shall we say.\"</p>\n<p>Profumo did not say whether there would be a change in production rates in the new plan to be released by Boeing. Leonardo manufactures part of the Dreamliner airframe.</p>\n<p>A Boeing representative told Reuters the planemaker did not have any updates on 787 production. They did not say whether a new production plan would soon be released.</p>\n<p>\"We are constantly analysing the global aviation market, coordinating closely with suppliers and aligning supply with demand.”</p>\n<p>Leonardo expects Boeing to produce at a rate of 10 Dreamliners a month by the end of 2025, Profumo said, citing existing advice from the planemaker.</p>\n<p>Boeing was producing at a rate of 14 a month in 2019, according to the latest available data.</p>\n<p>The U.S. planemaker suspended Dreamliner deliveries in late May after the Federal Aviation Administration raised concerns about its proposed inspection method. (Reporting by Alexander Cornwell; Editing by William Mallard)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Italy's Leonardo says Boeing to update 787 production plan this month</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nItaly's Leonardo says Boeing to update 787 production plan this month\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-03 13:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/italys-leonardo-says-boeing-787-051845587.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DUBAI, Oct 3 (Reuters) - The chief executive of Italian aerospace firm Leonardo said Boeing was expected this month to release an updated production plan for its 787 Dreamliner wide-body jet.\n\"In the ...</p>\n\n<a href=\"https://finance.yahoo.com/news/italys-leonardo-says-boeing-787-051845587.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/italys-leonardo-says-boeing-787-051845587.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2172964018","content_text":"DUBAI, Oct 3 (Reuters) - The chief executive of Italian aerospace firm Leonardo said Boeing was expected this month to release an updated production plan for its 787 Dreamliner wide-body jet.\n\"In the next day they will come out with a new plan,\" Leonardo CEO Alessandro Profumo told Reuters at the Dubai Expo on Saturday. \"They are saying they are 'slightly more optimistic', shall we say.\"\nProfumo did not say whether there would be a change in production rates in the new plan to be released by Boeing. Leonardo manufactures part of the Dreamliner airframe.\nA Boeing representative told Reuters the planemaker did not have any updates on 787 production. They did not say whether a new production plan would soon be released.\n\"We are constantly analysing the global aviation market, coordinating closely with suppliers and aligning supply with demand.”\nLeonardo expects Boeing to produce at a rate of 10 Dreamliners a month by the end of 2025, Profumo said, citing existing advice from the planemaker.\nBoeing was producing at a rate of 14 a month in 2019, according to the latest available data.\nThe U.S. planemaker suspended Dreamliner deliveries in late May after the Federal Aviation Administration raised concerns about its proposed inspection method. (Reporting by Alexander Cornwell; Editing by William Mallard)","news_type":1,"symbols_score_info":{"BA":0.9}},"isVote":1,"tweetType":1,"viewCount":506,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":867683187,"gmtCreate":1633252387382,"gmtModify":1633252387540,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584074223056401","idStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/867683187","repostId":"2172647479","repostType":4,"repost":{"id":"2172647479","kind":"highlight","pubTimestamp":1633243084,"share":"https://ttm.financial/m/news/2172647479?lang=&edition=full","pubTime":"2021-10-03 14:38","market":"hk","language":"en","title":"Why Coinbase Global Stock Was Down 12.2% in September","url":"https://stock-news.laohu8.com/highlight/detail?id=2172647479","media":"Motley Fool","summary":"The company is going head-to-head with financial regulators, and that is making investors nervous.","content":"<h2>What happened</h2>\n<p>Shares of <b>Coinbase Global</b> (NASDAQ:COIN) were down 12.2% in September, according to data from&nbsp;S&amp;P Global Market Intelligence. The stock tends to be correlated with cryptocurrency prices, which fell during the month, and the company announced the Securities and Exchange Comission (SEC) was going to sue the company if it launched its new stablecoin lending program.</p>\n<p>On top of this, the broad market indices took a tumble in September, with the<b> S&amp;P 500</b> index down around 5% in the period. This likely exacerbated Coinbase stock's decline.</p>\n<h2>So what</h2>\n<p>A stablecoin is a cryptocurrency that is backed by a reserve, typically a fiat currency like the U.S. dollar. This means that when you buy stablecoins, they will theoretically be able to be converted back to U.S. dollars at any point. Coinbase, as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the largest crypto companies in the world, helped start a stablecoin called USD Coin (USDC) with a company called Circle. There are currently 31.2 billion USDC in circulation, meaning $31.2 billion (in U.S. dollars) has been exchanged for the stablecoin.</p>\n<p>What does this have to do with Coinbase stock and the SEC? Well, in order to make some money, Coinbase was planning to offer USDC owners the ability to lend their stablecoins to Coinbase, paying them a 4% annual interest rate (eight times the national average) if they join the lending program. Coinbase can make money doing this because other crypto traders (or really anyone interested in getting a loan) are willing to pay higher interest rates to get USDC loaned to them from Coinbase. When Coinbase came to the SEC to launch the lending program, the SEC gave the company a Wells notice, which means the regulator intends to sue Coinbase if it launches the product.</p>\n<p>With almost $5.5 billion in projected sales this year, Coinbase's business won't go away because of this SEC crackdown. However, it does indicate the government might get more aggressive cracking down on any new initiatives the company has, which could hurt its ability to grow over the next decade.</p>\n<p>In other news, major cryptocurrencies like <b>Bitcoin</b> (CRYPTO:BTC) fell last month. The coin started at around $50,000 at the beginning of December but finished the month closer to $40,000. Coinbase owns Bitcoin and makes money through cryptocurrency trades, so its stock tends to correlate with any major moves in the cryptocurrency market.</p>\n<h2>Now what</h2>\n<p>This news from the SEC and Coinbase won't crush the company's current operations, but it is a concern that the SEC may crack down on the company's potential growth opportunities. If you are bullish on the crypto industry and think it is the future of finance, these regulatory risks are something to consider and could impact Coinbase's stock over the long term.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Coinbase Global Stock Was Down 12.2% in September</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Coinbase Global Stock Was Down 12.2% in September\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-03 14:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/03/why-coinbase-was-down-this-month/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happened\nShares of Coinbase Global (NASDAQ:COIN) were down 12.2% in September, according to data from S&P Global Market Intelligence. The stock tends to be correlated with cryptocurrency prices, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/03/why-coinbase-was-down-this-month/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/10/03/why-coinbase-was-down-this-month/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2172647479","content_text":"What happened\nShares of Coinbase Global (NASDAQ:COIN) were down 12.2% in September, according to data from S&P Global Market Intelligence. The stock tends to be correlated with cryptocurrency prices, which fell during the month, and the company announced the Securities and Exchange Comission (SEC) was going to sue the company if it launched its new stablecoin lending program.\nOn top of this, the broad market indices took a tumble in September, with the S&P 500 index down around 5% in the period. This likely exacerbated Coinbase stock's decline.\nSo what\nA stablecoin is a cryptocurrency that is backed by a reserve, typically a fiat currency like the U.S. dollar. This means that when you buy stablecoins, they will theoretically be able to be converted back to U.S. dollars at any point. Coinbase, as one of the largest crypto companies in the world, helped start a stablecoin called USD Coin (USDC) with a company called Circle. There are currently 31.2 billion USDC in circulation, meaning $31.2 billion (in U.S. dollars) has been exchanged for the stablecoin.\nWhat does this have to do with Coinbase stock and the SEC? Well, in order to make some money, Coinbase was planning to offer USDC owners the ability to lend their stablecoins to Coinbase, paying them a 4% annual interest rate (eight times the national average) if they join the lending program. Coinbase can make money doing this because other crypto traders (or really anyone interested in getting a loan) are willing to pay higher interest rates to get USDC loaned to them from Coinbase. When Coinbase came to the SEC to launch the lending program, the SEC gave the company a Wells notice, which means the regulator intends to sue Coinbase if it launches the product.\nWith almost $5.5 billion in projected sales this year, Coinbase's business won't go away because of this SEC crackdown. However, it does indicate the government might get more aggressive cracking down on any new initiatives the company has, which could hurt its ability to grow over the next decade.\nIn other news, major cryptocurrencies like Bitcoin (CRYPTO:BTC) fell last month. The coin started at around $50,000 at the beginning of December but finished the month closer to $40,000. Coinbase owns Bitcoin and makes money through cryptocurrency trades, so its stock tends to correlate with any major moves in the cryptocurrency market.\nNow what\nThis news from the SEC and Coinbase won't crush the company's current operations, but it is a concern that the SEC may crack down on the company's potential growth opportunities. If you are bullish on the crypto industry and think it is the future of finance, these regulatory risks are something to consider and could impact Coinbase's stock over the long term.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":350,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864889684,"gmtCreate":1633088132874,"gmtModify":1633088214440,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584074223056401","idStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/864889684","repostId":"1178374850","repostType":4,"repost":{"id":"1178374850","kind":"news","pubTimestamp":1633077146,"share":"https://ttm.financial/m/news/1178374850?lang=&edition=full","pubTime":"2021-10-01 16:32","market":"us","language":"en","title":"Here's the Newest Plant-Based Stock to Join the 'Eat More Plants' Boom","url":"https://stock-news.laohu8.com/highlight/detail?id=1178374850","media":"The Street","summary":"Eat Well Investment Group, also known as 'The Company', is a Canadian plant-protein company winning ","content":"<p>Eat Well Investment Group, also known as 'The Company', is a Canadian plant-protein company winning in the space. The latest news on the agri-tech company.</p>\n<p>Highlighted by the success of well-marketed plant-meat brands like Beyond Meat&nbsp;(<b>BYND</b>) -Get Beyond Meat, Inc. Report,&nbsp;Ingredion&nbsp;(<b>INGR</b>) -Get Ingredion Incorporated Report, Tyson Foods&nbsp;(<b>TSN</b>) -Get Tyson Foods, Inc. Class A Report, Oatly&nbsp;(<b>OAT,</b>)&nbsp;and Impossible Foods, the plant-based-food space has courted billions of dollars in inflows and likewise encouraged a host of entrants seeking to seize on the opportunity.</p>\n<p>Interestingly, one of the biggest winners in the space as of late is not one of those household names, but rather Vancouver-based Eat Well Investment Group&nbsp;(<b>EWGFF</b>) -Get EAT WELL INVESTMENT GROUP INC Report&nbsp;CA: EWG. Thursday, the OTC stock was at $.70 per share, up 1.7% just after the market open.</p>\n<p>“We have the total supply chain and the technology to know how to make incredible tasting and healthy food. That’s the overriding picture here,” Eat Well Chief Investment Officer Mark Coles said, helping to explain the contrasting stock trends.</p>\n<p>\"The Company\", wasfounded on the principleof “how do we feed our families while honoring time-valued health and wellness traditions.”</p>\n<p>Coles said, “Not only is it a superior product, less fat, fewer calories, etc., but it also comes with significantly more attractive margins than our competitors.”</p>\n<p>Promising Plant-Based Trends</p>\n<p>First and foremost, it is crucial to quantify the pace at which the opportunity in plant-based foods is progressing. Per Bloomberg Intelligence, the plant-based-foods market is expected toaccelerate to $162 billionin 2030&nbsp;from $29.4 billion at present.</p>\n<p><img src=\"https://static.tigerbbs.com/dd4274dfb92309681257d7893e3c1398\" tg-width=\"1200\" tg-height=\"729\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Source: Bloomberg Intelligence</p>\n<p>That pace puts the market on track to easily outpace growth in its protein peers, many of which are seeing demand plateau as consumer tastes shift, environmental concerns abound, and livestock epidemics hurt supply. By the end of the decade, vegetarian options will be near par with other proteins in terms of total market size, a position few could have anticipated even just a few years ago.</p>\n<p><i>Source: Eat Well Investment Group Inc.</i></p>\n<p>Crowded Competitive Landscape</p>\n<p>To be sure, the market opportunity available is no sign of assured success for individual companies. As with any major market gap, there is no shortage of firms seeking to deal with the growing demand.</p>\n<p>Thus far, longstanding meat-based protein players like JBS SA&nbsp;(<b>JBSAY</b>), Nestle&nbsp;(<b>NSRGY</b>) -Get NSRGY Report, and Tyson Foods&nbsp;(<b>TSN</b>) -Get Tyson Foods, Inc. Class A Report&nbsp;have attracted adulation from analysts and investors alike for shifting to accommodate plant-based products.</p>\n<p>Meanwhile, Beyond Meat and Impossible Foods have inked numerous high-profile partnerships, capitalizing on their marketability. In fact, Beyond Meat has even found itself on theshortlist of meme stocksthat traders have taken dearly to over the course of 2020 and 2021.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's the Newest Plant-Based Stock to Join the 'Eat More Plants' Boom</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's the Newest Plant-Based Stock to Join the 'Eat More Plants' Boom\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 16:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/eat-well-group-plant-based-opportunity><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Eat Well Investment Group, also known as 'The Company', is a Canadian plant-protein company winning in the space. The latest news on the agri-tech company.\nHighlighted by the success of well-marketed ...</p>\n\n<a href=\"https://www.thestreet.com/investing/eat-well-group-plant-based-opportunity\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OTLY":"Oatly Group AB","BYND":"Beyond Meat, Inc.","TSN":"泰森食品"},"source_url":"https://www.thestreet.com/investing/eat-well-group-plant-based-opportunity","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178374850","content_text":"Eat Well Investment Group, also known as 'The Company', is a Canadian plant-protein company winning in the space. The latest news on the agri-tech company.\nHighlighted by the success of well-marketed plant-meat brands like Beyond Meat (BYND) -Get Beyond Meat, Inc. Report, Ingredion (INGR) -Get Ingredion Incorporated Report, Tyson Foods (TSN) -Get Tyson Foods, Inc. Class A Report, Oatly (OAT,) and Impossible Foods, the plant-based-food space has courted billions of dollars in inflows and likewise encouraged a host of entrants seeking to seize on the opportunity.\nInterestingly, one of the biggest winners in the space as of late is not one of those household names, but rather Vancouver-based Eat Well Investment Group (EWGFF) -Get EAT WELL INVESTMENT GROUP INC Report CA: EWG. Thursday, the OTC stock was at $.70 per share, up 1.7% just after the market open.\n“We have the total supply chain and the technology to know how to make incredible tasting and healthy food. That’s the overriding picture here,” Eat Well Chief Investment Officer Mark Coles said, helping to explain the contrasting stock trends.\n\"The Company\", wasfounded on the principleof “how do we feed our families while honoring time-valued health and wellness traditions.”\nColes said, “Not only is it a superior product, less fat, fewer calories, etc., but it also comes with significantly more attractive margins than our competitors.”\nPromising Plant-Based Trends\nFirst and foremost, it is crucial to quantify the pace at which the opportunity in plant-based foods is progressing. Per Bloomberg Intelligence, the plant-based-foods market is expected toaccelerate to $162 billionin 2030 from $29.4 billion at present.\n\nSource: Bloomberg Intelligence\nThat pace puts the market on track to easily outpace growth in its protein peers, many of which are seeing demand plateau as consumer tastes shift, environmental concerns abound, and livestock epidemics hurt supply. By the end of the decade, vegetarian options will be near par with other proteins in terms of total market size, a position few could have anticipated even just a few years ago.\nSource: Eat Well Investment Group Inc.\nCrowded Competitive Landscape\nTo be sure, the market opportunity available is no sign of assured success for individual companies. As with any major market gap, there is no shortage of firms seeking to deal with the growing demand.\nThus far, longstanding meat-based protein players like JBS SA (JBSAY), Nestle (NSRGY) -Get NSRGY Report, and Tyson Foods (TSN) -Get Tyson Foods, Inc. Class A Report have attracted adulation from analysts and investors alike for shifting to accommodate plant-based products.\nMeanwhile, Beyond Meat and Impossible Foods have inked numerous high-profile partnerships, capitalizing on their marketability. In fact, Beyond Meat has even found itself on theshortlist of meme stocksthat traders have taken dearly to over the course of 2020 and 2021.","news_type":1,"symbols_score_info":{"BYND":0.9,"OTLY":0.9,"TSN":0.9}},"isVote":1,"tweetType":1,"viewCount":500,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":861411098,"gmtCreate":1632530634314,"gmtModify":1632711535934,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584074223056401","idStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/861411098","repostId":"2170619785","repostType":4,"isVote":1,"tweetType":1,"viewCount":598,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":887014758,"gmtCreate":1631943693874,"gmtModify":1632805154888,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584074223056401","idStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/887014758","repostId":"2168716185","repostType":4,"repost":{"id":"2168716185","kind":"news","pubTimestamp":1631916051,"share":"https://ttm.financial/m/news/2168716185?lang=&edition=full","pubTime":"2021-09-18 06:00","market":"us","language":"en","title":"Wall Street closes rollercoaster week sharply lower","url":"https://stock-news.laohu8.com/highlight/detail?id=2168716185","media":"The Straits Times","summary":"NEW YORK  - US stocks ended sharply lower in a broad sell-off on Friday , ending a week buffeted by strong economic data, corporate tax hike worries, the Delta Covid-19 variant, and possible shifts in the US Federal Reserve's timeline for tapering asset purchases.All three major US stock indexes lost ground, with the Nasdaq Composite Index's weighed down as rising US Treasury yields pressured market-leading growth stocks.They also posted weekly losses, with the S&P index suffering its biggest tw","content":"<div>\n<p>NEW YORK (REUTERS) - US stocks ended sharply lower in a broad sell-off on Friday (Sept 17), ending a week buffeted by strong economic data, corporate tax hike worries, the Delta Covid-19 variant, and ...</p>\n\n<a href=\"http://www.straitstimes.com/business/companies-markets/wall-street-closes-rollercoaster-week-sharply-lower\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street closes rollercoaster week sharply lower</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street closes rollercoaster week sharply lower\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-18 06:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://www.straitstimes.com/business/companies-markets/wall-street-closes-rollercoaster-week-sharply-lower><strong>The Straits Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK (REUTERS) - US stocks ended sharply lower in a broad sell-off on Friday (Sept 17), ending a week buffeted by strong economic data, corporate tax hike worries, the Delta Covid-19 variant, and ...</p>\n\n<a href=\"http://www.straitstimes.com/business/companies-markets/wall-street-closes-rollercoaster-week-sharply-lower\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SDS":"两倍做空标普500ETF","UPRO":"三倍做多标普500ETF",".SPX":"S&P 500 Index","SSO":"两倍做多标普500ETF","OEX":"标普100","OEF":"标普100指数ETF-iShares","IVV":"标普500指数ETF","SPXU":"三倍做空标普500ETF","SH":"标普500反向ETF"},"source_url":"http://www.straitstimes.com/business/companies-markets/wall-street-closes-rollercoaster-week-sharply-lower","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168716185","content_text":"NEW YORK (REUTERS) - US stocks ended sharply lower in a broad sell-off on Friday (Sept 17), ending a week buffeted by strong economic data, corporate tax hike worries, the Delta Covid-19 variant, and possible shifts in the US Federal Reserve's timeline for tapering asset purchases.\nAll three major US stock indexes lost ground, with the Nasdaq Composite Index's weighed down as rising US Treasury yields pressured market-leading growth stocks.\nThey also posted weekly losses, with the S&P index suffering its biggest two-week drop since February.\n\"The market is struggling with prospects for tighter fiscal policy due to tax increases, and tighter monetary policy due to Fed tapering,\" said David Carter, chief investment officer at Lenox Wealth Advisors in New York.\n\"Equity markets are also a little softer due to today's weak Consumer Sentiment data,\" Carter added. \"It's triggering concerns that the Delta variant could slow economic growth.\"\nA potential hike in corporate taxes could eat into earnings also weigh on markets, with leading Democrats seeking to raise the top tax rate on corporations to 26.5 per cent from the current 21 per cent.\nWhile consumer sentiment steadied this month it remains depressed, according to a University of Michigan report, as Americans postpone purchases while inflation remains high.\nInflation is likely to be a major issue next week, when the Federal Open Markets Committee holds its two-day monetary policy meeting. Market participants will be watching closely for changes in nuance which could signal a shift in the Fed's tapering timeline.\n\"It has been a week of mixed economic data and we are focused clearly on what will come out of the Fed meeting next week,\" said Bill Northey, senior investment director at US Bank Wealth Management in Helena, Montana.\nThe Dow Jones Industrial Average fell 166.44 points, or 0.48 per cent, to 34,584.88; the S&P 500 lost 40.76 points, or 0.91 per cent, at 4,432.99; and the Nasdaq Composite dropped 137.96 points, or 0.91 per cent, to 15,043.97.\nThe S&P 500 ended below its 50-day moving average, which in recent history has proven a rather sturdy support level.\nOf the 11 major sectors in the S&P 500, all but healthcare ended in the red, with materials and utilities suffering the biggest percentage drops.\nWall Street ends rollercoaster week sharply lower\nCovid-19 vaccine manufacturers Pfizer and Moderna dropped 1.3 per cent and 2.4 per cent, respectively, as US health officials moved the debate over booster doses to a panel of independent experts.\nUS Steel Corp shed 8 per cent after it unveiled a US$3 billion (S$4 billion) mini-mill investment plan.\nVolume and volatility spiked toward the end of the session due to \"triple witching,\" which is the quarterly, simultaneous expiration of stock options, stock index futures, and stock index options contracts.\nVolume on US exchanges was 15.51 billion shares, compared with the 9.70 billion average over the last 20 trading days.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.97-to-1 ratio; on Nasdaq, a 1.00-to-1 ratio favoured advancers.\nThe S&P 500 posted seven new 52-week highs and two new lows; the Nasdaq Composite recorded 67 new highs and 82 new lows.","news_type":1,"symbols_score_info":{"161125":0.9,"513500":0.9,".SPX":0.9,"ESmain":0.9,"IVV":0.9,"OEF":0.9,"OEX":0.9,"SDS":0.9,"SH":0.9,"SPXU":0.9,"SSO":0.9,"UPRO":0.9}},"isVote":1,"tweetType":1,"viewCount":294,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":884889503,"gmtCreate":1631878573402,"gmtModify":1631890580343,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584074223056401","idStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/884889503","repostId":"2168529607","repostType":4,"repost":{"id":"2168529607","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1631865945,"share":"https://ttm.financial/m/news/2168529607?lang=&edition=full","pubTime":"2021-09-17 16:05","market":"sh","language":"en","title":"ADVISORY-China markets closed for Mid-Autumn Festival","url":"https://stock-news.laohu8.com/highlight/detail?id=2168529607","media":"Reuters","summary":"Mainland China's stock and bond markets, foreign exchange and commodity futures markets will be clos","content":"<p>Mainland China's stock and bond markets, foreign exchange and commodity futures markets will be closed through Sept. 21 for Mid-Autumn Festival.</p>\n<p>Markets will resume trade on Wednesday, Sept. 22.</p>\n<p>Meanwhile, Hong Kong's financial markets will be closed for the public holiday on Wednesday, Sept. 22.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ADVISORY-China markets closed for Mid-Autumn Festival</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nADVISORY-China markets closed for Mid-Autumn Festival\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-17 16:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Mainland China's stock and bond markets, foreign exchange and commodity futures markets will be closed through Sept. 21 for Mid-Autumn Festival.</p>\n<p>Markets will resume trade on Wednesday, Sept. 22.</p>\n<p>Meanwhile, Hong Kong's financial markets will be closed for the public holiday on Wednesday, Sept. 22.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"399001":"深证成指","399006":"创业板指","000001.SH":"上证指数","HSI":"恒生指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168529607","content_text":"Mainland China's stock and bond markets, foreign exchange and commodity futures markets will be closed through Sept. 21 for Mid-Autumn Festival.\nMarkets will resume trade on Wednesday, Sept. 22.\nMeanwhile, Hong Kong's financial markets will be closed for the public holiday on Wednesday, Sept. 22.","news_type":1,"symbols_score_info":{"399001":0.9,"399006":0.9,"000001.SH":0.9,"HSI":0.9}},"isVote":1,"tweetType":1,"viewCount":408,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":888753906,"gmtCreate":1631532379205,"gmtModify":1631890580349,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584074223056401","idStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/888753906","repostId":"2167630550","repostType":4,"isVote":1,"tweetType":1,"viewCount":434,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":888043649,"gmtCreate":1631416618381,"gmtModify":1631890580349,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584074223056401","idStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/888043649","repostId":"1189654544","repostType":4,"repost":{"id":"1189654544","kind":"news","pubTimestamp":1631406130,"share":"https://ttm.financial/m/news/1189654544?lang=&edition=full","pubTime":"2021-09-12 08:22","market":"us","language":"en","title":"US IPO Week Ahead: The Fall IPO market kicks off with a 10 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1189654544","media":"Renaissance Capital","summary":"After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion i","content":"<p>After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion in the week ahead.</p>\n<p>Tech consultancy&nbsp;<b>Thoughtworks</b>(TWKS) plans to raise $700 million at a $6.3 billion market cap. This agile software developer provides premium, end-to-end digital strategy, design, and engineering services to more than 300 enterprise customers. The company grew revenue at a 14% CAGR from 2017 to 2020, and expanded margins in 2020 and the 1H21.</p>\n<p>Swiss running shoe brand&nbsp;<b>On Holding</b>(ONON) plans to raise $591 million at a $5.9 billion market cap. On is a global provider of premium athletic footwear, apparel, and accessories that are designed using sustainable materials and its proprietary technology. The company has demonstrated growth and profitability, though it faces significant competition from other well-known sportswear brands.</p>\n<p>After ending talks to go public via SPAC,<b>Sportradar Group</b>(SRAD) plans to raise $504 million at a $7.9 billion market cap. Covering over 750,000 events annually across 83 sports, this Swiss company provides software, data, and content to sports leagues, betting operators, and media companies. Sportradar is profitable, and growth accelerated in the 1H21 as live sports resumed.</p>\n<p>Drive-thru coffee chain&nbsp;<b>Dutch Bros</b>(BROS) plans to raise $400 million at a $3.3 billion market cap. This Oregon-based company has a chain of 471 drive-thru coffee shops in the Western US, and it has been able to maintain a track record of same-store sales growth as it has expanded to new states. Insiders received pre-IPO dividends and will sell shares back to the company.</p>\n<p>Healthcare intelligence platform&nbsp;<b>Definitive Healthcare</b>(DH) plans to raise $350 million at a $3.3 billion market cap. This company provides a healthcare commercial intelligence and analytics platform, helping its customers to analyze, navigate, and sell into the complex healthcare ecosystem. Unprofitable with strong growth, Definitive Healthcare will be leveraged post-IPO.</p>\n<p>Identity management platform&nbsp;<b>ForgeRock</b>(FORG) plans to raise $248 million at a $2.1 billion market cap. The company provides identity and access management software, with a platform to provision, authenticate, and govern all types of digital identities. Unprofitable with high sales and marketing expenses, ForgeRock is a leading next-gen provider in the multi-billion-dollar identity and access market.</p>\n<p>Immunology biotech&nbsp;<b>DICE Therapeutics</b>(DICE) plans to raise $160 million at a $550 million market cap. This biotech is developing oral small molecule therapies to treat chronic diseases in immunology and other therapeutic areas. DICE plans to initiate a Phase 1 trial of its lead candidate S011806, an oral antagonist with a variety of immunology indications.</p>\n<p>Surgical robotics developer&nbsp;<b>PROCEPT BioRobotics</b>(PRCT) plans to raise $127 million at a $1.1 billion market cap. This commercial-stage company develops surgical robotic systems for minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics is highly unprofitable and saw revenue increase more than sixfold in the 1H21.</p>\n<p>Oncology biotech&nbsp;<b>Tyra Biosciences</b>(TYRA) plans to raise $101 million at a $584 million market cap. This preclinical biotech is developing FGFR kinase inhibitors for cancer, specifically solid tumors. Tyra’s lead candidate is initially focused on bladder cancer, and the company expects to submit an IND for it in mid-2022.</p>\n<p>Micro-cap gas delivery service&nbsp;<b>EzFill Holdings</b>(EZFL) plans to raise $25 million at a $104 million market cap. This mobile-fueling company provides an on-demand fuel delivery service in Florida via mobile app. Highly unprofitable with explosive growth, EzFill states that it is the dominant player in the South Florida market.</p>\n<p><img src=\"https://static.tigerbbs.com/718698ff98644c4026f32efe91d076c6\" tg-width=\"1128\" tg-height=\"684\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/97fe13300d9e4cf61effc59b9706776a\" tg-width=\"1129\" tg-height=\"247\" referrerpolicy=\"no-referrer\"></p>\n<p><b>IPO Market Snapshot</b></p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 9/9/21, the Renaissance IPO Index was up 7.7% year-to-date, while the S&amp;P 500 was up 19.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 11.0% year-to-date, while the ACWX was up 10.0%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.</p>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: The Fall IPO market kicks off with a 10 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: The Fall IPO market kicks off with a 10 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-12 08:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/85972/US-IPO-Week-Ahead-The-Fall-IPO-market-kicks-off-with-a-10-IPO-week><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion in the week ahead.\nTech consultancy Thoughtworks(TWKS) plans to raise $700 million at a $6.3 billion ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/85972/US-IPO-Week-Ahead-The-Fall-IPO-market-kicks-off-with-a-10-IPO-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/85972/US-IPO-Week-Ahead-The-Fall-IPO-market-kicks-off-with-a-10-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189654544","content_text":"After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion in the week ahead.\nTech consultancy Thoughtworks(TWKS) plans to raise $700 million at a $6.3 billion market cap. This agile software developer provides premium, end-to-end digital strategy, design, and engineering services to more than 300 enterprise customers. The company grew revenue at a 14% CAGR from 2017 to 2020, and expanded margins in 2020 and the 1H21.\nSwiss running shoe brand On Holding(ONON) plans to raise $591 million at a $5.9 billion market cap. On is a global provider of premium athletic footwear, apparel, and accessories that are designed using sustainable materials and its proprietary technology. The company has demonstrated growth and profitability, though it faces significant competition from other well-known sportswear brands.\nAfter ending talks to go public via SPAC,Sportradar Group(SRAD) plans to raise $504 million at a $7.9 billion market cap. Covering over 750,000 events annually across 83 sports, this Swiss company provides software, data, and content to sports leagues, betting operators, and media companies. Sportradar is profitable, and growth accelerated in the 1H21 as live sports resumed.\nDrive-thru coffee chain Dutch Bros(BROS) plans to raise $400 million at a $3.3 billion market cap. This Oregon-based company has a chain of 471 drive-thru coffee shops in the Western US, and it has been able to maintain a track record of same-store sales growth as it has expanded to new states. Insiders received pre-IPO dividends and will sell shares back to the company.\nHealthcare intelligence platform Definitive Healthcare(DH) plans to raise $350 million at a $3.3 billion market cap. This company provides a healthcare commercial intelligence and analytics platform, helping its customers to analyze, navigate, and sell into the complex healthcare ecosystem. Unprofitable with strong growth, Definitive Healthcare will be leveraged post-IPO.\nIdentity management platform ForgeRock(FORG) plans to raise $248 million at a $2.1 billion market cap. The company provides identity and access management software, with a platform to provision, authenticate, and govern all types of digital identities. Unprofitable with high sales and marketing expenses, ForgeRock is a leading next-gen provider in the multi-billion-dollar identity and access market.\nImmunology biotech DICE Therapeutics(DICE) plans to raise $160 million at a $550 million market cap. This biotech is developing oral small molecule therapies to treat chronic diseases in immunology and other therapeutic areas. DICE plans to initiate a Phase 1 trial of its lead candidate S011806, an oral antagonist with a variety of immunology indications.\nSurgical robotics developer PROCEPT BioRobotics(PRCT) plans to raise $127 million at a $1.1 billion market cap. This commercial-stage company develops surgical robotic systems for minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics is highly unprofitable and saw revenue increase more than sixfold in the 1H21.\nOncology biotech Tyra Biosciences(TYRA) plans to raise $101 million at a $584 million market cap. This preclinical biotech is developing FGFR kinase inhibitors for cancer, specifically solid tumors. Tyra’s lead candidate is initially focused on bladder cancer, and the company expects to submit an IND for it in mid-2022.\nMicro-cap gas delivery service EzFill Holdings(EZFL) plans to raise $25 million at a $104 million market cap. This mobile-fueling company provides an on-demand fuel delivery service in Florida via mobile app. Highly unprofitable with explosive growth, EzFill states that it is the dominant player in the South Florida market.\n\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 9/9/21, the Renaissance IPO Index was up 7.7% year-to-date, while the S&P 500 was up 19.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 11.0% year-to-date, while the ACWX was up 10.0%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"BROS":0.9,"DH":0.9,"DICE":0.9,"EZFL":0.9,"FORG":0.9,"ONON":0.9,"PRCT":0.9,"SRAD":0.9,"TWKS":0.9,"TYRA":0.9}},"isVote":1,"tweetType":1,"viewCount":225,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881697024,"gmtCreate":1631328943068,"gmtModify":1631890580355,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584074223056401","idStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/881697024","repostId":"2166711943","repostType":4,"repost":{"id":"2166711943","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1631315453,"share":"https://ttm.financial/m/news/2166711943?lang=&edition=full","pubTime":"2021-09-11 07:10","market":"us","language":"en","title":"Wall Street ends down, Apple sinks on app store ruling","url":"https://stock-news.laohu8.com/highlight/detail?id=2166711943","media":"Reuters","summary":"Sept 10  - Wall Street ended sharply lower on Friday as investors weighed signs of higher inflation, while Apple Inc tumbled following an unfavorable court ruling related to its app store.U.S. producer prices rose solidly in August, leading to the biggest annual gain in nearly 11 years and indicating that high inflation was likely to persist as the pandemic pressures supply chains, data showed.Sentiment also took a hit from Cleveland Federal Reserve Bank President Loretta Mester's comments that ","content":"<p>* U.S. producer prices rise solidly in August</p>\n<p>* Apple falls after 'Fortnite' case ruling</p>\n<p>* Kroger falls as shipping woes hurt margins</p>\n<p>Sept 10 (Reuters) - Wall Street ended sharply lower on Friday as investors weighed signs of higher inflation, while Apple Inc tumbled following an unfavorable court ruling related to its app store.</p>\n<p>U.S. producer prices rose solidly in August, leading to the biggest annual gain in nearly 11 years and indicating that high inflation was likely to persist as the pandemic pressures supply chains, data showed.</p>\n<p>Sentiment also took a hit from Cleveland Federal Reserve Bank President Loretta Mester's comments that she would still like the central bank to begin tapering asset purchases this year despite the weak August jobs report.</p>\n<p>The S&amp;P 500 has risen about 19% in 2021, buoyed by support from dovish central bank policies and re-opening optimism.</p>\n<p>However, Wall Street has moved sideways in recent sessions as investor digest indications of increased inflation and concerns about the Delta variant's impact on the economic recovery. Investors are also uncertain about when the Federal Reserve may begin reducing massive measures enacted last year to shield the economy from the pandemic.</p>\n<p>\"The market is taking a breather,\" said Greg Bassuk, CEO of AXS Investments. \"Investors are looking for some outsized news or information that is beyond the band of expectations, something much more outsized, positively or negatively, that will give investors better visibility into how things are going to look for the balance of the year.\"</p>\n<p>Apple dropped 3.3% after a judge struck down a core part of its App Store rules, benefiting app makers. Its drop contributed more than any other stocks to the Nasdaq and S&amp;P 500's declines.</p>\n<p>Shares of app makers rallied, with Spotify Technology&nbsp;up 0.7%, and Activision Blizzard and Electronic Arts both gaining about 2%.</p>\n<p>Losses in the three main indexes accelerated toward the end of the session.</p>\n<p>The Dow Jones Industrial Average fell 0.78% to close at 34,607.72 points, while the S&amp;P 500 lost 0.77% to 4,458.58.</p>\n<p>The Nasdaq Composite dropped 0.87% to 15,115.49.</p>\n<p>For the week, the S&amp;P 500 lost 1.7%, the Dow declined 2.15% and the Nasdaq shed 1.61%.</p>\n<p>Friday was the first time since February that the S&amp;P 500 declined five days in a row.</p>\n<p>All of the eleven S&amp;P 500 sector indexes fell, with real estate and utilities each down more than 1% and leading the declines.</p>\n<p>Affirm&nbsp;Exploded 34% on Robust Revenue Growth and Guidance, Analysts Impressive Amid Faster Than Expected Merchant and Customer Growth.</p>\n<p>Grocer Kroger Co slumped nearly 8% after it said global supply chain disruptions, freight costs, discounts and wastage would hit its profit margins.</p>\n<p>Volume on U.S. exchanges was 10.0 billion shares, compared with the 9.2 billion average for the full session over the last 20 trading days.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.84-to-1 ratio; on Nasdaq, a 1.88-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and 3 new lows; the Nasdaq Composite recorded 55 new highs and 47 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down, Apple sinks on app store ruling</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down, Apple sinks on app store ruling\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-11 07:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* U.S. producer prices rise solidly in August</p>\n<p>* Apple falls after 'Fortnite' case ruling</p>\n<p>* Kroger falls as shipping woes hurt margins</p>\n<p>Sept 10 (Reuters) - Wall Street ended sharply lower on Friday as investors weighed signs of higher inflation, while Apple Inc tumbled following an unfavorable court ruling related to its app store.</p>\n<p>U.S. producer prices rose solidly in August, leading to the biggest annual gain in nearly 11 years and indicating that high inflation was likely to persist as the pandemic pressures supply chains, data showed.</p>\n<p>Sentiment also took a hit from Cleveland Federal Reserve Bank President Loretta Mester's comments that she would still like the central bank to begin tapering asset purchases this year despite the weak August jobs report.</p>\n<p>The S&amp;P 500 has risen about 19% in 2021, buoyed by support from dovish central bank policies and re-opening optimism.</p>\n<p>However, Wall Street has moved sideways in recent sessions as investor digest indications of increased inflation and concerns about the Delta variant's impact on the economic recovery. Investors are also uncertain about when the Federal Reserve may begin reducing massive measures enacted last year to shield the economy from the pandemic.</p>\n<p>\"The market is taking a breather,\" said Greg Bassuk, CEO of AXS Investments. \"Investors are looking for some outsized news or information that is beyond the band of expectations, something much more outsized, positively or negatively, that will give investors better visibility into how things are going to look for the balance of the year.\"</p>\n<p>Apple dropped 3.3% after a judge struck down a core part of its App Store rules, benefiting app makers. Its drop contributed more than any other stocks to the Nasdaq and S&amp;P 500's declines.</p>\n<p>Shares of app makers rallied, with Spotify Technology&nbsp;up 0.7%, and Activision Blizzard and Electronic Arts both gaining about 2%.</p>\n<p>Losses in the three main indexes accelerated toward the end of the session.</p>\n<p>The Dow Jones Industrial Average fell 0.78% to close at 34,607.72 points, while the S&amp;P 500 lost 0.77% to 4,458.58.</p>\n<p>The Nasdaq Composite dropped 0.87% to 15,115.49.</p>\n<p>For the week, the S&amp;P 500 lost 1.7%, the Dow declined 2.15% and the Nasdaq shed 1.61%.</p>\n<p>Friday was the first time since February that the S&amp;P 500 declined five days in a row.</p>\n<p>All of the eleven S&amp;P 500 sector indexes fell, with real estate and utilities each down more than 1% and leading the declines.</p>\n<p>Affirm&nbsp;Exploded 34% on Robust Revenue Growth and Guidance, Analysts Impressive Amid Faster Than Expected Merchant and Customer Growth.</p>\n<p>Grocer Kroger Co slumped nearly 8% after it said global supply chain disruptions, freight costs, discounts and wastage would hit its profit margins.</p>\n<p>Volume on U.S. exchanges was 10.0 billion shares, compared with the 9.2 billion average for the full session over the last 20 trading days.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.84-to-1 ratio; on Nasdaq, a 1.88-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and 3 new lows; the Nasdaq Composite recorded 55 new highs and 47 new lows.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2166711943","content_text":"* U.S. producer prices rise solidly in August\n* Apple falls after 'Fortnite' case ruling\n* Kroger falls as shipping woes hurt margins\nSept 10 (Reuters) - Wall Street ended sharply lower on Friday as investors weighed signs of higher inflation, while Apple Inc tumbled following an unfavorable court ruling related to its app store.\nU.S. producer prices rose solidly in August, leading to the biggest annual gain in nearly 11 years and indicating that high inflation was likely to persist as the pandemic pressures supply chains, data showed.\nSentiment also took a hit from Cleveland Federal Reserve Bank President Loretta Mester's comments that she would still like the central bank to begin tapering asset purchases this year despite the weak August jobs report.\nThe S&P 500 has risen about 19% in 2021, buoyed by support from dovish central bank policies and re-opening optimism.\nHowever, Wall Street has moved sideways in recent sessions as investor digest indications of increased inflation and concerns about the Delta variant's impact on the economic recovery. Investors are also uncertain about when the Federal Reserve may begin reducing massive measures enacted last year to shield the economy from the pandemic.\n\"The market is taking a breather,\" said Greg Bassuk, CEO of AXS Investments. \"Investors are looking for some outsized news or information that is beyond the band of expectations, something much more outsized, positively or negatively, that will give investors better visibility into how things are going to look for the balance of the year.\"\nApple dropped 3.3% after a judge struck down a core part of its App Store rules, benefiting app makers. Its drop contributed more than any other stocks to the Nasdaq and S&P 500's declines.\nShares of app makers rallied, with Spotify Technology up 0.7%, and Activision Blizzard and Electronic Arts both gaining about 2%.\nLosses in the three main indexes accelerated toward the end of the session.\nThe Dow Jones Industrial Average fell 0.78% to close at 34,607.72 points, while the S&P 500 lost 0.77% to 4,458.58.\nThe Nasdaq Composite dropped 0.87% to 15,115.49.\nFor the week, the S&P 500 lost 1.7%, the Dow declined 2.15% and the Nasdaq shed 1.61%.\nFriday was the first time since February that the S&P 500 declined five days in a row.\nAll of the eleven S&P 500 sector indexes fell, with real estate and utilities each down more than 1% and leading the declines.\nAffirm Exploded 34% on Robust Revenue Growth and Guidance, Analysts Impressive Amid Faster Than Expected Merchant and Customer Growth.\nGrocer Kroger Co slumped nearly 8% after it said global supply chain disruptions, freight costs, discounts and wastage would hit its profit margins.\nVolume on U.S. exchanges was 10.0 billion shares, compared with the 9.2 billion average for the full session over the last 20 trading days.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.84-to-1 ratio; on Nasdaq, a 1.88-to-1 ratio favored decliners.\nThe S&P 500 posted 15 new 52-week highs and 3 new lows; the Nasdaq Composite recorded 55 new highs and 47 new lows.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"AAPL":0.9,"ATVI":0.9,"DIDI":0.9,"EA":0.9,"KR":0.9,"SPOT":0.9}},"isVote":1,"tweetType":1,"viewCount":284,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":814083186,"gmtCreate":1630727801845,"gmtModify":1631890580359,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584074223056401","idStr":"3584074223056401"},"themes":[],"htmlText":"Please like","listText":"Please like","text":"Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/814083186","repostId":"1186003479","repostType":4,"isVote":1,"tweetType":1,"viewCount":310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":876227153,"gmtCreate":1637322809726,"gmtModify":1637322951688,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584074223056401","authorIdStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/876227153","repostId":"1153021579","repostType":4,"repost":{"id":"1153021579","kind":"news","pubTimestamp":1637322554,"share":"https://ttm.financial/m/news/1153021579?lang=&edition=full","pubTime":"2021-11-19 19:49","market":"us","language":"en","title":"54 Biggest Movers From Yesterday","url":"https://stock-news.laohu8.com/highlight/detail?id=1153021579","media":"Benzinga","summary":"Gainers\n\nLongeveron Inc. shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FD","content":"<p><b>Gainers</b></p>\n<ul>\n <li><b>Longeveron Inc.</b>&nbsp;shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the treatment of hypoplastic left heart syndrome.</li>\n <li><b>Dicerna Pharmaceuticals, Inc.</b>&nbsp;shares climbed 78.7% to close at $38.03.<b>Novo Nordisk A/S</b>NVO-0.02%agreed to acquire Dicerna Pharmaceuticals for $38.25 per share in cash, representing a total equity value of $3.3 billion and a premium of 80% to Dicerna's closing price on November 17, 2021.</li>\n <li><b>Sweetgreen, Inc.</b>&nbsp;gained 76.8% to close at $49.50 after the company priced its IPO at $28 per share.</li>\n <li><b>Virtuoso Acquisition Corp.</b>&nbsp;jumped 44% to settle at $14.51. Virtuoso Acquisition’s stockholders recently approved proposed merger with Wejo.</li>\n <li><b>Jowell Global Ltd.</b>&nbsp;climbed 25.8% to close at $14.75 after the company announced a collaboration with Unilever's Uni-Excubator.</li>\n <li><b>Macy's, Inc.</b>&nbsp;gained 21.2% to close at $37.37 after the company reported strong Q3 results and also raised FY21 guidance.</li>\n <li><b>BJ's Wholesale Club Holdings, Inc.</b>&nbsp;gained 19.9% to settle at $71.93 after the company reported better-than-expected Q3 EPS and sales results and announced a $500 million buyback.</li>\n <li><b>Cardiff Oncology, Inc.</b>&nbsp;rose 18.7% to close at $6.21. Pfizer made a $15 million equity investment in Cardiff Oncology as part of the Pfizer Breakthrough Growth Initiative.</li>\n <li><b>Arcus Biosciences, Inc.</b>&nbsp;climbed 18% to close at $43.54 after the company announced Gilead has exercised its options to three programs in Arcus's clinical-stage portfolio. The companies also added a research collaboration.</li>\n <li><b>Enthusiast Gaming Holdings Inc.</b>&nbsp;rose 17.6% to close at $4.35 after the company reported US Unique Visitors reached 47.8 million in October.</li>\n <li><b>Smith-Midland Corporation</b>&nbsp;gained 16.4% to settle at $32.27. Smith-Midland recently posted Q3 EPS of $0.71.</li>\n <li><b>Dogness (International) Corporation</b>&nbsp;surged 15.1% to close at $4.50.</li>\n <li><b>Vera Therapeutics, Inc.</b>&nbsp;gained 14.9% to settle at $28.43. Vera Therapeutics recently posted a Q3 loss of $0.36 per share.</li>\n <li><b>Victoria's Secret &amp; Co.</b>&nbsp;rose 14.7% to close at $57.91 after the company reported better-than-expected Q3 earnings.</li>\n <li><b>OMNIQ Corp.</b>&nbsp;jumped 12.7% to settle at $9.47. OMNIQ recently posted a Q3 loss of $0.73 per share.</li>\n <li><b>Volcon, Inc.</b>&nbsp;rose 12.4% to close at $16.48.</li>\n <li><b>Universal Technical Institute, Inc.</b>&nbsp;gained 12.3% to close at $7.75 following Q4 results.</li>\n <li><b>Arco Platform Limited</b>&nbsp;climbed 11.5% to close at $19.28. Arco Platform reported $150 million investments from Dragoneer and General Atlantic Partners.</li>\n <li><b>Yatsen Holding Limited</b>&nbsp;surged 10.7% to close at $2.99 after the company reported better-than-expected Q3 EPS results and announced a $100 million buyback.</li>\n <li><b>Kohl's Corporation</b>&nbsp;jumped 10.6% to close at $62.48 after the company reported better-than-expected Q3 EPS and sales results and raised FY21 EPS guidance.</li>\n <li><b>ReTo Eco-Solutions, Inc.</b>&nbsp;gained 10.1% to close at $3.05.</li>\n <li><b>180 Life Sciences Corp.</b>&nbsp;gained 9.9% to close at $4.01.</li>\n <li><b>ZTO Express (Cayman) Inc.</b>&nbsp;shares rose 9.6% to close at $31.58 following Q3 earnings.</li>\n <li><b>Express, Inc.</b>&nbsp;gained 9.6% to settle at $4.55. Express is expected to report its third quarter 2021 financial results on Thursday, December 2, 2021.</li>\n <li><b>BM Technologies, Inc.</b>&nbsp;rose 9.4% to close at $14.12 after gaining 5% on Wednesday.</li>\n <li><b>NVIDIA Corporation</b>&nbsp;climbed 8.3% to settle at $316.75 after the company reported better-than-expected results for its third quarter, driven by record revenues in Gaming, Data Center and Professional Visualization segments. The company also issued a strong forecast for the fourth quarter.</li>\n</ul>\n<p><b>Losers</b></p>\n<ul>\n <li><b>Amtech Systems, Inc.</b>&nbsp;fell 26.6% to close at $11.20 after the company reported downbeat Q4 results and issued weak Q1 sales forecast.</li>\n <li><b>Zhangmen Education Inc.</b>&nbsp;shares dipped 25.4% to close at $1.56 on Thursday after jumping more than 38% on Wednesday.</li>\n <li><b>Sono Group N.V.</b>&nbsp;fell 23.3% to settle at $29.29.</li>\n <li><b>Gracell Biotechnologies Inc.</b>&nbsp;declined 22.1% to close at $8.98. Gracell Biotechnologies recently reported Q3 sales of $57.00 thousand.</li>\n <li><b>Femasys Inc.</b>&nbsp;fell 20.5% to close at $5.11.</li>\n <li><b>Lottery.com Inc.</b>&nbsp;dropped 19.9% to settle at $8.65. Lottery.com’s S-1 showed registration for primary offering of 30.125 million shares and secondary offering of 25.395 million shares via selling shareholders.</li>\n <li><b>Williams Industrial Services Group Inc.</b>&nbsp;dropped 19.6% to close at $3.70 after the company posted weak Q3 results and lowered FY21 revenue guidance.</li>\n <li><b>Altamira Therapeutics Ltd.</b>&nbsp;dipped 19.6% to settle at $1.68.</li>\n <li><b>Odonate Therapeutics, Inc.</b>&nbsp;dipped 18.5% to settle at $1.90.</li>\n <li><b>Vipshop Holdings Limited</b>&nbsp;dropped 18% to close at $10.03 after the company reported Q3 earnings results and issued guidance.</li>\n <li><b>SeqLL Inc.</b>&nbsp;dropped 17.5% to close at $3.07.</li>\n <li><b>Bilibili Inc.</b>&nbsp;fell 17.2% to close at $67.12 after the company announced a proposed offering of $1,400 million convertible senior notes. The company could also be trading lower following their Q3 earnings results yesterday.</li>\n <li><b>17 Education &amp; Technology Group Inc.</b>&nbsp;dipped 16.4% to settle at $2.35.</li>\n <li><b>Aehr Test Systems</b>&nbsp;dropped 15.7% to close at $19.61.</li>\n <li><b>Rivian Automotive, Inc.</b>&nbsp;fell 15.5% to settle at $123.38 as the stock continued to pull back following its post-IPO surge. CNBC's Jim Cramer discussed momentum in the stock and noted investors may want to consider partial profit taking.</li>\n <li><b>Certara, Inc.</b>&nbsp;fell 14.7% to close at $30.73 after the company priced its underwritten public offering of 10 million shares by certain existing stockholders at $31.00 per share.</li>\n <li><b>Gambling.com Group Limited</b>&nbsp;fell 13.9% to close at $13.00 after the company reported worse-than-expected Q3 sales results.</li>\n <li><b>Petco Health and Wellness Company, Inc.</b>&nbsp;dipped 13.2% to close at $21.45 after the company reported Q3 earnings results and issued updated guidance.</li>\n <li><b>Maxeon Solar Technologies, Ltd.</b>&nbsp;shares declined 12.9% to close at $17.61 after the company reported worse-than-expected Q3 results and issued Q4 revenue guidance below estimates.</li>\n <li><b>Lantronix, Inc.</b>&nbsp;dropped 12.4% to close at $7.88. Lantronix priced underwritten offering of 4.7 million shares of common stock at $7.50 per share.</li>\n <li><b>Progenity, Inc.</b>&nbsp;fell 11.9% to settle at $4.30. Progenity recently reported worse-than-expected Q3 EPS results.</li>\n <li><b>Tivic Health Systems, Inc.</b>&nbsp;dipped 11.8% to close at $4.56. The company recently priced its IPO at $5 per share.</li>\n <li><b>QuickLogic Corporation</b>&nbsp;fell 10.8% to close at $6.88 following Q3 results.</li>\n <li><b>InMed Pharmaceuticals Inc.</b>&nbsp;shares fell 8.7% to close at $1.78. InMed Pharmaceuticals shares jumped around 40% on Wednesday after the company provided a business update.</li>\n <li><b>The Original BARK Company</b>&nbsp;dropped 6.8% to settle at $5.78. Mike Novotny, Insider at Original Bark, made a large buy and sell of company shares on November 12, according to a new SEC filing.</li>\n <li><b>COMSovereign Holding Corp.</b>&nbsp;fell 6.2% to close at $1.37 after jumping 20% on Wednesday.</li>\n <li><b>iBio, Inc.</b>&nbsp;fell 6.1% to close at $0.66. A leading independent proxy advisory firm, Glass Lewis, recommended iBio shareholders vote \"FOR\" all proposals ahead of annual meeting.</li>\n <li><b>Cisco Systems, Inc.</b>&nbsp;fell 5.5% to close at $53.63. Cisco reported upbeat earnings for its first quarter, while sales missed estimates. The company also issued weal sales forecast for the current quarter.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>54 Biggest Movers From Yesterday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n54 Biggest Movers From Yesterday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-19 19:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/11/24189383/54-biggest-movers-from-yesterday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gainers\n\nLongeveron Inc. shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the treatment of ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/11/24189383/54-biggest-movers-from-yesterday\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.benzinga.com/news/21/11/24189383/54-biggest-movers-from-yesterday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153021579","content_text":"Gainers\n\nLongeveron Inc. shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the treatment of hypoplastic left heart syndrome.\nDicerna Pharmaceuticals, Inc. shares climbed 78.7% to close at $38.03.Novo Nordisk A/SNVO-0.02%agreed to acquire Dicerna Pharmaceuticals for $38.25 per share in cash, representing a total equity value of $3.3 billion and a premium of 80% to Dicerna's closing price on November 17, 2021.\nSweetgreen, Inc. gained 76.8% to close at $49.50 after the company priced its IPO at $28 per share.\nVirtuoso Acquisition Corp. jumped 44% to settle at $14.51. Virtuoso Acquisition’s stockholders recently approved proposed merger with Wejo.\nJowell Global Ltd. climbed 25.8% to close at $14.75 after the company announced a collaboration with Unilever's Uni-Excubator.\nMacy's, Inc. gained 21.2% to close at $37.37 after the company reported strong Q3 results and also raised FY21 guidance.\nBJ's Wholesale Club Holdings, Inc. gained 19.9% to settle at $71.93 after the company reported better-than-expected Q3 EPS and sales results and announced a $500 million buyback.\nCardiff Oncology, Inc. rose 18.7% to close at $6.21. Pfizer made a $15 million equity investment in Cardiff Oncology as part of the Pfizer Breakthrough Growth Initiative.\nArcus Biosciences, Inc. climbed 18% to close at $43.54 after the company announced Gilead has exercised its options to three programs in Arcus's clinical-stage portfolio. The companies also added a research collaboration.\nEnthusiast Gaming Holdings Inc. rose 17.6% to close at $4.35 after the company reported US Unique Visitors reached 47.8 million in October.\nSmith-Midland Corporation gained 16.4% to settle at $32.27. Smith-Midland recently posted Q3 EPS of $0.71.\nDogness (International) Corporation surged 15.1% to close at $4.50.\nVera Therapeutics, Inc. gained 14.9% to settle at $28.43. Vera Therapeutics recently posted a Q3 loss of $0.36 per share.\nVictoria's Secret & Co. rose 14.7% to close at $57.91 after the company reported better-than-expected Q3 earnings.\nOMNIQ Corp. jumped 12.7% to settle at $9.47. OMNIQ recently posted a Q3 loss of $0.73 per share.\nVolcon, Inc. rose 12.4% to close at $16.48.\nUniversal Technical Institute, Inc. gained 12.3% to close at $7.75 following Q4 results.\nArco Platform Limited climbed 11.5% to close at $19.28. Arco Platform reported $150 million investments from Dragoneer and General Atlantic Partners.\nYatsen Holding Limited surged 10.7% to close at $2.99 after the company reported better-than-expected Q3 EPS results and announced a $100 million buyback.\nKohl's Corporation jumped 10.6% to close at $62.48 after the company reported better-than-expected Q3 EPS and sales results and raised FY21 EPS guidance.\nReTo Eco-Solutions, Inc. gained 10.1% to close at $3.05.\n180 Life Sciences Corp. gained 9.9% to close at $4.01.\nZTO Express (Cayman) Inc. shares rose 9.6% to close at $31.58 following Q3 earnings.\nExpress, Inc. gained 9.6% to settle at $4.55. Express is expected to report its third quarter 2021 financial results on Thursday, December 2, 2021.\nBM Technologies, Inc. rose 9.4% to close at $14.12 after gaining 5% on Wednesday.\nNVIDIA Corporation climbed 8.3% to settle at $316.75 after the company reported better-than-expected results for its third quarter, driven by record revenues in Gaming, Data Center and Professional Visualization segments. The company also issued a strong forecast for the fourth quarter.\n\nLosers\n\nAmtech Systems, Inc. fell 26.6% to close at $11.20 after the company reported downbeat Q4 results and issued weak Q1 sales forecast.\nZhangmen Education Inc. shares dipped 25.4% to close at $1.56 on Thursday after jumping more than 38% on Wednesday.\nSono Group N.V. fell 23.3% to settle at $29.29.\nGracell Biotechnologies Inc. declined 22.1% to close at $8.98. Gracell Biotechnologies recently reported Q3 sales of $57.00 thousand.\nFemasys Inc. fell 20.5% to close at $5.11.\nLottery.com Inc. dropped 19.9% to settle at $8.65. Lottery.com’s S-1 showed registration for primary offering of 30.125 million shares and secondary offering of 25.395 million shares via selling shareholders.\nWilliams Industrial Services Group Inc. dropped 19.6% to close at $3.70 after the company posted weak Q3 results and lowered FY21 revenue guidance.\nAltamira Therapeutics Ltd. dipped 19.6% to settle at $1.68.\nOdonate Therapeutics, Inc. dipped 18.5% to settle at $1.90.\nVipshop Holdings Limited dropped 18% to close at $10.03 after the company reported Q3 earnings results and issued guidance.\nSeqLL Inc. dropped 17.5% to close at $3.07.\nBilibili Inc. fell 17.2% to close at $67.12 after the company announced a proposed offering of $1,400 million convertible senior notes. The company could also be trading lower following their Q3 earnings results yesterday.\n17 Education & Technology Group Inc. dipped 16.4% to settle at $2.35.\nAehr Test Systems dropped 15.7% to close at $19.61.\nRivian Automotive, Inc. fell 15.5% to settle at $123.38 as the stock continued to pull back following its post-IPO surge. CNBC's Jim Cramer discussed momentum in the stock and noted investors may want to consider partial profit taking.\nCertara, Inc. fell 14.7% to close at $30.73 after the company priced its underwritten public offering of 10 million shares by certain existing stockholders at $31.00 per share.\nGambling.com Group Limited fell 13.9% to close at $13.00 after the company reported worse-than-expected Q3 sales results.\nPetco Health and Wellness Company, Inc. dipped 13.2% to close at $21.45 after the company reported Q3 earnings results and issued updated guidance.\nMaxeon Solar Technologies, Ltd. shares declined 12.9% to close at $17.61 after the company reported worse-than-expected Q3 results and issued Q4 revenue guidance below estimates.\nLantronix, Inc. dropped 12.4% to close at $7.88. Lantronix priced underwritten offering of 4.7 million shares of common stock at $7.50 per share.\nProgenity, Inc. fell 11.9% to settle at $4.30. Progenity recently reported worse-than-expected Q3 EPS results.\nTivic Health Systems, Inc. dipped 11.8% to close at $4.56. The company recently priced its IPO at $5 per share.\nQuickLogic Corporation fell 10.8% to close at $6.88 following Q3 results.\nInMed Pharmaceuticals Inc. shares fell 8.7% to close at $1.78. InMed Pharmaceuticals shares jumped around 40% on Wednesday after the company provided a business update.\nThe Original BARK Company dropped 6.8% to settle at $5.78. Mike Novotny, Insider at Original Bark, made a large buy and sell of company shares on November 12, according to a new SEC filing.\nCOMSovereign Holding Corp. fell 6.2% to close at $1.37 after jumping 20% on Wednesday.\niBio, Inc. fell 6.1% to close at $0.66. A leading independent proxy advisory firm, Glass Lewis, recommended iBio shareholders vote \"FOR\" all proposals ahead of annual meeting.\nCisco Systems, Inc. fell 5.5% to close at $53.63. Cisco reported upbeat earnings for its first quarter, while sales missed estimates. The company also issued weal sales forecast for the current quarter.","news_type":1,"symbols_score_info":{"BILI":0.9,"CSCO":0.9,"M":0.9}},"isVote":1,"tweetType":1,"viewCount":2953,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":814083186,"gmtCreate":1630727801845,"gmtModify":1631890580359,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584074223056401","authorIdStr":"3584074223056401"},"themes":[],"htmlText":"Please like","listText":"Please like","text":"Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/814083186","repostId":"1186003479","repostType":4,"isVote":1,"tweetType":1,"viewCount":310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":845007737,"gmtCreate":1636250512994,"gmtModify":1636250513161,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584074223056401","authorIdStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/845007737","repostId":"2181074782","repostType":4,"isVote":1,"tweetType":1,"viewCount":2454,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":851613538,"gmtCreate":1634902061887,"gmtModify":1634902138766,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584074223056401","authorIdStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/851613538","repostId":"2177663497","repostType":4,"repost":{"id":"2177663497","kind":"highlight","pubTimestamp":1634901730,"share":"https://ttm.financial/m/news/2177663497?lang=&edition=full","pubTime":"2021-10-22 19:22","market":"us","language":"en","title":"Novavax Faces 1 Major Risk Right Now. Should You Buy the Stock Anyway?","url":"https://stock-news.laohu8.com/highlight/detail?id=2177663497","media":"Motley Fool","summary":"Novavax (NASDAQ:NVAX) started the coronavirus vaccine race as a favorite. The company's shares even ","content":"<p><b>Novavax</b> (NASDAQ:NVAX) started the coronavirus vaccine race as a favorite. The company's shares even soared more than 2,700% last year. But the tide has turned for the biotech company. The problem? Manufacturing issues have delayed Novavax's submission for emergency authorization in the U.S. and other countries. As a result, the shares have given back a large percentage of this year's gain.</p>\n<p>But things worsened in recent days. A news report suggested Novavax's delays may not be over. The stock sank nearly 15% in one trading session. Even before that decline, the shares were trading below Wall Street's most pessimistic 12-month share price forecast.</p>\n<p>As you might be guessing right now, the biggest risk Novavax faces is this: missing its latest goal to apply for authorization in the U.S., Europe, and other areas by the end of the year. That kind of news could crush the stock. Does this mean you should flee Novavax shares -- or use recent declines as a buying opportunity?</p>\n<h2>U.K. and U.S. trial data</h2>\n<p>First, let's take a look at what's happened so far. Novavax reported positive data from a U.K. trial early this year -- and solid results from its U.S. trial a few months later. With data from both trials, Novavax aimed to file for emergency authorization in the second quarter.</p>\n<p>Then, in May, Novavax said it wouldn't make that deadline. That was due to raw materials shortages and other manufacturing issues. To win authorization, a company must demonstrate it can manufacture quality product at scale over time. At this point, Novavax said it would complete its regulatory submission in the third quarter.</p>\n<p>In the most recent earnings call, Novavax extended the deadline once again -- to the fourth quarter. The company said it was still working with third parties on some elements and completing the validation of its analytical methods.</p>\n<p>So that brings us to the latest news. This week, Politico, citing people familiar with the situation, reported more troubles: Novavax's testing method to ensure the purity of vaccine batches hasn't met regulators' expectations. These people told Politico the manufacturing and testing issues could delay authorization of Novavax's vaccine candidate until the end of 2022.</p>\n<h2>Novavax reconfirms timeline</h2>\n<p>In response, Novavax issued a statement reconfirming its regulatory timeline. The company says it's \"now routinely producing high-quality product at commercial scale at multiple sites across the world.\"</p>\n<p>Now, let's talk about risk. Do we put our confidence in Novavax and its management team? The company <i>has</i> postponed its filing goal more than once. It's not impossible that another delay might be on the horizon. So, this is a risk we have to face. It's clear that more delays would damage investors' confidence in the company -- even if Novavax is trying its hardest to get everything right. And the share price would suffer.</p>\n<p>But if Novavax files for authorization according to plan, the shares could skyrocket. And vaccine revenue down the road represents another catalyst for share performance. In an earnings call earlier this year, Novavax predicted billions of dollars in revenue over the four to six quarters ahead. That's huge for a company's first commercialized product.</p>\n<p>From today's level, Novavax stock could climb 91% in the coming 12 months, according to Wall Street's average forecast. And if it meets its goals, it could move much higher over the longer term.</p>\n<p>Speaking of the long term, Novavax has a lot to offer down the road. The company's flu vaccine candidate -- NanoFlu -- met primary endpoints in its pivotal trial. The next step is a regulatory submission. And Novavax has launched a clinical trial of a combined COVID/flu vaccine. So far, it's ahead of rivals on that potential product.</p>\n<p>Of course, all of that sounds great. But to be successful in today's or future projects, it's critical that Novavax resolve any manufacturing and testing issues. They are key to gaining the regulatory nod -- and eventually selling products.</p>\n<h2>Should you buy Novavax?</h2>\n<p>So, should you flee Novavax or buy the shares? It all depends on your investing style. If you're a cautious investor, you probably should avoid Novavax shares right now. If Novavax disappoints investors again, the shares likely will tumble. And if the timeline to commercialization is long, the stock may take quite a while to recover.</p>\n<p>That said, if you're an aggressive investor, this could be a buying opportunity. Novavax still has what it takes to win in coronavirus and flu prevention down the road. I'm optimistic that it eventually will work out manufacturing problems. So, if you're willing to go through potential ups and downs in the meantime, now might be a good time to get in on this biotech stock.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Faces 1 Major Risk Right Now. Should You Buy the Stock Anyway?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Faces 1 Major Risk Right Now. Should You Buy the Stock Anyway?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-22 19:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/22/novavax-faces-1-major-risk-should-you-buy-anyway/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novavax (NASDAQ:NVAX) started the coronavirus vaccine race as a favorite. The company's shares even soared more than 2,700% last year. But the tide has turned for the biotech company. The problem? ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/22/novavax-faces-1-major-risk-should-you-buy-anyway/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/10/22/novavax-faces-1-major-risk-should-you-buy-anyway/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2177663497","content_text":"Novavax (NASDAQ:NVAX) started the coronavirus vaccine race as a favorite. The company's shares even soared more than 2,700% last year. But the tide has turned for the biotech company. The problem? Manufacturing issues have delayed Novavax's submission for emergency authorization in the U.S. and other countries. As a result, the shares have given back a large percentage of this year's gain.\nBut things worsened in recent days. A news report suggested Novavax's delays may not be over. The stock sank nearly 15% in one trading session. Even before that decline, the shares were trading below Wall Street's most pessimistic 12-month share price forecast.\nAs you might be guessing right now, the biggest risk Novavax faces is this: missing its latest goal to apply for authorization in the U.S., Europe, and other areas by the end of the year. That kind of news could crush the stock. Does this mean you should flee Novavax shares -- or use recent declines as a buying opportunity?\nU.K. and U.S. trial data\nFirst, let's take a look at what's happened so far. Novavax reported positive data from a U.K. trial early this year -- and solid results from its U.S. trial a few months later. With data from both trials, Novavax aimed to file for emergency authorization in the second quarter.\nThen, in May, Novavax said it wouldn't make that deadline. That was due to raw materials shortages and other manufacturing issues. To win authorization, a company must demonstrate it can manufacture quality product at scale over time. At this point, Novavax said it would complete its regulatory submission in the third quarter.\nIn the most recent earnings call, Novavax extended the deadline once again -- to the fourth quarter. The company said it was still working with third parties on some elements and completing the validation of its analytical methods.\nSo that brings us to the latest news. This week, Politico, citing people familiar with the situation, reported more troubles: Novavax's testing method to ensure the purity of vaccine batches hasn't met regulators' expectations. These people told Politico the manufacturing and testing issues could delay authorization of Novavax's vaccine candidate until the end of 2022.\nNovavax reconfirms timeline\nIn response, Novavax issued a statement reconfirming its regulatory timeline. The company says it's \"now routinely producing high-quality product at commercial scale at multiple sites across the world.\"\nNow, let's talk about risk. Do we put our confidence in Novavax and its management team? The company has postponed its filing goal more than once. It's not impossible that another delay might be on the horizon. So, this is a risk we have to face. It's clear that more delays would damage investors' confidence in the company -- even if Novavax is trying its hardest to get everything right. And the share price would suffer.\nBut if Novavax files for authorization according to plan, the shares could skyrocket. And vaccine revenue down the road represents another catalyst for share performance. In an earnings call earlier this year, Novavax predicted billions of dollars in revenue over the four to six quarters ahead. That's huge for a company's first commercialized product.\nFrom today's level, Novavax stock could climb 91% in the coming 12 months, according to Wall Street's average forecast. And if it meets its goals, it could move much higher over the longer term.\nSpeaking of the long term, Novavax has a lot to offer down the road. The company's flu vaccine candidate -- NanoFlu -- met primary endpoints in its pivotal trial. The next step is a regulatory submission. And Novavax has launched a clinical trial of a combined COVID/flu vaccine. So far, it's ahead of rivals on that potential product.\nOf course, all of that sounds great. But to be successful in today's or future projects, it's critical that Novavax resolve any manufacturing and testing issues. They are key to gaining the regulatory nod -- and eventually selling products.\nShould you buy Novavax?\nSo, should you flee Novavax or buy the shares? It all depends on your investing style. If you're a cautious investor, you probably should avoid Novavax shares right now. If Novavax disappoints investors again, the shares likely will tumble. And if the timeline to commercialization is long, the stock may take quite a while to recover.\nThat said, if you're an aggressive investor, this could be a buying opportunity. Novavax still has what it takes to win in coronavirus and flu prevention down the road. I'm optimistic that it eventually will work out manufacturing problems. So, if you're willing to go through potential ups and downs in the meantime, now might be a good time to get in on this biotech stock.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":2527,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840089266,"gmtCreate":1635567994264,"gmtModify":1635567994264,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584074223056401","authorIdStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/840089266","repostId":"2179424781","repostType":4,"repost":{"id":"2179424781","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1635538990,"share":"https://ttm.financial/m/news/2179424781?lang=&edition=full","pubTime":"2021-10-30 04:23","market":"sh","language":"en","title":"Wall Street shakes off Amazon, Apple weakness to end modestly higher","url":"https://stock-news.laohu8.com/highlight/detail?id=2179424781","media":"Reuters","summary":"* $Apple$, Amazon fall on dismal holiday-quarter forecast. * $Microsoft$ tops Apple as the most valuable U.S. public company. The S&P 500 had fallen as much as 0.65% earlier in the day. The benchmark index advanced 1.3% for the week, its fourth straight weekly climb, marking its longest weekly streak of gains since April. For the month, the S&P rose 6.9%, its biggest monthly rise since November 2020.The Dow rose 0.4% for the week while the Nasdaq gained 2.7%, also marking four straight weekly ga","content":"<p>* <a href=\"https://laohu8.com/S/AAPL\">Apple</a>, Amazon fall on dismal holiday-quarter forecast</p>\n<p>* <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> tops Apple as the most valuable U.S. public company</p>\n<p>* Dow up 0.25%, S&amp;P 500 up 0.19%, <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> up 0.33%</p>\n<p>(Updates with volume data, market breadth)</p>\n<p>By Chuck Mikolajczak</p>\n<p>NEW YORK, Oct 29 (Reuters) - U.S. stocks shook off early declines and closed out the last trading day of the month with modest gains on Friday as a rise in Microsoft helped offset declines in Amazon and Apple after disappointing quarterly earnings from the online retailer and iPhone maker.</p>\n<p>Microsoft Corp's shares closed at a record high of $331.62 and ended the session with a market capitalization of $2.49 trillion, surpassing Apple Inc's market cap of roughly $2.48 trillion.</p>\n<p>Apple lost 1.81% after it warned the impact of supply-chain disruptions will be even worse during the current holiday sales quarter, while <a href=\"https://laohu8.com/S/AMZN\">Amazon.com</a> Inc declined 2.15% as it forecast downbeat holiday-quarter sales amid labor shortages.</p>\n<p>\"The takeaway from today is the resilience to the overall index despite 10% of market cap in two companies disappointing and yet the market is flat. It’s the resilience of the marketplace, it suggests to me the trend is still intact,\" said David Joy, chief market strategist at <a href=\"https://laohu8.com/S/AMP\">Ameriprise</a> Financial in Boston.</p>\n<p>\"Maybe the numbers were a surprise to the analyst community but not the reasons for the disappointment so there is still a general view that this is not business lost but business postponed and the trend in the economy and in the market continues to be to the upside.\"</p>\n<p>The Dow Jones Industrial Average rose 89.08 points, or 0.25%, to 35,819.56, the S&amp;P 500 gained 8.96 points, or 0.19%, to 4,605.38 and the Nasdaq Composite added 50.27 points, or 0.33%, to 15,498.39.</p>\n<p>The S&amp;P 500 had fallen as much as 0.65% earlier in the day. The benchmark index advanced 1.3% for the week, its fourth straight weekly climb, marking its longest weekly streak of gains since April. For the month, the S&amp;P rose 6.9%, its biggest monthly rise since November 2020.</p>\n<p>The Dow rose 0.4% for the week while the Nasdaq gained 2.7%, also marking four straight weekly gains for each. The Dow climbed 5.8% for October, its best monthly performance since March, while the Nasdaq jumped 7.3% for its biggest monthly percentage gain since November 2020.</p>\n<p>Apple had risen about 2.5% while Amazon gained 1.6% in Thursday's session, helping to send the S&amp;P 500 and Nasdaq to closing record highs.</p>\n<p>With 279 companies in the S&amp;P 500 having reported results through Friday morning, 82.1% have topped earnings expectations, according to Refinitiv data. The current year-over-year earnings growth rate for the third quarter is 39.2%.</p>\n<p>Market participants have been closely attuned to the ability of companies to maneuver through labor shortages, rising price pressures and clogs in the supply chain, and a solid earnings season has helped investors overlook a mixed macroeconomic picture with a Federal Reserve that is poised to begin to trim its massive bond purchases soon.</p>\n<p>The central bank's next policy announcement is on Nov. 3.</p>\n<p>Data showed U.S. consumer spending increased solidly in September, while inflation pressures are broadening.</p>\n<p>The data indicated the jury is still out on whether the Fed's \"transitory\" view on inflation will hold true.</p>\n<p><a href=\"https://laohu8.com/S/ABBV\">AbbVie</a> Inc advanced 4.56% as the U.S. drugmaker raised its 2021 adjusted profit forecast for the third time this year.</p>\n<p><a href=\"https://laohu8.com/S/SBUX\">Starbucks</a> Corp tumbled 6.30% after the coffee chain said it expects fiscal 2022 operating margin to be below its long-term target due to inflation and investments.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.14-to-1 ratio; on Nasdaq, a 1.02-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 50 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 127 new highs and 78 new lows.</p>\n<p>Volume on U.S. exchanges was 11.12 billion shares, compared with the 10.35 billion average for the full session over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street shakes off Amazon, Apple weakness to end modestly higher</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street shakes off Amazon, Apple weakness to end modestly higher\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-10-30 04:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* <a href=\"https://laohu8.com/S/AAPL\">Apple</a>, Amazon fall on dismal holiday-quarter forecast</p>\n<p>* <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> tops Apple as the most valuable U.S. public company</p>\n<p>* Dow up 0.25%, S&amp;P 500 up 0.19%, <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> up 0.33%</p>\n<p>(Updates with volume data, market breadth)</p>\n<p>By Chuck Mikolajczak</p>\n<p>NEW YORK, Oct 29 (Reuters) - U.S. stocks shook off early declines and closed out the last trading day of the month with modest gains on Friday as a rise in Microsoft helped offset declines in Amazon and Apple after disappointing quarterly earnings from the online retailer and iPhone maker.</p>\n<p>Microsoft Corp's shares closed at a record high of $331.62 and ended the session with a market capitalization of $2.49 trillion, surpassing Apple Inc's market cap of roughly $2.48 trillion.</p>\n<p>Apple lost 1.81% after it warned the impact of supply-chain disruptions will be even worse during the current holiday sales quarter, while <a href=\"https://laohu8.com/S/AMZN\">Amazon.com</a> Inc declined 2.15% as it forecast downbeat holiday-quarter sales amid labor shortages.</p>\n<p>\"The takeaway from today is the resilience to the overall index despite 10% of market cap in two companies disappointing and yet the market is flat. It’s the resilience of the marketplace, it suggests to me the trend is still intact,\" said David Joy, chief market strategist at <a href=\"https://laohu8.com/S/AMP\">Ameriprise</a> Financial in Boston.</p>\n<p>\"Maybe the numbers were a surprise to the analyst community but not the reasons for the disappointment so there is still a general view that this is not business lost but business postponed and the trend in the economy and in the market continues to be to the upside.\"</p>\n<p>The Dow Jones Industrial Average rose 89.08 points, or 0.25%, to 35,819.56, the S&amp;P 500 gained 8.96 points, or 0.19%, to 4,605.38 and the Nasdaq Composite added 50.27 points, or 0.33%, to 15,498.39.</p>\n<p>The S&amp;P 500 had fallen as much as 0.65% earlier in the day. The benchmark index advanced 1.3% for the week, its fourth straight weekly climb, marking its longest weekly streak of gains since April. For the month, the S&amp;P rose 6.9%, its biggest monthly rise since November 2020.</p>\n<p>The Dow rose 0.4% for the week while the Nasdaq gained 2.7%, also marking four straight weekly gains for each. The Dow climbed 5.8% for October, its best monthly performance since March, while the Nasdaq jumped 7.3% for its biggest monthly percentage gain since November 2020.</p>\n<p>Apple had risen about 2.5% while Amazon gained 1.6% in Thursday's session, helping to send the S&amp;P 500 and Nasdaq to closing record highs.</p>\n<p>With 279 companies in the S&amp;P 500 having reported results through Friday morning, 82.1% have topped earnings expectations, according to Refinitiv data. The current year-over-year earnings growth rate for the third quarter is 39.2%.</p>\n<p>Market participants have been closely attuned to the ability of companies to maneuver through labor shortages, rising price pressures and clogs in the supply chain, and a solid earnings season has helped investors overlook a mixed macroeconomic picture with a Federal Reserve that is poised to begin to trim its massive bond purchases soon.</p>\n<p>The central bank's next policy announcement is on Nov. 3.</p>\n<p>Data showed U.S. consumer spending increased solidly in September, while inflation pressures are broadening.</p>\n<p>The data indicated the jury is still out on whether the Fed's \"transitory\" view on inflation will hold true.</p>\n<p><a href=\"https://laohu8.com/S/ABBV\">AbbVie</a> Inc advanced 4.56% as the U.S. drugmaker raised its 2021 adjusted profit forecast for the third time this year.</p>\n<p><a href=\"https://laohu8.com/S/SBUX\">Starbucks</a> Corp tumbled 6.30% after the coffee chain said it expects fiscal 2022 operating margin to be below its long-term target due to inflation and investments.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.14-to-1 ratio; on Nasdaq, a 1.02-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 50 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 127 new highs and 78 new lows.</p>\n<p>Volume on U.S. exchanges was 11.12 billion shares, compared with the 10.35 billion average for the full session over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯","AAPL":"苹果",".IXIC":"NASDAQ Composite","MSFT":"微软"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2179424781","content_text":"* Apple, Amazon fall on dismal holiday-quarter forecast\n* Microsoft tops Apple as the most valuable U.S. public company\n* Dow up 0.25%, S&P 500 up 0.19%, Nasdaq up 0.33%\n(Updates with volume data, market breadth)\nBy Chuck Mikolajczak\nNEW YORK, Oct 29 (Reuters) - U.S. stocks shook off early declines and closed out the last trading day of the month with modest gains on Friday as a rise in Microsoft helped offset declines in Amazon and Apple after disappointing quarterly earnings from the online retailer and iPhone maker.\nMicrosoft Corp's shares closed at a record high of $331.62 and ended the session with a market capitalization of $2.49 trillion, surpassing Apple Inc's market cap of roughly $2.48 trillion.\nApple lost 1.81% after it warned the impact of supply-chain disruptions will be even worse during the current holiday sales quarter, while Amazon.com Inc declined 2.15% as it forecast downbeat holiday-quarter sales amid labor shortages.\n\"The takeaway from today is the resilience to the overall index despite 10% of market cap in two companies disappointing and yet the market is flat. It’s the resilience of the marketplace, it suggests to me the trend is still intact,\" said David Joy, chief market strategist at Ameriprise Financial in Boston.\n\"Maybe the numbers were a surprise to the analyst community but not the reasons for the disappointment so there is still a general view that this is not business lost but business postponed and the trend in the economy and in the market continues to be to the upside.\"\nThe Dow Jones Industrial Average rose 89.08 points, or 0.25%, to 35,819.56, the S&P 500 gained 8.96 points, or 0.19%, to 4,605.38 and the Nasdaq Composite added 50.27 points, or 0.33%, to 15,498.39.\nThe S&P 500 had fallen as much as 0.65% earlier in the day. The benchmark index advanced 1.3% for the week, its fourth straight weekly climb, marking its longest weekly streak of gains since April. For the month, the S&P rose 6.9%, its biggest monthly rise since November 2020.\nThe Dow rose 0.4% for the week while the Nasdaq gained 2.7%, also marking four straight weekly gains for each. The Dow climbed 5.8% for October, its best monthly performance since March, while the Nasdaq jumped 7.3% for its biggest monthly percentage gain since November 2020.\nApple had risen about 2.5% while Amazon gained 1.6% in Thursday's session, helping to send the S&P 500 and Nasdaq to closing record highs.\nWith 279 companies in the S&P 500 having reported results through Friday morning, 82.1% have topped earnings expectations, according to Refinitiv data. The current year-over-year earnings growth rate for the third quarter is 39.2%.\nMarket participants have been closely attuned to the ability of companies to maneuver through labor shortages, rising price pressures and clogs in the supply chain, and a solid earnings season has helped investors overlook a mixed macroeconomic picture with a Federal Reserve that is poised to begin to trim its massive bond purchases soon.\nThe central bank's next policy announcement is on Nov. 3.\nData showed U.S. consumer spending increased solidly in September, while inflation pressures are broadening.\nThe data indicated the jury is still out on whether the Fed's \"transitory\" view on inflation will hold true.\nAbbVie Inc advanced 4.56% as the U.S. drugmaker raised its 2021 adjusted profit forecast for the third time this year.\nStarbucks Corp tumbled 6.30% after the coffee chain said it expects fiscal 2022 operating margin to be below its long-term target due to inflation and investments.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.14-to-1 ratio; on Nasdaq, a 1.02-to-1 ratio favored advancers.\nThe S&P 500 posted 50 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 127 new highs and 78 new lows.\nVolume on U.S. exchanges was 11.12 billion shares, compared with the 10.35 billion average for the full session over the last 20 trading days.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"AAPL":0.9,"MSFT":0.9}},"isVote":1,"tweetType":1,"viewCount":2893,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":881697024,"gmtCreate":1631328943068,"gmtModify":1631890580355,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584074223056401","authorIdStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/881697024","repostId":"2166711943","repostType":4,"repost":{"id":"2166711943","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1631315453,"share":"https://ttm.financial/m/news/2166711943?lang=&edition=full","pubTime":"2021-09-11 07:10","market":"us","language":"en","title":"Wall Street ends down, Apple sinks on app store ruling","url":"https://stock-news.laohu8.com/highlight/detail?id=2166711943","media":"Reuters","summary":"Sept 10  - Wall Street ended sharply lower on Friday as investors weighed signs of higher inflation, while Apple Inc tumbled following an unfavorable court ruling related to its app store.U.S. producer prices rose solidly in August, leading to the biggest annual gain in nearly 11 years and indicating that high inflation was likely to persist as the pandemic pressures supply chains, data showed.Sentiment also took a hit from Cleveland Federal Reserve Bank President Loretta Mester's comments that ","content":"<p>* U.S. producer prices rise solidly in August</p>\n<p>* Apple falls after 'Fortnite' case ruling</p>\n<p>* Kroger falls as shipping woes hurt margins</p>\n<p>Sept 10 (Reuters) - Wall Street ended sharply lower on Friday as investors weighed signs of higher inflation, while Apple Inc tumbled following an unfavorable court ruling related to its app store.</p>\n<p>U.S. producer prices rose solidly in August, leading to the biggest annual gain in nearly 11 years and indicating that high inflation was likely to persist as the pandemic pressures supply chains, data showed.</p>\n<p>Sentiment also took a hit from Cleveland Federal Reserve Bank President Loretta Mester's comments that she would still like the central bank to begin tapering asset purchases this year despite the weak August jobs report.</p>\n<p>The S&amp;P 500 has risen about 19% in 2021, buoyed by support from dovish central bank policies and re-opening optimism.</p>\n<p>However, Wall Street has moved sideways in recent sessions as investor digest indications of increased inflation and concerns about the Delta variant's impact on the economic recovery. Investors are also uncertain about when the Federal Reserve may begin reducing massive measures enacted last year to shield the economy from the pandemic.</p>\n<p>\"The market is taking a breather,\" said Greg Bassuk, CEO of AXS Investments. \"Investors are looking for some outsized news or information that is beyond the band of expectations, something much more outsized, positively or negatively, that will give investors better visibility into how things are going to look for the balance of the year.\"</p>\n<p>Apple dropped 3.3% after a judge struck down a core part of its App Store rules, benefiting app makers. Its drop contributed more than any other stocks to the Nasdaq and S&amp;P 500's declines.</p>\n<p>Shares of app makers rallied, with Spotify Technology&nbsp;up 0.7%, and Activision Blizzard and Electronic Arts both gaining about 2%.</p>\n<p>Losses in the three main indexes accelerated toward the end of the session.</p>\n<p>The Dow Jones Industrial Average fell 0.78% to close at 34,607.72 points, while the S&amp;P 500 lost 0.77% to 4,458.58.</p>\n<p>The Nasdaq Composite dropped 0.87% to 15,115.49.</p>\n<p>For the week, the S&amp;P 500 lost 1.7%, the Dow declined 2.15% and the Nasdaq shed 1.61%.</p>\n<p>Friday was the first time since February that the S&amp;P 500 declined five days in a row.</p>\n<p>All of the eleven S&amp;P 500 sector indexes fell, with real estate and utilities each down more than 1% and leading the declines.</p>\n<p>Affirm&nbsp;Exploded 34% on Robust Revenue Growth and Guidance, Analysts Impressive Amid Faster Than Expected Merchant and Customer Growth.</p>\n<p>Grocer Kroger Co slumped nearly 8% after it said global supply chain disruptions, freight costs, discounts and wastage would hit its profit margins.</p>\n<p>Volume on U.S. exchanges was 10.0 billion shares, compared with the 9.2 billion average for the full session over the last 20 trading days.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.84-to-1 ratio; on Nasdaq, a 1.88-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and 3 new lows; the Nasdaq Composite recorded 55 new highs and 47 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down, Apple sinks on app store ruling</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down, Apple sinks on app store ruling\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-11 07:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* U.S. producer prices rise solidly in August</p>\n<p>* Apple falls after 'Fortnite' case ruling</p>\n<p>* Kroger falls as shipping woes hurt margins</p>\n<p>Sept 10 (Reuters) - Wall Street ended sharply lower on Friday as investors weighed signs of higher inflation, while Apple Inc tumbled following an unfavorable court ruling related to its app store.</p>\n<p>U.S. producer prices rose solidly in August, leading to the biggest annual gain in nearly 11 years and indicating that high inflation was likely to persist as the pandemic pressures supply chains, data showed.</p>\n<p>Sentiment also took a hit from Cleveland Federal Reserve Bank President Loretta Mester's comments that she would still like the central bank to begin tapering asset purchases this year despite the weak August jobs report.</p>\n<p>The S&amp;P 500 has risen about 19% in 2021, buoyed by support from dovish central bank policies and re-opening optimism.</p>\n<p>However, Wall Street has moved sideways in recent sessions as investor digest indications of increased inflation and concerns about the Delta variant's impact on the economic recovery. Investors are also uncertain about when the Federal Reserve may begin reducing massive measures enacted last year to shield the economy from the pandemic.</p>\n<p>\"The market is taking a breather,\" said Greg Bassuk, CEO of AXS Investments. \"Investors are looking for some outsized news or information that is beyond the band of expectations, something much more outsized, positively or negatively, that will give investors better visibility into how things are going to look for the balance of the year.\"</p>\n<p>Apple dropped 3.3% after a judge struck down a core part of its App Store rules, benefiting app makers. Its drop contributed more than any other stocks to the Nasdaq and S&amp;P 500's declines.</p>\n<p>Shares of app makers rallied, with Spotify Technology&nbsp;up 0.7%, and Activision Blizzard and Electronic Arts both gaining about 2%.</p>\n<p>Losses in the three main indexes accelerated toward the end of the session.</p>\n<p>The Dow Jones Industrial Average fell 0.78% to close at 34,607.72 points, while the S&amp;P 500 lost 0.77% to 4,458.58.</p>\n<p>The Nasdaq Composite dropped 0.87% to 15,115.49.</p>\n<p>For the week, the S&amp;P 500 lost 1.7%, the Dow declined 2.15% and the Nasdaq shed 1.61%.</p>\n<p>Friday was the first time since February that the S&amp;P 500 declined five days in a row.</p>\n<p>All of the eleven S&amp;P 500 sector indexes fell, with real estate and utilities each down more than 1% and leading the declines.</p>\n<p>Affirm&nbsp;Exploded 34% on Robust Revenue Growth and Guidance, Analysts Impressive Amid Faster Than Expected Merchant and Customer Growth.</p>\n<p>Grocer Kroger Co slumped nearly 8% after it said global supply chain disruptions, freight costs, discounts and wastage would hit its profit margins.</p>\n<p>Volume on U.S. exchanges was 10.0 billion shares, compared with the 9.2 billion average for the full session over the last 20 trading days.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.84-to-1 ratio; on Nasdaq, a 1.88-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and 3 new lows; the Nasdaq Composite recorded 55 new highs and 47 new lows.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2166711943","content_text":"* U.S. producer prices rise solidly in August\n* Apple falls after 'Fortnite' case ruling\n* Kroger falls as shipping woes hurt margins\nSept 10 (Reuters) - Wall Street ended sharply lower on Friday as investors weighed signs of higher inflation, while Apple Inc tumbled following an unfavorable court ruling related to its app store.\nU.S. producer prices rose solidly in August, leading to the biggest annual gain in nearly 11 years and indicating that high inflation was likely to persist as the pandemic pressures supply chains, data showed.\nSentiment also took a hit from Cleveland Federal Reserve Bank President Loretta Mester's comments that she would still like the central bank to begin tapering asset purchases this year despite the weak August jobs report.\nThe S&P 500 has risen about 19% in 2021, buoyed by support from dovish central bank policies and re-opening optimism.\nHowever, Wall Street has moved sideways in recent sessions as investor digest indications of increased inflation and concerns about the Delta variant's impact on the economic recovery. Investors are also uncertain about when the Federal Reserve may begin reducing massive measures enacted last year to shield the economy from the pandemic.\n\"The market is taking a breather,\" said Greg Bassuk, CEO of AXS Investments. \"Investors are looking for some outsized news or information that is beyond the band of expectations, something much more outsized, positively or negatively, that will give investors better visibility into how things are going to look for the balance of the year.\"\nApple dropped 3.3% after a judge struck down a core part of its App Store rules, benefiting app makers. Its drop contributed more than any other stocks to the Nasdaq and S&P 500's declines.\nShares of app makers rallied, with Spotify Technology up 0.7%, and Activision Blizzard and Electronic Arts both gaining about 2%.\nLosses in the three main indexes accelerated toward the end of the session.\nThe Dow Jones Industrial Average fell 0.78% to close at 34,607.72 points, while the S&P 500 lost 0.77% to 4,458.58.\nThe Nasdaq Composite dropped 0.87% to 15,115.49.\nFor the week, the S&P 500 lost 1.7%, the Dow declined 2.15% and the Nasdaq shed 1.61%.\nFriday was the first time since February that the S&P 500 declined five days in a row.\nAll of the eleven S&P 500 sector indexes fell, with real estate and utilities each down more than 1% and leading the declines.\nAffirm Exploded 34% on Robust Revenue Growth and Guidance, Analysts Impressive Amid Faster Than Expected Merchant and Customer Growth.\nGrocer Kroger Co slumped nearly 8% after it said global supply chain disruptions, freight costs, discounts and wastage would hit its profit margins.\nVolume on U.S. exchanges was 10.0 billion shares, compared with the 9.2 billion average for the full session over the last 20 trading days.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.84-to-1 ratio; on Nasdaq, a 1.88-to-1 ratio favored decliners.\nThe S&P 500 posted 15 new 52-week highs and 3 new lows; the Nasdaq Composite recorded 55 new highs and 47 new lows.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"AAPL":0.9,"ATVI":0.9,"DIDI":0.9,"EA":0.9,"KR":0.9,"SPOT":0.9}},"isVote":1,"tweetType":1,"viewCount":284,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":842206374,"gmtCreate":1636176767406,"gmtModify":1636177198943,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584074223056401","authorIdStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/842206374","repostId":"1173813098","repostType":4,"repost":{"id":"1173813098","kind":"news","pubTimestamp":1636156499,"share":"https://ttm.financial/m/news/1173813098?lang=&edition=full","pubTime":"2021-11-06 07:54","market":"us","language":"en","title":"Wall St books records, weekly gains on strong jobs report, Pfizer COVID-19 pill cheer","url":"https://stock-news.laohu8.com/highlight/detail?id=1173813098","media":"Reuters","summary":"(Reuters) - Wall Street's main indexes scored record closing highs on Friday and booked solid gains ","content":"<p>(Reuters) - Wall Street's main indexes scored record closing highs on Friday and booked solid gains for the week following a strong U.S. jobs report and positive data for Pfizer's experimental pill against COVID-19.</p>\n<p>The S&amp;P 500 and the Nasdaq notched record high closes for their seventh straight sessions, while the Dow Jones Industrial Average also closed at a record. All three indexes posted weekly gains for their fifth straight weeks.</p>\n<p>The Labor Department report showed U.S. employment increased more than expected in October as the headwind from the surge in COVID-19 infections over the summer subsided.</p>\n<p>A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease. Pfizer shares jumped about 11%.</p>\n<p>The news kept the run going for equities after investors earlier in the week digested the Federal Reserve's decision to start reducing its monthly bond purchases put in place to support the economy.</p>\n<p>\"Momentum that we have seen this week has continued, and the jobs report and the Pfizer announcement certainly are providing positive datapoints for investors to put more money into the market right now,” said Chuck Carlson, chief executive officer at Horizon Investment Services in Hammond, Indiana.</p>\n<p>The Dow Jones Industrial Average rose 203.72 points, or 0.56%, to 36,327.95, the S&amp;P 500 gained 17.47 points, or 0.37%, to 4,697.53 and the Nasdaq Composite added 31.28 points, or 0.2%, to 15,971.59.</p>\n<p>For the week, the S&amp;P 500 rose 2%, the Dow added 1.42%, while the Nasdaq gained 3.05%.</p>\n<p>Travel stocks rose following Pfizer's announcement, with the S&amp;P 1500 airlines index climbing 7%, and cruise operators Carnival Corp, Royal Caribbean Cruises and Norwegian Cruise rising between about 8% to 9%.</p>\n<p>\"Still early to be definitive but this (pill) looks like a true game changer for many industries like leisure and transportation, you're seeing it reflected in the prices,\" said Andre Bakhos, managing director at New Vines Capital LLC in Bernardsville, New Jersey.</p>\n<p>Among S&amp;P 500 sectors, energy and industrials led the way, rising 1.4% and 1%, respectively.</p>\n<p>Healthcare was the only sector that ended negative, falling 1%. The Pfizer news weighed on shares of competitors such as Merck, which fell nearly 10%, and COVID-19 vaccine makers such as Moderna, which slumped 16.6%.</p>\n<p>Shares of so-called \"stay-at-home\" names fell, with <a href=\"https://laohu8.com/S/ZM\">Zoom</a> Video Communications down 6.2% and Netflix Inc off 3.4%.</p>\n<p>Better-than-expected third-quarter earnings have helped lift sentiment for equities. With about 440 companies having reported, S&amp;P 500 earnings are expected to have climbed 41.5% in the third quarter from a year earlier, according to Refinitiv IBES.</p>\n<p>Pinterest Inc shares climbed 5.9% after the company's strong fourth-quarter revenue forecast.</p>\n<p>Peloton Interactive Inc shares slumped 35.3% after the company slashed its full-year sales forecast by up to $1 billion.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.16-to-1 ratio; on Nasdaq, a 1.22-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 83 new 52-week highs and two new lows; the Nasdaq Composite recorded 303 new highs and 80 new lows.</p>\n<p>About 11.5 billion shares changed hands in U.S. exchanges, compared with the 10.5 billion daily average over the last 20 sessions.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St books records, weekly gains on strong jobs report, Pfizer COVID-19 pill cheer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St books records, weekly gains on strong jobs report, Pfizer COVID-19 pill cheer\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-06 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19167545><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Wall Street's main indexes scored record closing highs on Friday and booked solid gains for the week following a strong U.S. jobs report and positive data for Pfizer's experimental pill ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19167545\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.streetinsider.com/dr/news.php?id=19167545","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173813098","content_text":"(Reuters) - Wall Street's main indexes scored record closing highs on Friday and booked solid gains for the week following a strong U.S. jobs report and positive data for Pfizer's experimental pill against COVID-19.\nThe S&P 500 and the Nasdaq notched record high closes for their seventh straight sessions, while the Dow Jones Industrial Average also closed at a record. All three indexes posted weekly gains for their fifth straight weeks.\nThe Labor Department report showed U.S. employment increased more than expected in October as the headwind from the surge in COVID-19 infections over the summer subsided.\nA trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease. Pfizer shares jumped about 11%.\nThe news kept the run going for equities after investors earlier in the week digested the Federal Reserve's decision to start reducing its monthly bond purchases put in place to support the economy.\n\"Momentum that we have seen this week has continued, and the jobs report and the Pfizer announcement certainly are providing positive datapoints for investors to put more money into the market right now,” said Chuck Carlson, chief executive officer at Horizon Investment Services in Hammond, Indiana.\nThe Dow Jones Industrial Average rose 203.72 points, or 0.56%, to 36,327.95, the S&P 500 gained 17.47 points, or 0.37%, to 4,697.53 and the Nasdaq Composite added 31.28 points, or 0.2%, to 15,971.59.\nFor the week, the S&P 500 rose 2%, the Dow added 1.42%, while the Nasdaq gained 3.05%.\nTravel stocks rose following Pfizer's announcement, with the S&P 1500 airlines index climbing 7%, and cruise operators Carnival Corp, Royal Caribbean Cruises and Norwegian Cruise rising between about 8% to 9%.\n\"Still early to be definitive but this (pill) looks like a true game changer for many industries like leisure and transportation, you're seeing it reflected in the prices,\" said Andre Bakhos, managing director at New Vines Capital LLC in Bernardsville, New Jersey.\nAmong S&P 500 sectors, energy and industrials led the way, rising 1.4% and 1%, respectively.\nHealthcare was the only sector that ended negative, falling 1%. The Pfizer news weighed on shares of competitors such as Merck, which fell nearly 10%, and COVID-19 vaccine makers such as Moderna, which slumped 16.6%.\nShares of so-called \"stay-at-home\" names fell, with Zoom Video Communications down 6.2% and Netflix Inc off 3.4%.\nBetter-than-expected third-quarter earnings have helped lift sentiment for equities. With about 440 companies having reported, S&P 500 earnings are expected to have climbed 41.5% in the third quarter from a year earlier, according to Refinitiv IBES.\nPinterest Inc shares climbed 5.9% after the company's strong fourth-quarter revenue forecast.\nPeloton Interactive Inc shares slumped 35.3% after the company slashed its full-year sales forecast by up to $1 billion.\nAdvancing issues outnumbered declining ones on the NYSE by a 2.16-to-1 ratio; on Nasdaq, a 1.22-to-1 ratio favored advancers.\nThe S&P 500 posted 83 new 52-week highs and two new lows; the Nasdaq Composite recorded 303 new highs and 80 new lows.\nAbout 11.5 billion shares changed hands in U.S. exchanges, compared with the 10.5 billion daily average over the last 20 sessions.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1925,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":858285978,"gmtCreate":1635058911987,"gmtModify":1635058912161,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584074223056401","authorIdStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/858285978","repostId":"1174514229","repostType":4,"repost":{"id":"1174514229","kind":"news","pubTimestamp":1635035471,"share":"https://ttm.financial/m/news/1174514229?lang=&edition=full","pubTime":"2021-10-24 08:31","market":"us","language":"en","title":"US IPO Week Ahead: Semiconductors, energy storage, designer apparel, and more in a 12 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1174514229","media":"Renaissance Capital","summary":"The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.","content":"<p>The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.</p>\n<p>Semiconductor foundry&nbsp;<b>GlobalFoundries</b>(GFS) plans to raise $2.4 billion at a $24.6 billion market cap. Backed by Abu Dhabi’s Mubadala, US-based GlobalFoundries is one of the world’s leading specialty semiconductor foundries. Unprofitable with lumpy growth, the company states that it is the only scaled pure-play foundry with a global footprint that is not based in China.</p>\n<p>Enterprise cloud data management platform&nbsp;<b>Informatica</b>(INFA) plans to raise $885 million at an $8.7 billion market cap. This company provides data integration services on its AI-powered platform to over 5,700 customers through both licenses and subscriptions. Although it will be highly leveraged post-IPO, Informatica is a recognized leader in the global data management market and saw strong subscription ARR growth in the 1H21.</p>\n<p>Energy storage provider&nbsp;<b>Fluence Energy</b>(FLNC) plans to raise $698 million at a $3.8 billion market cap. Formed by Siemens and AES, this company sells energy storage products and services to utilities, independent power producers, project developers, and commercial and industrial customers. Fast growing but unprofitable, Fluence Energy deployed 942 MW of storage products as of 6/30/21.</p>\n<p>Revenue cycle management platform&nbsp;<b>Ensemble Health Partners</b>(ENSB) plans to raise $605 million at a $3.6 billion market cap. This platform provides revenue cycle management solutions to the healthcare industry. Profitable with accelerating growth in the 1H21, Ensemble Health has over $20 billion in annual client net patient revenue under management.</p>\n<p>Hiring solutions provider&nbsp;<b>HireRight Holdings</b>(HRT) plans to raise $500 million at a $1.8 billion market cap. This company provides background checks, verification, identification, monitoring, and drug and health screening services to over 40,000 customers. HireRight was profitable on an EBIT basis in the 1H21, though cash flow swung negative.</p>\n<p>Online education marketplace&nbsp;<b>Udemy</b>(UDMY) plans to raise $406 million at a $4.3 billion market cap. This education platform provides over 183,000 courses in 75 languages to over 44 million customers in over 180 countries. Growing but unprofitable, Udemy has registered more than 73 million users since its inception.</p>\n<p>Chinese drug in-licensor&nbsp;<b>LianBio</b>(LIAN) plans to raise $325 million at a $1.8 billion market cap. Focused on China and other Asian markets, this biopharmaceutical company develops and commercializes drugs for a variety of indications. LianBio’s pipeline currently consists of nine product candidates across five different therapeutics areas.</p>\n<p><b>Rent the Runway</b>(RENT) plans to raise $293 million at a $1.4 billion market cap. This apparel rental company originally focused on a-la-carte rentals of dresses for events, but has gradually transitioned to mostly generating revenue from monthly subscription boxes. While the company has seen active subscribers and revenue rebound in the last two quarters, it is unprofitable and leveraged post-IPO.</p>\n<p>Aesthetic medical device maker&nbsp;<b>Candela Medical</b>(CDLA) plans to raise $250 million at a $1.7 billion market cap. Selling products directly in 18 countries and indirectly in 66 countries, this company develops medical devices for elective aesthetic procedures. Despite being hard hit by the pandemic, Candela Medical saw strong growth and turned profitable in the 1H21.</p>\n<p>Fire pit brand&nbsp;<b>Solo Brands</b>(DTC) plans to raise $200 million at a $1.5 billion market cap. Solo Brands sells fire pits, camp stoves, and other outdoor gear through its DTC platform. Fast growing and profitable, this outdoor e-commerce has an installed base of more than 2.3 million customers.</p>\n<p>Body contouring provider&nbsp;<b>AirSculpt Technologies</b>(AIRS) plans to raise $160 million at an $886 million market cap. This company provides minimally-invasive body contouring procedures through 16 centers across 13 states in the US. AirSculpt Technologies is profitable with solid growth, and has seen an increase in same-center case volume as a result of lessening effects of COVID-19.</p>\n<p>Technology firm&nbsp;<b>Arteris</b>(AIP) plans to raise $75 million at a $555 million market cap. This technology company develops and licenses interconnect intellectual property that manages the on-chip communications in System-on-Chip semiconductor devices. Arteris is unprofitable but saw growth accelerate in the 1H21.</p>\n<p><img src=\"https://static.tigerbbs.com/99c3b0173e59f4e69ff484c12bd137e7\" tg-width=\"1270\" tg-height=\"704\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/64e34b3c49a856e99ba64a2d57410844\" tg-width=\"1272\" tg-height=\"582\" referrerpolicy=\"no-referrer\"></p>\n<p>Street research is expected for six companies, and lock-up periods will be expiring for up to 12 companies.</p>\n<p><b>IPO Market Snapshot</b></p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 10/22/21, the Renaissance IPO Index was up 8.2% year-to-date, while the S&amp;P 500 was up 21.1%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Uber Technologies (UBER) and Moderna (MRNA). The Renaissance International IPO Index was down 15.8% year-to-date, while the ACWX was up 9.1%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.</p>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: Semiconductors, energy storage, designer apparel, and more in a 12 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: Semiconductors, energy storage, designer apparel, and more in a 12 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-24 08:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/87676/US-IPO-Week-Ahead-Semiconductors-energy-storage-designer-apparel-and-more-i><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.\nSemiconductor foundry GlobalFoundries(GFS) plans to raise $2.4 billion at a $24.6 billion market ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/87676/US-IPO-Week-Ahead-Semiconductors-energy-storage-designer-apparel-and-more-i\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DTC":"Solo Brands, Inc.","RENT":"Rent the Runway, Inc.",".DJI":"道琼斯","HRT":"HireRight Holdings Corp.",".IXIC":"NASDAQ Composite","AIRS":"Airsculpt Technologies","FLNC":"Fluence Energy, Inc.","GFS":"GLOBALFOUNDRIES Inc.","AIP":"Arteris, Inc.",".SPX":"S&P 500 Index","UDMY":"Udemy, Inc.","INFA":"Informatica Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/87676/US-IPO-Week-Ahead-Semiconductors-energy-storage-designer-apparel-and-more-i","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174514229","content_text":"The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.\nSemiconductor foundry GlobalFoundries(GFS) plans to raise $2.4 billion at a $24.6 billion market cap. Backed by Abu Dhabi’s Mubadala, US-based GlobalFoundries is one of the world’s leading specialty semiconductor foundries. Unprofitable with lumpy growth, the company states that it is the only scaled pure-play foundry with a global footprint that is not based in China.\nEnterprise cloud data management platform Informatica(INFA) plans to raise $885 million at an $8.7 billion market cap. This company provides data integration services on its AI-powered platform to over 5,700 customers through both licenses and subscriptions. Although it will be highly leveraged post-IPO, Informatica is a recognized leader in the global data management market and saw strong subscription ARR growth in the 1H21.\nEnergy storage provider Fluence Energy(FLNC) plans to raise $698 million at a $3.8 billion market cap. Formed by Siemens and AES, this company sells energy storage products and services to utilities, independent power producers, project developers, and commercial and industrial customers. Fast growing but unprofitable, Fluence Energy deployed 942 MW of storage products as of 6/30/21.\nRevenue cycle management platform Ensemble Health Partners(ENSB) plans to raise $605 million at a $3.6 billion market cap. This platform provides revenue cycle management solutions to the healthcare industry. Profitable with accelerating growth in the 1H21, Ensemble Health has over $20 billion in annual client net patient revenue under management.\nHiring solutions provider HireRight Holdings(HRT) plans to raise $500 million at a $1.8 billion market cap. This company provides background checks, verification, identification, monitoring, and drug and health screening services to over 40,000 customers. HireRight was profitable on an EBIT basis in the 1H21, though cash flow swung negative.\nOnline education marketplace Udemy(UDMY) plans to raise $406 million at a $4.3 billion market cap. This education platform provides over 183,000 courses in 75 languages to over 44 million customers in over 180 countries. Growing but unprofitable, Udemy has registered more than 73 million users since its inception.\nChinese drug in-licensor LianBio(LIAN) plans to raise $325 million at a $1.8 billion market cap. Focused on China and other Asian markets, this biopharmaceutical company develops and commercializes drugs for a variety of indications. LianBio’s pipeline currently consists of nine product candidates across five different therapeutics areas.\nRent the Runway(RENT) plans to raise $293 million at a $1.4 billion market cap. This apparel rental company originally focused on a-la-carte rentals of dresses for events, but has gradually transitioned to mostly generating revenue from monthly subscription boxes. While the company has seen active subscribers and revenue rebound in the last two quarters, it is unprofitable and leveraged post-IPO.\nAesthetic medical device maker Candela Medical(CDLA) plans to raise $250 million at a $1.7 billion market cap. Selling products directly in 18 countries and indirectly in 66 countries, this company develops medical devices for elective aesthetic procedures. Despite being hard hit by the pandemic, Candela Medical saw strong growth and turned profitable in the 1H21.\nFire pit brand Solo Brands(DTC) plans to raise $200 million at a $1.5 billion market cap. Solo Brands sells fire pits, camp stoves, and other outdoor gear through its DTC platform. Fast growing and profitable, this outdoor e-commerce has an installed base of more than 2.3 million customers.\nBody contouring provider AirSculpt Technologies(AIRS) plans to raise $160 million at an $886 million market cap. This company provides minimally-invasive body contouring procedures through 16 centers across 13 states in the US. AirSculpt Technologies is profitable with solid growth, and has seen an increase in same-center case volume as a result of lessening effects of COVID-19.\nTechnology firm Arteris(AIP) plans to raise $75 million at a $555 million market cap. This technology company develops and licenses interconnect intellectual property that manages the on-chip communications in System-on-Chip semiconductor devices. Arteris is unprofitable but saw growth accelerate in the 1H21.\n\nStreet research is expected for six companies, and lock-up periods will be expiring for up to 12 companies.\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 10/22/21, the Renaissance IPO Index was up 8.2% year-to-date, while the S&P 500 was up 21.1%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Uber Technologies (UBER) and Moderna (MRNA). The Renaissance International IPO Index was down 15.8% year-to-date, while the ACWX was up 9.1%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"AIP":0.9,"AIRS":0.9,"CDLA":0.9,"DTC":0.9,"ENSB":0.9,"FLNC":0.9,"GFS":0.9,"HRT":0.9,"INFA":0.9,"LIAN":0.9,"RENT":0.9,"UDMY":0.9}},"isVote":1,"tweetType":1,"viewCount":1428,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":888753906,"gmtCreate":1631532379205,"gmtModify":1631890580349,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584074223056401","authorIdStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/888753906","repostId":"2167630550","repostType":4,"isVote":1,"tweetType":1,"viewCount":434,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":873136254,"gmtCreate":1636877022008,"gmtModify":1636877022008,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584074223056401","authorIdStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873136254","repostId":"1103944030","repostType":4,"isVote":1,"tweetType":1,"viewCount":1858,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":867683187,"gmtCreate":1633252387382,"gmtModify":1633252387540,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584074223056401","authorIdStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/867683187","repostId":"2172647479","repostType":4,"repost":{"id":"2172647479","kind":"highlight","pubTimestamp":1633243084,"share":"https://ttm.financial/m/news/2172647479?lang=&edition=full","pubTime":"2021-10-03 14:38","market":"hk","language":"en","title":"Why Coinbase Global Stock Was Down 12.2% in September","url":"https://stock-news.laohu8.com/highlight/detail?id=2172647479","media":"Motley Fool","summary":"The company is going head-to-head with financial regulators, and that is making investors nervous.","content":"<h2>What happened</h2>\n<p>Shares of <b>Coinbase Global</b> (NASDAQ:COIN) were down 12.2% in September, according to data from&nbsp;S&amp;P Global Market Intelligence. The stock tends to be correlated with cryptocurrency prices, which fell during the month, and the company announced the Securities and Exchange Comission (SEC) was going to sue the company if it launched its new stablecoin lending program.</p>\n<p>On top of this, the broad market indices took a tumble in September, with the<b> S&amp;P 500</b> index down around 5% in the period. This likely exacerbated Coinbase stock's decline.</p>\n<h2>So what</h2>\n<p>A stablecoin is a cryptocurrency that is backed by a reserve, typically a fiat currency like the U.S. dollar. This means that when you buy stablecoins, they will theoretically be able to be converted back to U.S. dollars at any point. Coinbase, as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the largest crypto companies in the world, helped start a stablecoin called USD Coin (USDC) with a company called Circle. There are currently 31.2 billion USDC in circulation, meaning $31.2 billion (in U.S. dollars) has been exchanged for the stablecoin.</p>\n<p>What does this have to do with Coinbase stock and the SEC? Well, in order to make some money, Coinbase was planning to offer USDC owners the ability to lend their stablecoins to Coinbase, paying them a 4% annual interest rate (eight times the national average) if they join the lending program. Coinbase can make money doing this because other crypto traders (or really anyone interested in getting a loan) are willing to pay higher interest rates to get USDC loaned to them from Coinbase. When Coinbase came to the SEC to launch the lending program, the SEC gave the company a Wells notice, which means the regulator intends to sue Coinbase if it launches the product.</p>\n<p>With almost $5.5 billion in projected sales this year, Coinbase's business won't go away because of this SEC crackdown. However, it does indicate the government might get more aggressive cracking down on any new initiatives the company has, which could hurt its ability to grow over the next decade.</p>\n<p>In other news, major cryptocurrencies like <b>Bitcoin</b> (CRYPTO:BTC) fell last month. The coin started at around $50,000 at the beginning of December but finished the month closer to $40,000. Coinbase owns Bitcoin and makes money through cryptocurrency trades, so its stock tends to correlate with any major moves in the cryptocurrency market.</p>\n<h2>Now what</h2>\n<p>This news from the SEC and Coinbase won't crush the company's current operations, but it is a concern that the SEC may crack down on the company's potential growth opportunities. If you are bullish on the crypto industry and think it is the future of finance, these regulatory risks are something to consider and could impact Coinbase's stock over the long term.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Coinbase Global Stock Was Down 12.2% in September</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Coinbase Global Stock Was Down 12.2% in September\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-03 14:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/03/why-coinbase-was-down-this-month/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happened\nShares of Coinbase Global (NASDAQ:COIN) were down 12.2% in September, according to data from S&P Global Market Intelligence. The stock tends to be correlated with cryptocurrency prices, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/03/why-coinbase-was-down-this-month/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/10/03/why-coinbase-was-down-this-month/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2172647479","content_text":"What happened\nShares of Coinbase Global (NASDAQ:COIN) were down 12.2% in September, according to data from S&P Global Market Intelligence. The stock tends to be correlated with cryptocurrency prices, which fell during the month, and the company announced the Securities and Exchange Comission (SEC) was going to sue the company if it launched its new stablecoin lending program.\nOn top of this, the broad market indices took a tumble in September, with the S&P 500 index down around 5% in the period. This likely exacerbated Coinbase stock's decline.\nSo what\nA stablecoin is a cryptocurrency that is backed by a reserve, typically a fiat currency like the U.S. dollar. This means that when you buy stablecoins, they will theoretically be able to be converted back to U.S. dollars at any point. Coinbase, as one of the largest crypto companies in the world, helped start a stablecoin called USD Coin (USDC) with a company called Circle. There are currently 31.2 billion USDC in circulation, meaning $31.2 billion (in U.S. dollars) has been exchanged for the stablecoin.\nWhat does this have to do with Coinbase stock and the SEC? Well, in order to make some money, Coinbase was planning to offer USDC owners the ability to lend their stablecoins to Coinbase, paying them a 4% annual interest rate (eight times the national average) if they join the lending program. Coinbase can make money doing this because other crypto traders (or really anyone interested in getting a loan) are willing to pay higher interest rates to get USDC loaned to them from Coinbase. When Coinbase came to the SEC to launch the lending program, the SEC gave the company a Wells notice, which means the regulator intends to sue Coinbase if it launches the product.\nWith almost $5.5 billion in projected sales this year, Coinbase's business won't go away because of this SEC crackdown. However, it does indicate the government might get more aggressive cracking down on any new initiatives the company has, which could hurt its ability to grow over the next decade.\nIn other news, major cryptocurrencies like Bitcoin (CRYPTO:BTC) fell last month. The coin started at around $50,000 at the beginning of December but finished the month closer to $40,000. Coinbase owns Bitcoin and makes money through cryptocurrency trades, so its stock tends to correlate with any major moves in the cryptocurrency market.\nNow what\nThis news from the SEC and Coinbase won't crush the company's current operations, but it is a concern that the SEC may crack down on the company's potential growth opportunities. If you are bullish on the crypto industry and think it is the future of finance, these regulatory risks are something to consider and could impact Coinbase's stock over the long term.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":350,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":861411098,"gmtCreate":1632530634314,"gmtModify":1632711535934,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584074223056401","authorIdStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/861411098","repostId":"2170619785","repostType":4,"isVote":1,"tweetType":1,"viewCount":598,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":854156844,"gmtCreate":1635429461642,"gmtModify":1635429764889,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584074223056401","authorIdStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/854156844","repostId":"1153909226","repostType":4,"repost":{"id":"1153909226","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635428011,"share":"https://ttm.financial/m/news/1153909226?lang=&edition=full","pubTime":"2021-10-28 21:33","market":"us","language":"en","title":"Rafael Holdings stock plummets after cancer-treatment trial missed primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=1153909226","media":"Tiger Newspress","summary":"Shares of Rafael Holdings Inc. $(RFL)$ plummeted 78% in morning trading Thursday, after the develope","content":"<p>Shares of Rafael Holdings Inc. <a href=\"https://laohu8.com/S/RFL\">$(RFL)$</a> plummeted 78% in morning trading Thursday,&nbsp;after the developer of cancer treatments said a Phase 3 trial of CPI-613 (devimistat) in patients with relapsed or refractory acute myeloid leukemia failed to meet its primary endpoint. </p>\n<p><img src=\"https://static.tigerbbs.com/0208843fbf8264bc77269e3fd7a5cba5\" tg-width=\"885\" tg-height=\"630\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>The company said devimistat, given with Folfirinox (mFFX), a current standard of care chemotherapy regimen, did not significantly improve overall survival. </p>\n<p>\"While we are disappointed by the outcomes of these well-designed and well-executed studies, we remain committed to furthering our research and development in cancer metabolism for the treatment of hard-to-treat cancers, as our other studies continue,\" said Rafael Chief Executive Sanjeev Luther. </p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rafael Holdings stock plummets after cancer-treatment trial missed primary endpoint</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRafael Holdings stock plummets after cancer-treatment trial missed primary endpoint\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-28 21:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Rafael Holdings Inc. <a href=\"https://laohu8.com/S/RFL\">$(RFL)$</a> plummeted 78% in morning trading Thursday,&nbsp;after the developer of cancer treatments said a Phase 3 trial of CPI-613 (devimistat) in patients with relapsed or refractory acute myeloid leukemia failed to meet its primary endpoint. </p>\n<p><img src=\"https://static.tigerbbs.com/0208843fbf8264bc77269e3fd7a5cba5\" tg-width=\"885\" tg-height=\"630\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>The company said devimistat, given with Folfirinox (mFFX), a current standard of care chemotherapy regimen, did not significantly improve overall survival. </p>\n<p>\"While we are disappointed by the outcomes of these well-designed and well-executed studies, we remain committed to furthering our research and development in cancer metabolism for the treatment of hard-to-treat cancers, as our other studies continue,\" said Rafael Chief Executive Sanjeev Luther. </p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153909226","content_text":"Shares of Rafael Holdings Inc. $(RFL)$ plummeted 78% in morning trading Thursday, after the developer of cancer treatments said a Phase 3 trial of CPI-613 (devimistat) in patients with relapsed or refractory acute myeloid leukemia failed to meet its primary endpoint. \n\nThe company said devimistat, given with Folfirinox (mFFX), a current standard of care chemotherapy regimen, did not significantly improve overall survival. \n\"While we are disappointed by the outcomes of these well-designed and well-executed studies, we remain committed to furthering our research and development in cancer metabolism for the treatment of hard-to-treat cancers, as our other studies continue,\" said Rafael Chief Executive Sanjeev Luther.","news_type":1,"symbols_score_info":{"RFL":0.9}},"isVote":1,"tweetType":1,"viewCount":1483,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":884889503,"gmtCreate":1631878573402,"gmtModify":1631890580343,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584074223056401","authorIdStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/884889503","repostId":"2168529607","repostType":4,"repost":{"id":"2168529607","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1631865945,"share":"https://ttm.financial/m/news/2168529607?lang=&edition=full","pubTime":"2021-09-17 16:05","market":"sh","language":"en","title":"ADVISORY-China markets closed for Mid-Autumn Festival","url":"https://stock-news.laohu8.com/highlight/detail?id=2168529607","media":"Reuters","summary":"Mainland China's stock and bond markets, foreign exchange and commodity futures markets will be clos","content":"<p>Mainland China's stock and bond markets, foreign exchange and commodity futures markets will be closed through Sept. 21 for Mid-Autumn Festival.</p>\n<p>Markets will resume trade on Wednesday, Sept. 22.</p>\n<p>Meanwhile, Hong Kong's financial markets will be closed for the public holiday on Wednesday, Sept. 22.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ADVISORY-China markets closed for Mid-Autumn Festival</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nADVISORY-China markets closed for Mid-Autumn Festival\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-17 16:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Mainland China's stock and bond markets, foreign exchange and commodity futures markets will be closed through Sept. 21 for Mid-Autumn Festival.</p>\n<p>Markets will resume trade on Wednesday, Sept. 22.</p>\n<p>Meanwhile, Hong Kong's financial markets will be closed for the public holiday on Wednesday, Sept. 22.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"399001":"深证成指","399006":"创业板指","000001.SH":"上证指数","HSI":"恒生指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168529607","content_text":"Mainland China's stock and bond markets, foreign exchange and commodity futures markets will be closed through Sept. 21 for Mid-Autumn Festival.\nMarkets will resume trade on Wednesday, Sept. 22.\nMeanwhile, Hong Kong's financial markets will be closed for the public holiday on Wednesday, Sept. 22.","news_type":1,"symbols_score_info":{"399001":0.9,"399006":0.9,"000001.SH":0.9,"HSI":0.9}},"isVote":1,"tweetType":1,"viewCount":408,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":888043649,"gmtCreate":1631416618381,"gmtModify":1631890580349,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584074223056401","authorIdStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/888043649","repostId":"1189654544","repostType":4,"repost":{"id":"1189654544","kind":"news","pubTimestamp":1631406130,"share":"https://ttm.financial/m/news/1189654544?lang=&edition=full","pubTime":"2021-09-12 08:22","market":"us","language":"en","title":"US IPO Week Ahead: The Fall IPO market kicks off with a 10 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1189654544","media":"Renaissance Capital","summary":"After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion i","content":"<p>After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion in the week ahead.</p>\n<p>Tech consultancy&nbsp;<b>Thoughtworks</b>(TWKS) plans to raise $700 million at a $6.3 billion market cap. This agile software developer provides premium, end-to-end digital strategy, design, and engineering services to more than 300 enterprise customers. The company grew revenue at a 14% CAGR from 2017 to 2020, and expanded margins in 2020 and the 1H21.</p>\n<p>Swiss running shoe brand&nbsp;<b>On Holding</b>(ONON) plans to raise $591 million at a $5.9 billion market cap. On is a global provider of premium athletic footwear, apparel, and accessories that are designed using sustainable materials and its proprietary technology. The company has demonstrated growth and profitability, though it faces significant competition from other well-known sportswear brands.</p>\n<p>After ending talks to go public via SPAC,<b>Sportradar Group</b>(SRAD) plans to raise $504 million at a $7.9 billion market cap. Covering over 750,000 events annually across 83 sports, this Swiss company provides software, data, and content to sports leagues, betting operators, and media companies. Sportradar is profitable, and growth accelerated in the 1H21 as live sports resumed.</p>\n<p>Drive-thru coffee chain&nbsp;<b>Dutch Bros</b>(BROS) plans to raise $400 million at a $3.3 billion market cap. This Oregon-based company has a chain of 471 drive-thru coffee shops in the Western US, and it has been able to maintain a track record of same-store sales growth as it has expanded to new states. Insiders received pre-IPO dividends and will sell shares back to the company.</p>\n<p>Healthcare intelligence platform&nbsp;<b>Definitive Healthcare</b>(DH) plans to raise $350 million at a $3.3 billion market cap. This company provides a healthcare commercial intelligence and analytics platform, helping its customers to analyze, navigate, and sell into the complex healthcare ecosystem. Unprofitable with strong growth, Definitive Healthcare will be leveraged post-IPO.</p>\n<p>Identity management platform&nbsp;<b>ForgeRock</b>(FORG) plans to raise $248 million at a $2.1 billion market cap. The company provides identity and access management software, with a platform to provision, authenticate, and govern all types of digital identities. Unprofitable with high sales and marketing expenses, ForgeRock is a leading next-gen provider in the multi-billion-dollar identity and access market.</p>\n<p>Immunology biotech&nbsp;<b>DICE Therapeutics</b>(DICE) plans to raise $160 million at a $550 million market cap. This biotech is developing oral small molecule therapies to treat chronic diseases in immunology and other therapeutic areas. DICE plans to initiate a Phase 1 trial of its lead candidate S011806, an oral antagonist with a variety of immunology indications.</p>\n<p>Surgical robotics developer&nbsp;<b>PROCEPT BioRobotics</b>(PRCT) plans to raise $127 million at a $1.1 billion market cap. This commercial-stage company develops surgical robotic systems for minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics is highly unprofitable and saw revenue increase more than sixfold in the 1H21.</p>\n<p>Oncology biotech&nbsp;<b>Tyra Biosciences</b>(TYRA) plans to raise $101 million at a $584 million market cap. This preclinical biotech is developing FGFR kinase inhibitors for cancer, specifically solid tumors. Tyra’s lead candidate is initially focused on bladder cancer, and the company expects to submit an IND for it in mid-2022.</p>\n<p>Micro-cap gas delivery service&nbsp;<b>EzFill Holdings</b>(EZFL) plans to raise $25 million at a $104 million market cap. This mobile-fueling company provides an on-demand fuel delivery service in Florida via mobile app. Highly unprofitable with explosive growth, EzFill states that it is the dominant player in the South Florida market.</p>\n<p><img src=\"https://static.tigerbbs.com/718698ff98644c4026f32efe91d076c6\" tg-width=\"1128\" tg-height=\"684\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/97fe13300d9e4cf61effc59b9706776a\" tg-width=\"1129\" tg-height=\"247\" referrerpolicy=\"no-referrer\"></p>\n<p><b>IPO Market Snapshot</b></p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 9/9/21, the Renaissance IPO Index was up 7.7% year-to-date, while the S&amp;P 500 was up 19.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 11.0% year-to-date, while the ACWX was up 10.0%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.</p>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: The Fall IPO market kicks off with a 10 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: The Fall IPO market kicks off with a 10 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-12 08:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/85972/US-IPO-Week-Ahead-The-Fall-IPO-market-kicks-off-with-a-10-IPO-week><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion in the week ahead.\nTech consultancy Thoughtworks(TWKS) plans to raise $700 million at a $6.3 billion ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/85972/US-IPO-Week-Ahead-The-Fall-IPO-market-kicks-off-with-a-10-IPO-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/85972/US-IPO-Week-Ahead-The-Fall-IPO-market-kicks-off-with-a-10-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189654544","content_text":"After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion in the week ahead.\nTech consultancy Thoughtworks(TWKS) plans to raise $700 million at a $6.3 billion market cap. This agile software developer provides premium, end-to-end digital strategy, design, and engineering services to more than 300 enterprise customers. The company grew revenue at a 14% CAGR from 2017 to 2020, and expanded margins in 2020 and the 1H21.\nSwiss running shoe brand On Holding(ONON) plans to raise $591 million at a $5.9 billion market cap. On is a global provider of premium athletic footwear, apparel, and accessories that are designed using sustainable materials and its proprietary technology. The company has demonstrated growth and profitability, though it faces significant competition from other well-known sportswear brands.\nAfter ending talks to go public via SPAC,Sportradar Group(SRAD) plans to raise $504 million at a $7.9 billion market cap. Covering over 750,000 events annually across 83 sports, this Swiss company provides software, data, and content to sports leagues, betting operators, and media companies. Sportradar is profitable, and growth accelerated in the 1H21 as live sports resumed.\nDrive-thru coffee chain Dutch Bros(BROS) plans to raise $400 million at a $3.3 billion market cap. This Oregon-based company has a chain of 471 drive-thru coffee shops in the Western US, and it has been able to maintain a track record of same-store sales growth as it has expanded to new states. Insiders received pre-IPO dividends and will sell shares back to the company.\nHealthcare intelligence platform Definitive Healthcare(DH) plans to raise $350 million at a $3.3 billion market cap. This company provides a healthcare commercial intelligence and analytics platform, helping its customers to analyze, navigate, and sell into the complex healthcare ecosystem. Unprofitable with strong growth, Definitive Healthcare will be leveraged post-IPO.\nIdentity management platform ForgeRock(FORG) plans to raise $248 million at a $2.1 billion market cap. The company provides identity and access management software, with a platform to provision, authenticate, and govern all types of digital identities. Unprofitable with high sales and marketing expenses, ForgeRock is a leading next-gen provider in the multi-billion-dollar identity and access market.\nImmunology biotech DICE Therapeutics(DICE) plans to raise $160 million at a $550 million market cap. This biotech is developing oral small molecule therapies to treat chronic diseases in immunology and other therapeutic areas. DICE plans to initiate a Phase 1 trial of its lead candidate S011806, an oral antagonist with a variety of immunology indications.\nSurgical robotics developer PROCEPT BioRobotics(PRCT) plans to raise $127 million at a $1.1 billion market cap. This commercial-stage company develops surgical robotic systems for minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics is highly unprofitable and saw revenue increase more than sixfold in the 1H21.\nOncology biotech Tyra Biosciences(TYRA) plans to raise $101 million at a $584 million market cap. This preclinical biotech is developing FGFR kinase inhibitors for cancer, specifically solid tumors. Tyra’s lead candidate is initially focused on bladder cancer, and the company expects to submit an IND for it in mid-2022.\nMicro-cap gas delivery service EzFill Holdings(EZFL) plans to raise $25 million at a $104 million market cap. This mobile-fueling company provides an on-demand fuel delivery service in Florida via mobile app. Highly unprofitable with explosive growth, EzFill states that it is the dominant player in the South Florida market.\n\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 9/9/21, the Renaissance IPO Index was up 7.7% year-to-date, while the S&P 500 was up 19.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 11.0% year-to-date, while the ACWX was up 10.0%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"BROS":0.9,"DH":0.9,"DICE":0.9,"EZFL":0.9,"FORG":0.9,"ONON":0.9,"PRCT":0.9,"SRAD":0.9,"TWKS":0.9,"TYRA":0.9}},"isVote":1,"tweetType":1,"viewCount":225,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":841533429,"gmtCreate":1635923405428,"gmtModify":1635923405488,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584074223056401","authorIdStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/841533429","repostId":"1117766576","repostType":4,"isVote":1,"tweetType":1,"viewCount":1789,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":825898799,"gmtCreate":1634215107459,"gmtModify":1634215107459,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584074223056401","authorIdStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/825898799","repostId":"1160666478","repostType":4,"isVote":1,"tweetType":1,"viewCount":1406,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":867683213,"gmtCreate":1633252411906,"gmtModify":1633252412028,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584074223056401","authorIdStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/867683213","repostId":"2172964018","repostType":4,"isVote":1,"tweetType":1,"viewCount":506,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":887014758,"gmtCreate":1631943693874,"gmtModify":1632805154888,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584074223056401","authorIdStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/887014758","repostId":"2168716185","repostType":4,"repost":{"id":"2168716185","kind":"news","pubTimestamp":1631916051,"share":"https://ttm.financial/m/news/2168716185?lang=&edition=full","pubTime":"2021-09-18 06:00","market":"us","language":"en","title":"Wall Street closes rollercoaster week sharply lower","url":"https://stock-news.laohu8.com/highlight/detail?id=2168716185","media":"The Straits Times","summary":"NEW YORK  - US stocks ended sharply lower in a broad sell-off on Friday , ending a week buffeted by strong economic data, corporate tax hike worries, the Delta Covid-19 variant, and possible shifts in the US Federal Reserve's timeline for tapering asset purchases.All three major US stock indexes lost ground, with the Nasdaq Composite Index's weighed down as rising US Treasury yields pressured market-leading growth stocks.They also posted weekly losses, with the S&P index suffering its biggest tw","content":"<div>\n<p>NEW YORK (REUTERS) - US stocks ended sharply lower in a broad sell-off on Friday (Sept 17), ending a week buffeted by strong economic data, corporate tax hike worries, the Delta Covid-19 variant, and ...</p>\n\n<a href=\"http://www.straitstimes.com/business/companies-markets/wall-street-closes-rollercoaster-week-sharply-lower\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street closes rollercoaster week sharply lower</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street closes rollercoaster week sharply lower\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-18 06:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://www.straitstimes.com/business/companies-markets/wall-street-closes-rollercoaster-week-sharply-lower><strong>The Straits Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK (REUTERS) - US stocks ended sharply lower in a broad sell-off on Friday (Sept 17), ending a week buffeted by strong economic data, corporate tax hike worries, the Delta Covid-19 variant, and ...</p>\n\n<a href=\"http://www.straitstimes.com/business/companies-markets/wall-street-closes-rollercoaster-week-sharply-lower\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SDS":"两倍做空标普500ETF","UPRO":"三倍做多标普500ETF",".SPX":"S&P 500 Index","SSO":"两倍做多标普500ETF","OEX":"标普100","OEF":"标普100指数ETF-iShares","IVV":"标普500指数ETF","SPXU":"三倍做空标普500ETF","SH":"标普500反向ETF"},"source_url":"http://www.straitstimes.com/business/companies-markets/wall-street-closes-rollercoaster-week-sharply-lower","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168716185","content_text":"NEW YORK (REUTERS) - US stocks ended sharply lower in a broad sell-off on Friday (Sept 17), ending a week buffeted by strong economic data, corporate tax hike worries, the Delta Covid-19 variant, and possible shifts in the US Federal Reserve's timeline for tapering asset purchases.\nAll three major US stock indexes lost ground, with the Nasdaq Composite Index's weighed down as rising US Treasury yields pressured market-leading growth stocks.\nThey also posted weekly losses, with the S&P index suffering its biggest two-week drop since February.\n\"The market is struggling with prospects for tighter fiscal policy due to tax increases, and tighter monetary policy due to Fed tapering,\" said David Carter, chief investment officer at Lenox Wealth Advisors in New York.\n\"Equity markets are also a little softer due to today's weak Consumer Sentiment data,\" Carter added. \"It's triggering concerns that the Delta variant could slow economic growth.\"\nA potential hike in corporate taxes could eat into earnings also weigh on markets, with leading Democrats seeking to raise the top tax rate on corporations to 26.5 per cent from the current 21 per cent.\nWhile consumer sentiment steadied this month it remains depressed, according to a University of Michigan report, as Americans postpone purchases while inflation remains high.\nInflation is likely to be a major issue next week, when the Federal Open Markets Committee holds its two-day monetary policy meeting. Market participants will be watching closely for changes in nuance which could signal a shift in the Fed's tapering timeline.\n\"It has been a week of mixed economic data and we are focused clearly on what will come out of the Fed meeting next week,\" said Bill Northey, senior investment director at US Bank Wealth Management in Helena, Montana.\nThe Dow Jones Industrial Average fell 166.44 points, or 0.48 per cent, to 34,584.88; the S&P 500 lost 40.76 points, or 0.91 per cent, at 4,432.99; and the Nasdaq Composite dropped 137.96 points, or 0.91 per cent, to 15,043.97.\nThe S&P 500 ended below its 50-day moving average, which in recent history has proven a rather sturdy support level.\nOf the 11 major sectors in the S&P 500, all but healthcare ended in the red, with materials and utilities suffering the biggest percentage drops.\nWall Street ends rollercoaster week sharply lower\nCovid-19 vaccine manufacturers Pfizer and Moderna dropped 1.3 per cent and 2.4 per cent, respectively, as US health officials moved the debate over booster doses to a panel of independent experts.\nUS Steel Corp shed 8 per cent after it unveiled a US$3 billion (S$4 billion) mini-mill investment plan.\nVolume and volatility spiked toward the end of the session due to \"triple witching,\" which is the quarterly, simultaneous expiration of stock options, stock index futures, and stock index options contracts.\nVolume on US exchanges was 15.51 billion shares, compared with the 9.70 billion average over the last 20 trading days.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.97-to-1 ratio; on Nasdaq, a 1.00-to-1 ratio favoured advancers.\nThe S&P 500 posted seven new 52-week highs and two new lows; the Nasdaq Composite recorded 67 new highs and 82 new lows.","news_type":1,"symbols_score_info":{"161125":0.9,"513500":0.9,".SPX":0.9,"ESmain":0.9,"IVV":0.9,"OEF":0.9,"OEX":0.9,"SDS":0.9,"SH":0.9,"SPXU":0.9,"SSO":0.9,"UPRO":0.9}},"isVote":1,"tweetType":1,"viewCount":294,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":864889684,"gmtCreate":1633088132874,"gmtModify":1633088214440,"author":{"id":"3584074223056401","authorId":"3584074223056401","name":"Jncy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584074223056401","authorIdStr":"3584074223056401"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/864889684","repostId":"1178374850","repostType":4,"repost":{"id":"1178374850","kind":"news","pubTimestamp":1633077146,"share":"https://ttm.financial/m/news/1178374850?lang=&edition=full","pubTime":"2021-10-01 16:32","market":"us","language":"en","title":"Here's the Newest Plant-Based Stock to Join the 'Eat More Plants' Boom","url":"https://stock-news.laohu8.com/highlight/detail?id=1178374850","media":"The Street","summary":"Eat Well Investment Group, also known as 'The Company', is a Canadian plant-protein company winning ","content":"<p>Eat Well Investment Group, also known as 'The Company', is a Canadian plant-protein company winning in the space. The latest news on the agri-tech company.</p>\n<p>Highlighted by the success of well-marketed plant-meat brands like Beyond Meat&nbsp;(<b>BYND</b>) -Get Beyond Meat, Inc. Report,&nbsp;Ingredion&nbsp;(<b>INGR</b>) -Get Ingredion Incorporated Report, Tyson Foods&nbsp;(<b>TSN</b>) -Get Tyson Foods, Inc. Class A Report, Oatly&nbsp;(<b>OAT,</b>)&nbsp;and Impossible Foods, the plant-based-food space has courted billions of dollars in inflows and likewise encouraged a host of entrants seeking to seize on the opportunity.</p>\n<p>Interestingly, one of the biggest winners in the space as of late is not one of those household names, but rather Vancouver-based Eat Well Investment Group&nbsp;(<b>EWGFF</b>) -Get EAT WELL INVESTMENT GROUP INC Report&nbsp;CA: EWG. Thursday, the OTC stock was at $.70 per share, up 1.7% just after the market open.</p>\n<p>“We have the total supply chain and the technology to know how to make incredible tasting and healthy food. That’s the overriding picture here,” Eat Well Chief Investment Officer Mark Coles said, helping to explain the contrasting stock trends.</p>\n<p>\"The Company\", wasfounded on the principleof “how do we feed our families while honoring time-valued health and wellness traditions.”</p>\n<p>Coles said, “Not only is it a superior product, less fat, fewer calories, etc., but it also comes with significantly more attractive margins than our competitors.”</p>\n<p>Promising Plant-Based Trends</p>\n<p>First and foremost, it is crucial to quantify the pace at which the opportunity in plant-based foods is progressing. Per Bloomberg Intelligence, the plant-based-foods market is expected toaccelerate to $162 billionin 2030&nbsp;from $29.4 billion at present.</p>\n<p><img src=\"https://static.tigerbbs.com/dd4274dfb92309681257d7893e3c1398\" tg-width=\"1200\" tg-height=\"729\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Source: Bloomberg Intelligence</p>\n<p>That pace puts the market on track to easily outpace growth in its protein peers, many of which are seeing demand plateau as consumer tastes shift, environmental concerns abound, and livestock epidemics hurt supply. By the end of the decade, vegetarian options will be near par with other proteins in terms of total market size, a position few could have anticipated even just a few years ago.</p>\n<p><i>Source: Eat Well Investment Group Inc.</i></p>\n<p>Crowded Competitive Landscape</p>\n<p>To be sure, the market opportunity available is no sign of assured success for individual companies. As with any major market gap, there is no shortage of firms seeking to deal with the growing demand.</p>\n<p>Thus far, longstanding meat-based protein players like JBS SA&nbsp;(<b>JBSAY</b>), Nestle&nbsp;(<b>NSRGY</b>) -Get NSRGY Report, and Tyson Foods&nbsp;(<b>TSN</b>) -Get Tyson Foods, Inc. Class A Report&nbsp;have attracted adulation from analysts and investors alike for shifting to accommodate plant-based products.</p>\n<p>Meanwhile, Beyond Meat and Impossible Foods have inked numerous high-profile partnerships, capitalizing on their marketability. In fact, Beyond Meat has even found itself on theshortlist of meme stocksthat traders have taken dearly to over the course of 2020 and 2021.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's the Newest Plant-Based Stock to Join the 'Eat More Plants' Boom</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's the Newest Plant-Based Stock to Join the 'Eat More Plants' Boom\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 16:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/eat-well-group-plant-based-opportunity><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Eat Well Investment Group, also known as 'The Company', is a Canadian plant-protein company winning in the space. The latest news on the agri-tech company.\nHighlighted by the success of well-marketed ...</p>\n\n<a href=\"https://www.thestreet.com/investing/eat-well-group-plant-based-opportunity\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OTLY":"Oatly Group AB","BYND":"Beyond Meat, Inc.","TSN":"泰森食品"},"source_url":"https://www.thestreet.com/investing/eat-well-group-plant-based-opportunity","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178374850","content_text":"Eat Well Investment Group, also known as 'The Company', is a Canadian plant-protein company winning in the space. The latest news on the agri-tech company.\nHighlighted by the success of well-marketed plant-meat brands like Beyond Meat (BYND) -Get Beyond Meat, Inc. Report, Ingredion (INGR) -Get Ingredion Incorporated Report, Tyson Foods (TSN) -Get Tyson Foods, Inc. Class A Report, Oatly (OAT,) and Impossible Foods, the plant-based-food space has courted billions of dollars in inflows and likewise encouraged a host of entrants seeking to seize on the opportunity.\nInterestingly, one of the biggest winners in the space as of late is not one of those household names, but rather Vancouver-based Eat Well Investment Group (EWGFF) -Get EAT WELL INVESTMENT GROUP INC Report CA: EWG. Thursday, the OTC stock was at $.70 per share, up 1.7% just after the market open.\n“We have the total supply chain and the technology to know how to make incredible tasting and healthy food. That’s the overriding picture here,” Eat Well Chief Investment Officer Mark Coles said, helping to explain the contrasting stock trends.\n\"The Company\", wasfounded on the principleof “how do we feed our families while honoring time-valued health and wellness traditions.”\nColes said, “Not only is it a superior product, less fat, fewer calories, etc., but it also comes with significantly more attractive margins than our competitors.”\nPromising Plant-Based Trends\nFirst and foremost, it is crucial to quantify the pace at which the opportunity in plant-based foods is progressing. Per Bloomberg Intelligence, the plant-based-foods market is expected toaccelerate to $162 billionin 2030 from $29.4 billion at present.\n\nSource: Bloomberg Intelligence\nThat pace puts the market on track to easily outpace growth in its protein peers, many of which are seeing demand plateau as consumer tastes shift, environmental concerns abound, and livestock epidemics hurt supply. By the end of the decade, vegetarian options will be near par with other proteins in terms of total market size, a position few could have anticipated even just a few years ago.\nSource: Eat Well Investment Group Inc.\nCrowded Competitive Landscape\nTo be sure, the market opportunity available is no sign of assured success for individual companies. As with any major market gap, there is no shortage of firms seeking to deal with the growing demand.\nThus far, longstanding meat-based protein players like JBS SA (JBSAY), Nestle (NSRGY) -Get NSRGY Report, and Tyson Foods (TSN) -Get Tyson Foods, Inc. Class A Report have attracted adulation from analysts and investors alike for shifting to accommodate plant-based products.\nMeanwhile, Beyond Meat and Impossible Foods have inked numerous high-profile partnerships, capitalizing on their marketability. In fact, Beyond Meat has even found itself on theshortlist of meme stocksthat traders have taken dearly to over the course of 2020 and 2021.","news_type":1,"symbols_score_info":{"BYND":0.9,"OTLY":0.9,"TSN":0.9}},"isVote":1,"tweetType":1,"viewCount":500,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}